data_5w72_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5w72 _Structure_validation_residue.Date_analyzed 2017-12-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 CA-C-O 120.798 0.249 . . . . 75.42 112.321 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.33 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.077 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.123 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 73.42 110.876 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 75.42 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.11 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.32 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.13 111.153 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.2 111.155 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.23 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.41 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 64.2 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.04 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.03 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.04 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.34 111.141 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 73.24 111.075 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.42 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.44 110.897 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.799 0.333 . . . . 73.42 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.12 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.32 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 61.22 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.21 111.082 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.33 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 75.14 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 72.53 110.905 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.11 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.925 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 73.13 111.12 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 65.14 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.882 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.4 111.163 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.8 p30 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.916 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 74.32 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 72.23 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 70.22 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.32 110.982 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.31 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.53 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.32 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.13 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.859 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 73.13 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.121 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 60.32 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 75.21 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.41 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 73.01 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.24 111.097 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.51 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.34 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.42 111.136 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.41 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 73.24 111.13 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 65.31 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.02 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.53 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 73.04 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.24 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 75.2 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.24 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.53 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 CA-C-O 120.813 0.255 . . . . 75.42 112.353 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 73.33 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.127 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 60.12 111.137 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.45 111.146 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.926 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.825 -179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.517 -0.233 . . . . 75.42 112.517 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.11 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 73.13 111.174 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.23 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 62.01 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.41 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 64.2 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.04 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.03 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.04 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.34 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 73.31 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.161 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.44 110.877 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.811 0.339 . . . . 73.42 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.12 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.32 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 61.22 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.21 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.814 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.33 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 75.14 110.908 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.53 110.876 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.13 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 72.22 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.11 110.868 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 73.13 111.168 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.14 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.14 110.805 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.4 111.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 74.32 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 72.23 111.142 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 70.22 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.32 110.898 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 75.31 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.32 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.13 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.3 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.21 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 71.25 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 60.32 111.097 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 75.21 110.96 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 73.01 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.24 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.51 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.34 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.41 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.129 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 74.53 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.31 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.02 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.53 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 74.13 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.24 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 75.2 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 75.24 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.34 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 75.42 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.33 111.093 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 60.12 111.196 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.45 111.131 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.826 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.88 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.497 -0.241 . . . . 75.42 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.11 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.118 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.23 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.41 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 64.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.03 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.04 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.34 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 73.31 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.096 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.44 110.878 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 73.42 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.12 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.32 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 61.22 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.25 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.21 110.856 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.33 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 75.14 110.884 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 72.53 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.11 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.04 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.08 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.14 110.894 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.4 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 74.32 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 72.23 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 70.22 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.906 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.32 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.13 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.3 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 73.13 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 74.13 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 60.32 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 73.01 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.24 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.51 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.34 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.085 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.155 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 74.53 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 65.31 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.02 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.53 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 75.2 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.78 0.241 . . . . 75.42 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.33 111.121 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 60.12 111.179 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.179 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.85 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.851 -179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.486 -0.246 . . . . 75.42 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.11 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.099 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.2 111.128 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.23 112.522 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 62.01 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.41 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 64.2 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.04 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.03 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.04 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.34 111.134 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 73.31 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.844 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.44 110.858 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.888 0.375 . . . . 73.42 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.12 111.105 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.32 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 61.22 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.21 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 75.2 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.923 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.33 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 75.14 110.908 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 72.53 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 72.22 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.11 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 74.04 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.15 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 65.14 110.902 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.4 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.01 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 74.32 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 72.23 111.152 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.53 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.32 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.3 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.25 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 60.32 111.086 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 73.01 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.24 111.113 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.51 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.34 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.42 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 71.41 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.151 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 65.31 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.02 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.53 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.2 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.53 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.15 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.34 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.712 0.213 . . . . 75.42 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.878 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.33 111.159 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 60.12 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.45 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.912 -179.91 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.46 -0.256 . . . . 75.42 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.32 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.162 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.23 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 62.01 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.41 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 64.2 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.04 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.03 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.04 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.34 111.121 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.106 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.42 110.907 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.44 110.872 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.733 0.301 . . . . 73.42 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.12 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 61.22 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.083 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 74.25 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 75.2 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.33 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 75.14 110.928 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.53 110.882 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.11 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.13 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 65.14 110.908 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.835 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.4 111.087 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.01 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 74.32 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 72.23 111.173 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 70.22 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.873 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.32 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.13 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.3 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.21 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.25 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 74.13 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 60.32 111.074 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 75.21 110.922 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.41 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.01 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.51 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.34 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.42 111.15 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.1 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 73.24 111.077 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 65.31 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.02 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.53 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 73.04 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 75.2 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 75.24 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.53 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.34 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.781 0.242 . . . . 75.42 112.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.936 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.33 111.05 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 60.12 111.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.198 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.12 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 73.42 110.81 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.428 -0.269 . . . . 75.42 112.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.11 110.856 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.13 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.2 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.23 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 62.01 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.41 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 64.2 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.04 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.03 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.34 111.226 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.44 110.922 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.869 0.366 . . . . 73.42 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.12 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.32 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 61.22 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.101 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 74.25 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 74.21 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.33 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 75.14 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.53 110.905 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 75.13 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 72.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.11 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.13 111.109 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 65.14 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.4 111.144 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.01 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 74.32 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 72.23 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 70.22 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.916 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.53 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.32 111.094 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.13 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 73.13 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 71.25 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 74.31 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 75.21 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.24 111.111 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.51 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.34 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.42 111.138 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 71.41 111.12 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 73.24 111.154 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 74.53 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.02 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.53 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.2 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.53 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.15 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.34 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.738 0.224 . . . . 75.42 112.397 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.858 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.154 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 60.12 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.196 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.843 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.515 -0.234 . . . . 75.42 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.11 110.915 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.32 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 73.13 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.2 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.23 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 62.01 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.41 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.2 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.04 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.03 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.04 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.34 111.109 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 73.31 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 73.24 111.162 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.44 110.884 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 73.42 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.12 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.32 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 61.22 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.25 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.2 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.33 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 75.14 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 72.53 110.944 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 72.22 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.11 110.883 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.165 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 65.14 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.14 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.4 111.13 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.01 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 74.32 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 72.23 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.837 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.32 110.879 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.32 111.124 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.13 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.3 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 71.25 111.135 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.13 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.904 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.41 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 73.01 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.135 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.51 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.34 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.42 111.067 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.142 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.24 111.175 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.097 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 65.31 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.02 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.53 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 74.13 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 73.04 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.24 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 75.2 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 74.15 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.774 0.239 . . . . 75.42 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.895 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 60.12 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.45 111.131 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 75.12 110.859 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 73.42 110.915 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.435 -0.266 . . . . 75.42 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.11 110.882 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.121 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.2 111.15 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.23 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 62.01 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.41 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.2 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.04 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.03 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.04 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.34 111.114 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 73.31 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.09 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.44 110.949 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.805 0.336 . . . . 73.42 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.12 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.32 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 61.22 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.087 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.25 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 75.2 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.33 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 75.14 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 72.53 110.96 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 75.13 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.11 110.84 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 74.04 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 65.14 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.14 110.877 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.4 111.146 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 12.1 p30 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.888 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 74.32 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.23 111.067 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.874 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.32 111.001 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 75.31 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.53 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.19 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.13 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.3 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 73.13 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 71.25 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.096 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 74.13 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 75.21 110.909 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.24 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.51 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.34 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.066 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 71.41 111.101 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 73.24 111.118 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 65.31 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.02 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.53 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 73.04 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.24 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.53 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.466 -0.128 0 CA-C-O 120.738 0.224 . . . . 75.42 112.373 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.33 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 60.12 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.45 111.147 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.883 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.503 -0.239 . . . . 75.42 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.11 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.32 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 73.13 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.2 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.23 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 62.01 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.41 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.03 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.04 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.34 111.155 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 73.24 111.136 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.42 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.44 110.841 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.882 0.373 . . . . 73.42 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.32 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 61.22 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.21 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.25 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.2 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.33 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 75.14 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 72.53 110.946 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 72.22 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.11 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.082 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.14 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.876 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.4 111.126 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 17.0 p30 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.881 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 74.32 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 72.23 111.143 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.32 110.888 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.53 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.32 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.13 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.3 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 73.13 110.94 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.101 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 74.31 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.12 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 60.32 111.042 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.51 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.34 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.173 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 71.41 111.182 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.24 111.05 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 74.53 111.103 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 65.31 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.02 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.53 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 73.04 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 75.2 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.53 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.34 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.825 0.26 . . . . 75.42 112.348 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.33 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.12 111.177 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.45 111.075 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 75.12 110.905 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.896 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.496 -0.242 . . . . 75.42 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.11 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.32 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.13 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.2 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.23 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 62.01 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.41 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 64.2 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.04 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.03 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.34 111.113 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 73.24 111.171 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.44 110.863 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.828 0.347 . . . . 73.42 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.12 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.32 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.21 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 75.2 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.33 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 75.14 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 72.53 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.13 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 72.22 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.11 110.86 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.927 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.806 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.4 111.151 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.01 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 72.23 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 70.22 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.32 110.959 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.31 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.32 111.049 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.13 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 74.31 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 60.32 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.899 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.01 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.081 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.51 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.34 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.081 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 71.41 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 73.24 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.084 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.31 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.02 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.53 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 74.15 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.742 0.226 . . . . 75.42 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.883 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.33 111.146 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 60.12 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.45 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.902 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.439 -0.264 . . . . 75.42 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.11 110.898 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.32 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 73.13 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.2 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 62.01 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.41 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 64.2 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.04 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.03 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.04 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.34 111.189 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.31 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.092 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.42 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.44 110.906 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 73.42 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.12 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.32 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 61.22 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.111 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 74.25 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.33 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 75.14 110.903 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.53 110.949 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 75.13 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 72.22 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.11 110.915 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 74.04 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 73.13 111.169 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 65.14 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.14 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.4 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 17.1 p30 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.01 110.925 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 74.32 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 72.23 111.154 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 70.22 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.923 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 75.31 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.153 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.13 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.953 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 71.25 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.31 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 60.32 111.027 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 75.21 110.935 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.41 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.24 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.51 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.34 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.42 111.12 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 71.41 111.148 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.24 111.143 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.53 111.032 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 65.31 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.02 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.53 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 74.13 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.04 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.24 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 75.2 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.24 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.863 0.276 . . . . 75.42 112.363 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.33 111.091 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 60.12 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 73.42 110.943 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 75.42 112.474 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.11 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 73.13 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.2 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.23 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 62.01 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.41 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 64.2 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.04 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.03 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.04 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.34 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 73.24 111.155 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.44 110.911 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.908 0.385 . . . . 73.42 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.12 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.32 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.33 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 75.14 110.857 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.888 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.11 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 74.04 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.113 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 65.14 110.926 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.4 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 74.32 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 72.23 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.22 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.32 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.53 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.32 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.13 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.3 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 71.25 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.31 111.086 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 74.13 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 60.32 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 75.21 110.926 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.01 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.51 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.34 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.42 111.136 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 73.24 111.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 74.53 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 65.31 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.02 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.53 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.13 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 75.2 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.53 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.15 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.34 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 CA-C-O 120.783 0.243 . . . . 75.42 112.312 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.115 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 60.12 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.45 111.138 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 75.12 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.863 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.406 -0.278 . . . . 75.42 112.406 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.11 110.864 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.32 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.2 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.23 112.507 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 62.01 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.41 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.2 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.04 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.03 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.04 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.34 111.178 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.24 111.139 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.44 110.867 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.8 0.333 . . . . 73.42 110.952 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.32 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 61.22 112.461 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.21 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 75.2 110.89 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.33 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 75.14 110.968 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.877 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.11 110.83 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.954 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.126 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 65.14 110.885 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.14 110.845 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.4 111.144 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.01 110.911 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 74.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 72.23 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 70.22 110.856 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.897 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.53 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.32 111.105 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.13 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.919 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 71.25 111.131 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.13 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 60.32 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.863 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.24 111.114 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.51 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.34 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.096 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 73.24 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.53 111.064 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.02 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.53 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.04 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.24 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 75.2 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 75.24 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.53 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.15 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.707 0.211 . . . . 75.42 112.414 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.103 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 60.12 111.113 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.45 111.144 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.841 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.825 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.486 -0.246 . . . . 75.42 112.486 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.11 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.13 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.2 111.143 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.23 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 62.01 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.41 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 64.2 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.04 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.03 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.04 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.34 111.11 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.137 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.44 110.906 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.746 0.308 . . . . 73.42 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.12 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.32 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 61.22 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.33 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 75.14 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 72.53 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.11 110.833 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.152 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 65.14 110.951 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.4 111.182 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.01 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 74.32 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 72.23 111.148 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 70.22 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.966 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.32 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.13 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.3 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 73.13 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 71.25 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 74.13 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 60.32 111.115 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.956 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.51 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.34 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.42 111.16 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 71.41 111.165 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.118 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.53 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.02 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.53 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.13 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 75.24 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.844 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.15 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.34 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.756 0.232 . . . . 75.42 112.275 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.877 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.33 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 60.12 111.158 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.45 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 75.12 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.913 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.516 -0.234 . . . . 75.42 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.11 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.32 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 73.13 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.2 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.23 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 62.01 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.41 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 64.2 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.04 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.03 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.04 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.34 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 73.24 111.087 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.44 110.911 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.76 0.314 . . . . 73.42 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.32 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 61.22 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.102 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.33 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 75.14 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 75.13 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.11 110.862 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.13 111.114 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.14 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.4 111.181 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.01 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 74.32 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 72.23 111.1 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.32 110.922 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 75.31 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.32 111.149 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.21 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.879 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 71.25 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 74.31 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 74.13 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 60.32 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.21 110.897 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 73.01 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.51 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.34 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.42 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 71.41 111.094 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.161 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 65.31 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.02 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.53 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 73.04 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 75.24 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.53 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.15 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.746 0.228 . . . . 75.42 112.42 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.33 111.095 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 60.12 111.157 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.45 111.126 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.903 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.781 -179.845 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.491 -0.243 . . . . 75.42 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.11 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.13 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.2 111.075 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.23 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 62.01 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.41 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 64.2 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.04 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.03 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.04 112.516 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.34 111.107 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.892 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.146 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.42 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.44 110.909 -179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 73.42 110.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.12 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.32 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 61.22 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 75.2 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.33 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 75.14 110.879 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 72.53 110.924 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 75.13 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 72.22 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.11 110.785 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.13 111.109 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 65.14 110.975 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.4 111.151 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.01 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 72.23 111.133 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 70.22 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.879 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.31 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.32 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.13 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.3 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.21 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 71.25 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.31 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 74.13 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 60.32 111.166 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.836 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 73.01 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.24 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.51 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.34 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.42 111.17 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 71.41 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 73.24 111.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.089 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.02 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.53 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.24 110.892 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 75.24 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.779 0.241 . . . . 75.42 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.84 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 60.12 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.45 111.11 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 75.12 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.92 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.495 -0.242 . . . . 75.42 112.495 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.11 110.902 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.32 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.219 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.129 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.23 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 62.01 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.41 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 64.2 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.04 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.03 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.04 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.34 111.114 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 73.31 110.889 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.13 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.44 110.897 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.835 0.35 . . . . 73.42 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.12 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.32 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 61.22 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.069 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.33 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 75.14 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 72.53 110.87 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.12 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 72.22 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.11 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.04 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.13 111.164 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.4 111.151 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 74.32 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 72.23 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.898 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.32 111.135 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.13 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 73.13 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 71.25 111.073 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.31 111.122 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 60.32 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.899 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.41 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.24 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.51 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.34 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.42 111.125 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.101 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.109 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.086 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 65.31 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.02 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.53 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.24 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 75.2 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.887 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.794 0.248 . . . . 75.42 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.33 111.152 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 60.12 111.147 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.144 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.42 110.855 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.464 -0.255 . . . . 75.42 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.11 110.831 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.32 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.135 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.2 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.23 112.457 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 62.01 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.41 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.04 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.03 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.04 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.34 111.159 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.24 111.106 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.44 110.892 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.859 0.361 . . . . 73.42 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.12 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 61.22 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.2 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.33 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 75.14 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.914 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.12 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 72.22 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.11 110.855 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.04 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.145 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 65.14 110.919 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.14 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.4 111.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 74.32 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 72.23 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.32 110.847 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 75.31 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.53 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.32 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.13 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.3 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.25 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 74.31 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 74.13 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.41 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 73.01 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.51 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.34 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.42 111.115 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 71.41 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 73.24 111.152 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 74.53 111.139 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 65.31 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.02 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.53 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.24 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 75.2 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.53 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.34 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.845 0.269 . . . . 75.42 112.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.33 110.851 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.166 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 60.12 111.156 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.068 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.868 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.915 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.453 -0.259 . . . . 75.42 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.11 110.934 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.2 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 62.01 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.41 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 64.2 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.04 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.03 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.04 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.34 111.153 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.116 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.44 110.914 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.785 0.326 . . . . 73.42 110.888 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.12 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.32 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 61.22 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.21 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.2 110.909 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.859 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.33 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 75.14 110.916 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 72.22 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.11 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 74.04 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.13 111.07 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 65.14 110.98 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.4 111.061 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.01 110.919 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 74.32 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 72.23 111.103 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 70.22 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.901 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.31 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.32 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.13 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.25 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.31 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 74.13 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 60.32 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 75.21 110.906 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.41 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 73.01 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.137 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.51 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.34 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.149 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 71.41 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 73.24 111.148 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.53 111.086 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.02 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.53 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 75.2 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 75.24 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.735 0.223 . . . . 75.42 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.102 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 60.12 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.45 111.105 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 75.12 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.891 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.457 -0.257 . . . . 75.42 112.457 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.11 110.922 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 73.13 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.2 111.095 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.23 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 62.01 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.41 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 64.2 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.04 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.03 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.04 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.34 111.154 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 73.24 111.161 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.42 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.44 110.934 -179.913 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 46.2 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.785 0.326 . . . . 73.42 110.932 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.12 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.32 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 61.22 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.21 111.11 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.33 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 75.14 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 72.53 110.894 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 72.22 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.11 110.901 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 73.13 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.14 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.4 111.151 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.01 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 74.32 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 72.23 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.913 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.31 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.32 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.13 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.3 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 71.25 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.32 111.097 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.907 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.01 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.24 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.51 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.34 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.42 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.41 111.147 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.076 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 74.53 111.139 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 65.31 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.02 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.53 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 73.04 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.24 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 75.24 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.53 110.873 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 74.15 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.34 111.083 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.917 0.389 . . . . 74.15 110.864 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.46 -64.88 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.25 110.882 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.94 -168.81 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 64.03 112.498 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -102.02 120.89 41.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 74.34 110.878 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -153.2 -176.9 5.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.14 110.899 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.93 -171.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 65.03 110.853 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 23.7 mt 64.27 77.12 0.31 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 74.43 111.116 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.19 18.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 72.42 112.307 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -54.4 101.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 74.33 110.895 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.08 160.06 71.86 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.01 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 145.38 56.85 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 75.42 112.321 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.33 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 60.12 111.077 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.123 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -41.99 120.09 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 73.42 110.876 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.46 -27.06 16.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.24 112.511 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.1 m -51.24 -34.75 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 74.13 110.829 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -108.99 26.99 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 71.35 111.19 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.43 54.74 2.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 70.21 112.501 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 1.4 tp -93.63 -25.67 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 73.41 110.925 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.02 -37.25 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 75.42 112.452 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.11 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.32 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.13 111.153 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.2 111.155 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.23 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 62.01 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.41 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 64.2 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.04 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.03 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.04 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.34 111.141 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 73.31 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 73.24 111.075 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.42 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.92 155.76 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.44 110.897 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt -103.02 120.36 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 124.36 3.254 . . . . 73.42 110.925 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.12 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.32 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 61.22 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.21 111.082 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 75.2 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.33 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 75.14 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 72.53 110.905 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.12 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 75.13 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.11 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 74.04 110.925 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 73.13 111.12 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 65.14 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.882 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.4 111.163 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.8 p30 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.916 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 74.32 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 72.23 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 70.22 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.32 110.982 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.31 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.53 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.32 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.13 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.859 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 73.13 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.121 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 60.32 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 75.21 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.41 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 73.01 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.24 111.097 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.51 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.34 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.42 111.136 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.41 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 73.24 111.13 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.1 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 65.31 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.02 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.53 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.13 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 73.04 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.24 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 75.2 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.24 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.53 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 74.15 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.34 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.877 0.37 . . . . 74.15 110.833 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.23 150.26 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.971 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -81.07 90.28 1.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.708 -0.758 . . . . 64.03 112.518 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -96.03 -49.22 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 74.34 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -52.43 -52.05 55.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.853 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -172.22 168.43 5.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 65.03 110.859 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.28 69.44 14.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.634 0.73 . . . . 74.43 111.114 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.725 2.283 . . . . 72.42 112.321 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.07 36.73 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.941 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -87.1 160.47 49.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 74.01 110.912 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 129.64 17.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 2.251 . . . . 75.42 112.353 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 73.33 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.33 111.127 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 60.12 111.137 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.45 111.146 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 75.12 110.926 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -45.24 140.74 2.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 73.42 110.825 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -132.01 35.15 2.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 74.24 112.458 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 6.5 p -67.53 -35.82 79.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.403 . . . . 74.13 110.846 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.7 m -124.97 27.0 6.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 71.35 111.205 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -176.72 105.94 0.21 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.721 -0.752 . . . . 70.21 112.461 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.4 -46.74 7.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 73.41 110.862 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 78.55 27.71 56.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 75.42 112.517 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.11 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 73.13 111.174 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.2 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.23 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 62.01 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.41 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 64.2 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.04 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.03 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.04 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.34 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 73.31 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 73.24 111.161 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.42 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -162.45 141.92 9.38 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.44 110.877 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt -89.28 131.76 35.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 124.415 3.28 . . . . 73.42 110.936 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.12 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.32 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 61.22 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.21 111.104 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.814 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.33 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 75.14 110.908 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.53 110.876 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.12 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.13 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 72.22 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.11 110.868 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 73.13 111.168 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 65.14 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.14 110.805 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.4 111.217 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 74.32 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 72.23 111.142 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 70.22 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.32 110.898 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 75.31 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.32 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.13 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.3 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.21 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 71.25 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 74.31 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 74.13 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 60.32 111.097 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 75.21 110.96 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 73.01 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.24 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.51 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.34 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 71.41 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.129 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 74.53 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 65.31 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.02 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.53 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 74.13 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.24 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 75.2 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 75.24 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 74.15 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.34 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 74.15 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.23 156.59 34.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 74.25 110.876 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -162.28 -176.43 34.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.749 . . . . 64.03 112.467 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -147.03 171.64 14.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.304 . . . . 74.34 110.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -175.71 147.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.14 110.835 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -58.87 -178.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 65.03 110.853 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 4.0 tp -177.72 82.08 0.24 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.626 0.727 . . . . 74.43 111.08 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 175.43 8.11 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.739 2.293 . . . . 72.42 112.407 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -169.94 158.91 7.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 74.33 110.874 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.06 160.74 59.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 74.01 110.911 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 119.7 6.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.673 2.249 . . . . 75.42 112.323 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.33 111.093 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 60.12 111.196 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.45 111.131 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.826 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -48.06 121.55 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -129.24 55.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 74.24 112.448 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.7 p -90.71 11.12 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 74.13 110.901 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.3 m -110.3 27.02 10.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 71.35 111.159 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.35 106.0 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 70.21 112.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.72 -33.12 72.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 73.41 110.87 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.47 50.63 2.52 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 75.42 112.497 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.11 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.118 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.23 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 62.01 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.41 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 64.2 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.03 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.04 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.34 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 73.31 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 73.24 111.096 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -148.39 167.57 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.44 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.0 139.63 58.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 124.363 3.256 . . . . 73.42 110.893 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.12 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.32 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 61.22 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.21 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 74.25 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.21 110.856 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.33 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 75.14 110.884 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 72.53 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 75.13 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 72.22 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.11 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.04 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 73.13 111.08 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.14 110.894 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.4 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.01 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 74.32 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 72.23 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 70.22 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.906 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.53 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.32 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.13 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.3 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 73.13 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 74.31 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 74.13 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 60.32 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 75.21 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 73.01 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.24 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.51 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.34 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.42 111.085 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 71.41 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 73.24 111.155 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 74.53 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 65.31 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.02 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.53 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 74.13 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 73.04 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.24 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 75.2 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 74.15 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 5.7 t80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.826 0.346 . . . . 74.15 110.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.6 mt -129.22 177.65 7.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.936 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -106.17 -174.29 23.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.75 . . . . 64.03 112.434 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -108.64 -69.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 74.34 110.92 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -175.18 108.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 74.14 110.886 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.42 131.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 65.03 110.839 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 4.8 pt -124.72 67.65 51.04 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.613 0.721 . . . . 74.43 111.115 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.95 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.743 2.295 . . . . 72.42 112.337 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -89.06 -41.74 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 74.33 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.93 160.85 1.99 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.581 0.705 . . . . 74.01 110.935 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 126.69 13.64 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 75.42 112.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.33 111.121 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 60.12 111.179 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.179 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.85 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -42.51 137.7 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.851 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -70.93 81.65 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 74.24 112.453 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.02 -33.86 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 74.13 110.881 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 8.9 t -126.19 27.21 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 71.35 111.093 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.65 -27.87 13.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 70.21 112.431 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 9.4 tp -52.7 -24.05 7.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 73.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -46.38 -36.1 7.43 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 75.42 112.486 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.11 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.32 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.099 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.2 111.128 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.23 112.522 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 62.01 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.41 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 64.2 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.04 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.03 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.04 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.34 111.134 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 73.31 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.112 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.844 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.9 167.63 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.44 110.858 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.43 147.58 30.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 124.399 3.272 . . . . 73.42 110.91 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.12 111.105 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.32 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 61.22 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.21 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.25 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 75.2 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.21 110.923 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.33 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 75.14 110.908 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 72.53 110.906 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 72.22 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.11 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 74.04 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 73.13 111.15 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 65.14 110.902 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.4 111.112 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.01 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 74.32 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 72.23 111.152 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.32 110.883 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.53 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.32 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.3 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 71.25 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.31 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 74.13 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 60.32 111.086 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 75.21 110.968 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 73.01 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.24 111.113 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.51 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.34 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.42 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 71.41 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.24 111.151 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 74.53 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 65.31 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.02 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.53 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.2 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.53 110.855 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 74.15 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.34 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 74.15 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.01 -59.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 74.25 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -59.68 133.51 51.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 64.03 112.514 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.94 -46.58 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 74.34 110.931 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -89.23 57.27 3.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 74.14 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -122.65 -35.47 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 65.03 110.857 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.3 pp -121.4 158.96 52.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.43 111.164 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -31.26 21.03 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.683 2.255 . . . . 72.42 112.324 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -89.86 74.45 7.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 74.33 110.87 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.33 121.41 84.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 74.01 110.871 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 158.59 56.45 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.701 2.267 . . . . 75.42 112.396 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.878 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.33 111.159 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 60.12 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.45 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -46.74 124.32 5.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -137.55 130.4 5.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 74.24 112.472 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.4 t -93.14 -39.98 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 74.13 110.825 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.5 p -132.02 17.4 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 71.35 111.207 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 47.54 36.64 12.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 70.21 112.439 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.1 mt -50.88 -30.72 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 73.41 110.896 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.05 -29.83 15.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 75.42 112.46 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.32 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 73.13 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.162 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.23 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 62.01 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.41 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 64.2 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.04 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.03 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.04 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.34 111.121 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.106 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.42 110.907 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -162.26 167.52 23.81 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.44 110.872 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.08 132.66 52.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 124.396 3.271 . . . . 73.42 110.981 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.12 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.32 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 61.22 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.21 111.083 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 74.25 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 75.2 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.33 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 75.14 110.928 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 72.53 110.882 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 72.22 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.11 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 73.13 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 65.14 110.908 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.14 110.835 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.4 111.087 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.01 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 74.32 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 72.23 111.173 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 70.22 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.873 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 75.31 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.32 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.13 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.3 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.21 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.25 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 74.31 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 74.13 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 60.32 111.074 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 75.21 110.922 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.41 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 73.01 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.51 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.34 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.42 111.15 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 71.41 111.1 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 73.24 111.077 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 65.31 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.02 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.53 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 73.04 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.24 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 75.2 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 75.24 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.53 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 74.15 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.34 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 6.1 t80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.373 . . . . 74.15 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 12.1 mt -133.95 93.39 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 74.25 110.908 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.2 178.3 45.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 64.03 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 60.72 56.46 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 74.34 110.877 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 37.64 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.942 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -113.31 -75.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 65.03 110.869 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 26.7 mm -139.16 67.5 40.01 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 74.43 111.183 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 2.259 . . . . 72.42 112.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 32.5 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.33 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -87.43 160.28 48.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.649 0.738 . . . . 74.01 110.921 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 121.28 7.99 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.303 . . . . 75.42 112.362 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.936 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.33 111.05 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 60.12 111.174 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.45 111.198 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 75.12 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -44.97 118.85 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 73.42 110.81 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.35 33.29 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 74.24 112.484 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.0 t -62.15 -36.25 81.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 74.13 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 18.1 p -101.98 26.99 6.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 71.35 111.069 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.51 101.34 0.16 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.745 -0.74 . . . . 70.21 112.493 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.59 -47.46 6.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 73.41 110.909 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 74.16 33.37 57.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 75.42 112.428 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.11 110.856 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.32 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.13 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.2 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.23 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 62.01 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.41 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 64.2 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.04 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.03 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.34 111.226 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.121 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.42 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -151.32 167.23 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.44 110.922 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.67 139.94 30.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 124.308 3.231 . . . . 73.42 110.918 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.12 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.32 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 61.22 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.21 111.101 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 74.25 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 74.21 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.33 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 75.14 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.53 110.905 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 75.13 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 72.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.11 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 73.13 111.109 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 65.14 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.4 111.144 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.01 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 74.32 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 72.23 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 70.22 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.32 110.916 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.53 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.32 111.094 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.13 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.21 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 73.13 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 71.25 111.12 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 74.31 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.13 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 75.21 110.948 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.24 111.111 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.51 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.34 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.42 111.138 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 71.41 111.12 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 73.24 111.154 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 74.53 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 65.31 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.02 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.53 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 73.04 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 75.2 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 75.24 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.53 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 74.15 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.34 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.82 0.343 . . . . 74.15 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 tp -165.0 159.36 17.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.889 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -139.76 -174.52 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.818 -0.706 . . . . 64.03 112.508 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.86 155.76 7.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 74.34 110.913 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -175.52 156.18 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.866 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.38 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 65.03 110.911 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.22 67.86 36.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 74.43 111.143 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -33.15 17.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.699 2.266 . . . . 72.42 112.257 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 54.11 34.01 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 74.33 110.83 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.29 160.18 49.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 74.01 110.86 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 119.47 6.41 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.726 2.284 . . . . 75.42 112.397 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.858 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.154 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 60.12 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.45 111.196 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -46.69 126.02 7.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.843 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -126.73 35.23 2.95 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.799 -0.715 . . . . 74.24 112.543 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.5 p -74.62 -39.72 61.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.391 . . . . 74.13 110.779 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -117.9 27.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 71.35 111.107 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.34 103.49 0.18 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 70.21 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.54 -46.51 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 73.41 110.921 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.49 55.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 75.42 112.515 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.11 110.915 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.32 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 73.13 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.2 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.23 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 62.01 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.41 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 64.2 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.04 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.03 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.04 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.34 111.109 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 73.31 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 73.24 111.162 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.42 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -159.87 129.89 5.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.44 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt -93.65 115.68 28.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 124.324 3.238 . . . . 73.42 110.924 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.12 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.32 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 61.22 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.21 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 74.25 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.2 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.21 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.33 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 75.14 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 72.53 110.944 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 72.22 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.11 110.883 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 74.04 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.165 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 65.14 110.882 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.14 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.4 111.13 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.01 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 74.32 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 72.23 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.837 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.32 110.879 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.31 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.32 111.124 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.13 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.3 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.21 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 73.13 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 71.25 111.135 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.31 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.13 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 60.32 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.904 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.41 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 73.01 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.135 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.51 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.34 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.42 111.067 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.142 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 73.24 111.175 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.53 111.097 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 65.31 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.02 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.53 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 74.13 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 73.04 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.24 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 75.2 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.53 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 74.15 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.896 0.379 . . . . 74.15 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 15.4 mt -123.6 -74.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 74.25 110.932 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.34 41.54 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.759 -0.734 . . . . 64.03 112.527 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -168.91 166.43 11.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 74.34 110.883 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -127.09 68.13 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.909 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.35 -177.11 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 65.03 110.855 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.93 63.73 4.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 74.43 111.118 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -49.76 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 72.42 112.31 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -179.15 167.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.856 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.59 138.47 31.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.691 0.758 . . . . 74.01 110.847 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 147.11 61.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 75.42 112.322 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.895 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.33 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 60.12 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.45 111.131 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 75.12 110.859 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -47.91 128.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 73.42 110.915 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -107.89 105.29 2.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.783 -0.722 . . . . 74.24 112.487 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 93.6 p -94.94 -40.1 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 74.13 110.841 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 21.0 p -131.97 5.51 4.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 71.35 111.16 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.57 50.51 36.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 70.21 112.433 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.43 -34.08 25.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 73.41 110.931 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.76 -31.54 23.69 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 75.42 112.435 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.11 110.882 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 73.13 111.121 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.2 111.15 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.23 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 62.01 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.41 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 64.2 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.04 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.03 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.04 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.34 111.114 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 73.31 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 73.24 111.09 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.42 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -154.47 153.99 32.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.44 110.949 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 124.343 3.247 . . . . 73.42 110.908 169.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.12 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.32 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 61.22 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.087 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 74.25 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 75.2 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.33 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 75.14 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 72.53 110.96 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.12 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 75.13 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.11 110.84 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 74.04 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 65.14 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.14 110.877 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.4 111.146 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 12.1 p30 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.01 110.888 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 74.32 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 72.23 111.067 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 70.22 110.874 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.32 111.001 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 75.31 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.53 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.32 111.19 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.13 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.3 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.21 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 73.13 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 71.25 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.096 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 74.13 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 75.21 110.909 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.24 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.51 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.34 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.066 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 71.41 111.101 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 73.24 111.118 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 74.53 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 65.31 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.02 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.53 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 73.04 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.24 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.53 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 74.15 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.866 0.365 . . . . 74.15 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.32 78.07 1.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.958 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -101.75 -33.21 4.8 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 64.03 112.543 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.96 155.51 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 74.34 110.912 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.05 -57.2 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.14 110.869 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 307' ' ' ILE . 3.1 p-10 -96.78 -176.07 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 65.03 110.917 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 306' ' ' ASP . 11.5 pt 35.58 74.12 0.59 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.604 0.716 . . . . 74.43 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 78.61 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 72.42 112.382 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.32 35.63 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -55.64 160.59 3.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 74.01 110.918 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 148.33 65.0 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 75.42 112.373 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.842 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.33 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 60.12 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.45 111.147 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -47.51 119.88 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 73.42 110.883 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -131.98 51.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 74.24 112.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 78.8 p -53.96 -39.9 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 74.13 110.819 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.9 p -130.28 26.97 5.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 71.35 111.091 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -138.47 41.59 1.35 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 70.21 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.88 -46.94 71.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 73.41 110.884 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 75.82 28.73 60.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 75.42 112.503 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.11 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.32 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 73.13 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.2 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.23 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 62.01 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.41 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.04 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.03 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.04 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.34 111.155 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 73.24 111.136 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.42 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.66 167.59 21.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.44 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.54 114.81 5.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 124.407 3.276 . . . . 73.42 110.892 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.12 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.32 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 61.22 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.21 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.25 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.2 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.33 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 75.14 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 72.53 110.946 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.12 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 72.22 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.11 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 73.13 111.082 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.14 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.876 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.4 111.126 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 17.0 p30 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.881 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 74.32 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 72.23 111.143 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.32 110.888 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.53 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.32 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.13 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.3 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 73.13 110.94 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.101 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 74.31 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 74.13 111.12 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 60.32 111.042 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 75.21 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.41 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.01 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.51 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.34 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.173 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 71.41 111.182 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 73.24 111.05 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 74.53 111.103 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 65.31 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.02 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.53 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 73.04 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.24 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 75.2 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.53 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.15 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.34 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 74.15 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.81 133.31 44.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.892 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -159.54 142.73 8.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 64.03 112.528 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -151.73 172.31 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.342 . . . . 74.34 110.873 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -101.82 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.898 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.28 174.37 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 65.03 110.879 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 4.1 tp -126.79 80.87 70.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 74.43 111.089 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.85 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 72.42 112.288 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -61.9 95.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.935 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -86.92 137.33 33.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 74.01 110.899 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 158.59 56.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.662 2.241 . . . . 75.42 112.348 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 73.33 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.33 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 60.12 111.177 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.45 111.075 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 75.12 110.905 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.59 119.02 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 73.42 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -113.18 40.17 2.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 74.24 112.553 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.2 p -90.87 -38.4 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 74.13 110.83 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.2 m -113.44 27.01 9.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 71.35 111.103 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.37 106.83 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 70.21 112.49 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.0 mt -93.02 -47.11 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.41 110.905 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.88 26.12 63.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 75.42 112.496 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.11 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.32 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 73.13 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.2 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.23 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 62.01 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.41 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 64.2 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.04 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.03 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.34 111.113 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 73.24 111.171 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.42 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -160.86 167.56 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.44 110.863 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.47 131.4 46.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 124.38 3.263 . . . . 73.42 110.925 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.12 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.32 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 61.22 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.21 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 75.2 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.33 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 75.14 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 72.53 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.12 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 75.13 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 72.22 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.11 110.86 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 73.13 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.927 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.14 110.806 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.4 111.151 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.01 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 74.32 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 72.23 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 70.22 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.32 110.959 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 75.31 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.32 111.049 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.13 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 73.13 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 71.25 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 74.31 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 74.13 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 60.32 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.899 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.41 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 73.01 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.081 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.51 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.34 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.42 111.081 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 71.41 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 73.24 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.084 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.31 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.02 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.53 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 73.04 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.24 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 75.2 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 74.15 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.34 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 29.8 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.881 0.372 . . . . 74.15 110.895 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -130.27 122.97 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 74.25 110.875 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -130.17 -59.68 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.71 -0.757 . . . . 64.03 112.487 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.98 -176.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.334 . . . . 74.34 110.912 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -132.95 144.7 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.918 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 64.14 50.9 2.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.03 110.89 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -161.98 67.31 2.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.603 0.716 . . . . 74.43 111.142 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 111.73 2.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.649 2.233 . . . . 72.42 112.331 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.22 55.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.903 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -80.29 134.93 54.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.742 . . . . 74.01 110.874 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 75.42 112.378 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.883 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.33 111.146 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 60.12 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.45 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -48.37 121.59 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.6 103.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 74.24 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 20.4 t -60.74 -39.95 90.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 74.13 110.859 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 24.3 p -132.03 4.53 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 71.35 111.158 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.4 52.31 28.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 70.21 112.521 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 12.4 mt -51.1 -32.37 22.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 73.41 110.962 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.87 19.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 75.42 112.439 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.11 110.898 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.32 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 73.13 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.2 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 62.01 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.41 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 64.2 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.04 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.03 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.04 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.34 111.189 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.31 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.092 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.42 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.05 166.45 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.44 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 4.1 mp -80.23 133.77 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.393 3.269 . . . . 73.42 110.883 169.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.12 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.32 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 61.22 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.111 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 74.25 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.33 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 75.14 110.903 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 72.53 110.949 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 75.13 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 72.22 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.11 110.915 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 74.04 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 73.13 111.169 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 65.14 110.866 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.14 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.4 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 17.1 p30 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.01 110.925 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 74.32 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 72.23 111.154 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 70.22 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.32 110.923 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 75.31 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.53 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.153 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.13 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.3 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.953 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 71.25 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 74.31 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 60.32 111.027 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 75.21 110.935 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.41 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 73.01 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.24 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.51 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.34 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.42 111.12 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 71.41 111.148 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.24 111.143 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 74.53 111.032 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 65.31 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.02 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.53 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 74.13 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 73.04 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.24 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 75.2 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 75.24 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.53 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 30.0 t80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.896 0.379 . . . . 74.15 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.0 pp -129.75 -39.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 74.25 110.904 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -89.03 163.27 31.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 64.03 112.541 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -149.18 161.95 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.327 . . . . 74.34 110.924 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -131.09 -73.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.14 110.927 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.2 56.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 65.03 110.896 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 31.9 mt 51.83 68.06 3.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 74.43 111.114 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.92 -170.68 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.708 2.272 . . . . 72.42 112.293 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.99 77.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 74.33 110.848 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -85.92 137.53 35.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.661 0.743 . . . . 74.01 110.823 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.602 2.202 . . . . 75.42 112.363 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 73.33 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.33 111.091 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 60.12 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.45 111.13 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -44.33 119.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 73.42 110.943 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.81 36.98 1.96 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 74.24 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.2 t -75.9 -36.29 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.949 0.404 . . . . 74.13 110.927 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.2 p -102.69 27.05 7.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 71.35 111.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.37 107.42 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 70.21 112.485 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 6.4 mt -91.02 -46.54 8.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 73.41 110.909 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.68 61.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.792 -0.718 . . . . 75.42 112.474 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.11 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.32 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 73.13 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.2 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.23 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 62.01 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.41 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 64.2 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.04 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.03 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.04 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.34 111.138 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 73.24 111.155 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.42 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -157.58 167.85 28.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.44 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.02 132.23 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 124.421 3.282 . . . . 73.42 110.893 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.12 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.32 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 61.22 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 74.25 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.33 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 75.14 110.857 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 72.53 110.888 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.12 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 75.13 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 72.22 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.11 110.862 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 74.04 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.13 111.113 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 65.14 110.926 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.14 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.4 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 74.32 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 72.23 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 70.22 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.32 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.53 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.32 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.13 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.3 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 71.25 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.31 111.086 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 74.13 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 60.32 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 75.21 110.926 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.41 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 73.01 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.24 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.51 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.34 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.42 111.136 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 71.41 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 73.24 111.119 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 74.53 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 65.31 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.02 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.53 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.13 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 75.2 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 75.24 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.53 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.15 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.34 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.92 0.39 . . . . 74.15 110.897 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -125.32 161.96 25.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 74.25 110.907 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -119.99 -79.92 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 64.03 112.47 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.64 -177.82 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 74.34 110.859 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -162.1 172.15 16.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.879 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.05 56.22 3.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.839 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.7 tp -175.65 131.52 0.42 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 74.43 111.127 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 75.15 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.262 . . . . 72.42 112.309 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -135.51 59.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 74.33 110.823 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.24 153.48 66.04 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.01 110.873 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 158.46 56.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 75.42 112.312 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.115 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 60.12 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.45 111.138 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 75.12 110.867 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -47.25 119.76 2.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.863 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -120.58 117.89 3.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 74.24 112.507 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 70.2 p -93.08 -39.86 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.401 . . . . 74.13 110.895 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.02 -3.01 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 71.35 111.163 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.43 37.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.756 . . . . 70.21 112.504 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 2.3 tp -51.44 -31.28 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 73.41 110.916 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.28 -31.98 20.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 75.42 112.406 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.11 110.864 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.32 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.13 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.2 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.23 112.507 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 62.01 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.41 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.2 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.04 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.03 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.04 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.34 111.178 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 73.24 111.139 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.42 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -159.85 167.41 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.44 110.867 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.7 mt -83.12 139.9 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.431 3.287 . . . . 73.42 110.952 169.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.12 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.32 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 61.22 112.461 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.21 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 74.25 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 75.2 110.89 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.33 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 75.14 110.968 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.877 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.12 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 72.22 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.11 110.83 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.04 110.954 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.126 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 65.14 110.885 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.14 110.845 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.4 111.144 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.01 110.911 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 74.32 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 72.23 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 70.22 110.856 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.32 110.897 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 75.31 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.53 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.32 111.105 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.13 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.3 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.21 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.919 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 71.25 111.131 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 74.31 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.13 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 60.32 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 75.21 110.863 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.41 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 73.01 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.24 111.114 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.51 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.34 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.096 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 71.41 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 73.24 111.135 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 74.53 111.064 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.02 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.53 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.13 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 73.04 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.24 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 75.2 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 75.24 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.53 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 74.15 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.923 0.392 . . . . 74.15 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 1.3 mp -138.76 146.48 41.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.948 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -117.19 -35.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 64.03 112.432 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.99 156.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 74.34 110.86 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -157.52 101.98 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.916 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -174.47 150.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 65.03 110.858 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 24.4 mm 66.05 131.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 74.43 111.157 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.61 78.39 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 72.42 112.372 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -140.08 72.59 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.918 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.54 159.39 85.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.729 . . . . 74.01 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 156.68 62.65 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.642 2.228 . . . . 75.42 112.414 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.103 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 60.12 111.113 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.45 111.144 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 75.12 110.841 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.66 136.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 73.42 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -147.05 92.46 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 74.24 112.497 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 33.0 t -95.0 -32.23 13.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 74.13 110.852 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.1 27.03 6.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 71.35 111.129 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -73.68 72.76 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 70.21 112.443 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.48 -4.81 50.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.893 0.377 . . . . 73.41 110.965 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -46.93 -46.54 19.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.42 112.486 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.11 110.87 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 73.13 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.2 111.143 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.23 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 62.01 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.41 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 64.2 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.04 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.03 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.04 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.34 111.11 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 73.31 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.24 111.137 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.42 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.51 167.31 23.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.44 110.906 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 67.2 mt -105.42 150.88 24.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.466 3.303 . . . . 73.42 110.924 169.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.12 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.32 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 61.22 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.094 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 74.25 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.33 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 75.14 110.934 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 72.53 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.12 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 72.22 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.11 110.833 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.04 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 73.13 111.152 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 65.14 110.951 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.14 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.4 111.182 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.01 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 74.32 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 72.23 111.148 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 70.22 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.32 110.966 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 75.31 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.32 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.13 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.3 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 73.13 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 71.25 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.092 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 74.13 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 60.32 111.115 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 75.21 110.956 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.24 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.51 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.34 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.42 111.16 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 71.41 111.165 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.118 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 74.53 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 65.31 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.02 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.53 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 74.13 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 73.04 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 75.24 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.844 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 74.15 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.34 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.79 0.329 . . . . 74.15 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.96 79.36 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -112.65 131.85 10.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 64.03 112.462 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -112.06 -71.34 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 74.34 110.948 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -107.96 63.63 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.14 110.891 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.21 171.18 16.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 65.03 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.5 pt -152.37 67.37 6.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.636 0.732 . . . . 74.43 111.099 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -171.5 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.6 2.2 . . . . 72.42 112.385 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -103.15 174.14 6.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 74.33 110.915 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.44 120.03 58.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 74.01 110.946 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.26 69.11 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 75.42 112.275 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.877 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.33 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 60.12 111.158 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.45 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 75.12 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -49.37 119.73 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.913 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.26 47.76 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 74.24 112.5 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.0 t -51.8 -39.46 58.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.956 0.408 . . . . 74.13 110.86 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -101.97 26.98 6.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 71.35 111.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.98 103.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.788 -0.72 . . . . 70.21 112.457 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.22 -29.62 15.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 73.41 110.95 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.97 -49.61 35.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.42 112.516 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.11 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.32 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 73.13 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.2 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.23 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 62.01 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.41 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 64.2 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.04 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.03 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.04 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.34 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.31 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 73.24 111.087 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.82 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.44 110.911 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.71 132.19 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.445 3.293 . . . . 73.42 110.917 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.32 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 61.22 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.102 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 74.25 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 75.2 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.33 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 75.14 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.913 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 75.13 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 72.22 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.11 110.862 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.13 111.114 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.14 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.4 111.181 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.01 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 74.32 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 72.23 111.1 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 70.22 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.32 110.922 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 75.31 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.53 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.32 111.149 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.3 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.21 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.879 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 71.25 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 74.31 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 74.13 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 60.32 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.21 110.897 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 73.01 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.24 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.51 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.34 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.42 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 71.41 111.094 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.161 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 74.53 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 65.31 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.02 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.53 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 73.04 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 75.24 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.53 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.15 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.34 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.878 0.371 . . . . 74.15 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 10.5 mt -137.65 166.15 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 74.25 110.884 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.77 -176.54 42.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 64.03 112.548 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.59 -175.37 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 74.34 110.844 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -140.38 66.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 74.14 110.91 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -119.95 -49.99 2.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 65.03 110.901 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 48.6 mm -51.62 133.1 36.0 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.645 0.736 . . . . 74.43 111.129 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -42.23 3.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.724 2.283 . . . . 72.42 112.358 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -80.55 86.68 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.826 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -51.36 143.9 17.47 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.611 0.72 . . . . 74.01 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 158.6 56.48 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.629 2.219 . . . . 75.42 112.42 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 73.33 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.33 111.095 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 60.12 111.157 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.45 111.126 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 75.12 110.903 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -46.46 136.07 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 73.42 110.781 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -122.61 122.57 5.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.738 . . . . 74.24 112.491 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 13.2 p -95.01 -40.02 9.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.99 0.424 . . . . 74.13 110.875 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.8 p -131.98 3.17 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 71.35 111.132 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.05 31.88 18.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 70.21 112.471 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 9.6 tt -55.82 -30.53 61.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.41 110.92 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.52 -30.31 12.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.42 112.491 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.11 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.32 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.13 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.2 111.075 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.23 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 62.01 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.41 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 64.2 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.04 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.03 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.04 112.516 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.34 111.107 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.892 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.146 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.42 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -152.73 162.82 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.44 110.909 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.0 mt -106.12 128.34 53.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 124.319 3.236 . . . . 73.42 110.917 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.12 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.32 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 61.22 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 75.2 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 74.21 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.33 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 75.14 110.879 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 72.53 110.924 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 75.13 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 72.22 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.11 110.785 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 73.13 111.109 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 65.14 110.975 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.4 111.151 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.01 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 74.32 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 72.23 111.133 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 70.22 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.32 110.879 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 75.31 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.53 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.32 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.13 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.3 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.21 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 73.13 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 71.25 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 74.31 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 74.13 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 60.32 111.166 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 75.21 110.836 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 73.01 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.24 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.51 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.34 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.42 111.17 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 71.41 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 73.24 111.072 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 74.53 111.089 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 65.31 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.02 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.53 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 73.04 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.24 110.892 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 75.2 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 75.24 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.887 0.375 . . . . 74.15 110.878 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 3.0 tt -138.28 114.65 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 74.25 110.818 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.04 179.36 47.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 64.03 112.465 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.3 172.17 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 74.34 110.899 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -153.02 -179.54 7.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.14 110.925 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -68.74 -34.3 75.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 65.03 110.908 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 25.9 mt 65.07 67.86 0.77 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 74.43 111.09 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 119.03 6.04 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.723 2.282 . . . . 72.42 112.359 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -111.27 69.19 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.818 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -51.15 160.92 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.618 0.723 . . . . 74.01 110.839 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 121.18 7.87 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.618 2.212 . . . . 75.42 112.288 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.84 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.33 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 60.12 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.45 111.11 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 75.12 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -46.5 122.68 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.92 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -92.76 55.09 2.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 74.24 112.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 77.4 p -90.43 11.13 22.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 74.13 110.86 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -117.32 27.05 9.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.35 111.146 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 103.97 144.11 13.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 70.21 112.515 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 6.5 mt -71.0 -39.96 72.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 73.41 110.951 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.15 25.78 50.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 75.42 112.495 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.11 110.902 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.32 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 73.13 111.219 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.2 111.129 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.23 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 62.01 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.41 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 64.2 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.04 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.03 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.04 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.34 111.114 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 73.31 110.889 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 73.24 111.13 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -161.91 167.39 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.44 110.897 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt -95.54 138.78 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 124.386 3.266 . . . . 73.42 110.955 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.12 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.32 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 61.22 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.21 111.069 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.2 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 74.21 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.33 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 75.14 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 72.53 110.87 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.12 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 72.22 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.11 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.04 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.13 111.164 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.808 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.4 111.151 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.01 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 74.32 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 72.23 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 70.22 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.32 110.898 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 75.31 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.53 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.32 111.135 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.13 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 73.13 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 71.25 111.073 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.31 111.122 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 60.32 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.21 110.899 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.41 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.24 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.51 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.34 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.42 111.125 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 71.41 111.101 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.109 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.086 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 65.31 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.02 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.53 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 73.04 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.24 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 75.2 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.53 110.887 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 74.15 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.34 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.879 0.371 . . . . 74.15 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 153.51 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 74.25 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -52.76 128.51 36.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.826 -0.702 . . . . 64.03 112.534 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -138.97 -177.89 5.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 74.34 110.902 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -108.12 -178.14 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.895 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.75 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 65.03 110.853 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 8.9 pt -153.34 73.57 6.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 74.43 111.079 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 156.61 62.92 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.761 2.307 . . . . 72.42 112.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.2 106.89 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 74.33 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.7 160.17 53.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 74.01 110.882 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 131.95 22.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.724 2.283 . . . . 75.42 112.256 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.33 111.152 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 60.12 111.147 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.45 111.144 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -47.78 119.81 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 73.42 110.855 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.6 48.88 3.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 74.24 112.481 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 41.2 t -94.93 10.98 33.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.384 . . . . 74.13 110.808 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.8 m -115.35 26.97 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 71.35 111.149 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 105.74 107.18 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 70.21 112.451 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -50.78 -48.23 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 73.41 110.902 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.77 36.32 58.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 75.42 112.464 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.11 110.831 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.32 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.135 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.2 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.23 112.457 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 62.01 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.41 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 64.2 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.04 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.03 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.04 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.34 111.159 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 73.31 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 73.24 111.106 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.42 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.5 166.73 29.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.44 110.892 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt -108.24 129.41 55.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 124.377 3.262 . . . . 73.42 110.93 169.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.12 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.32 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 61.22 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.21 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.2 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.33 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 75.14 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.53 110.914 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.12 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 75.13 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 72.22 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.11 110.855 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 74.04 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.145 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 65.14 110.919 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.14 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.4 111.106 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.01 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 74.32 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 72.23 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.32 110.847 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 75.31 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.53 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.32 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.13 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.3 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.21 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.13 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 71.25 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 74.31 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 74.13 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 60.32 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 75.21 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.41 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 73.01 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.24 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.51 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.34 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.42 111.115 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 71.41 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 73.24 111.152 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 74.53 111.139 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 65.31 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.02 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.53 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.04 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.24 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 75.2 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.53 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.34 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 74.15 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.67 -74.43 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 74.25 110.937 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.35 -176.72 44.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 64.03 112.501 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.17 -174.7 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 74.34 110.883 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -165.77 166.84 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 74.14 110.885 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -51.86 -35.22 44.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 65.03 110.921 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.8 tp -51.4 131.49 34.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.606 0.717 . . . . 74.43 111.154 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 -39.67 6.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 72.42 112.326 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -92.12 44.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 74.33 110.887 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.42 153.69 13.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.64 0.733 . . . . 74.01 110.894 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 127.26 14.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.25 . . . . 75.42 112.26 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.33 110.851 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.166 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 60.12 111.156 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.45 111.068 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 75.12 110.868 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -44.74 122.85 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.42 -28.2 19.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 74.24 112.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.8 t -52.2 -35.59 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 74.13 110.866 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.1 m -103.13 26.97 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 71.35 111.131 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.62 32.54 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 70.21 112.509 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.87 -26.6 59.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 73.41 110.886 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -48.84 -40.68 26.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.721 . . . . 75.42 112.453 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.11 110.934 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.32 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 73.13 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.2 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.23 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 62.01 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.41 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 64.2 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.04 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.03 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.04 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.34 111.153 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 73.31 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.116 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -161.81 167.66 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.44 110.914 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.58 156.27 19.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 124.401 3.273 . . . . 73.42 110.888 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.12 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.32 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 61.22 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.21 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.2 110.909 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.859 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.33 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 75.14 110.916 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 72.53 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.12 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 72.22 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.11 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 74.04 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.13 111.07 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 65.14 110.98 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.14 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.4 111.061 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.01 110.919 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 74.32 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 72.23 111.103 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 70.22 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.901 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 75.31 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.32 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.13 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.3 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.25 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.31 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 74.13 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 60.32 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 75.21 110.906 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.41 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 73.01 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.137 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.51 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.34 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.149 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 71.41 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 73.24 111.148 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.53 111.086 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 65.31 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.02 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.53 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 73.04 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.24 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 75.2 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 75.24 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 74.15 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.932 0.396 . . . . 74.15 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.39 64.48 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 74.25 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -94.53 99.23 2.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 64.03 112.476 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -141.53 141.98 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 74.34 111.003 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.84 116.57 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.829 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 307' ' ' ILE . 0.1 OUTLIER -120.91 -74.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 65.03 110.927 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 306' ' ' ASP . 1.1 tt 35.28 79.67 0.29 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.576 0.703 . . . . 74.43 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 161.75 44.7 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 72.42 112.385 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -117.8 45.54 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 74.33 110.897 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.45 160.5 82.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.624 0.725 . . . . 74.01 110.936 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 158.61 56.39 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.696 2.264 . . . . 75.42 112.37 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.33 111.102 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 60.12 111.149 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.45 111.105 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 75.12 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -46.22 119.81 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.891 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.98 34.53 2.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.76 . . . . 74.24 112.483 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.5 t -58.86 -35.14 72.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 74.13 110.891 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.0 p -102.19 27.07 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 71.35 111.166 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.48 105.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.815 -0.707 . . . . 70.21 112.581 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.02 -46.84 7.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 73.41 110.895 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.82 27.24 61.01 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.744 -0.741 . . . . 75.42 112.457 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.11 110.922 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.32 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 73.13 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.2 111.095 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.23 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 62.01 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.41 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 64.2 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.04 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.03 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.04 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.34 111.154 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 73.24 111.161 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.42 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -162.11 167.47 24.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.44 110.934 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 46.2 mt -108.31 142.93 37.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.476 3.307 . . . . 73.42 110.932 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.12 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.32 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 61.22 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.21 111.11 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 74.25 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.2 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.33 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 75.14 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 72.53 110.894 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.12 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 75.13 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 72.22 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.11 110.901 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 74.04 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 73.13 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 65.14 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.4 111.151 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.01 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 74.32 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 72.23 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 70.22 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.32 110.913 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.31 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.32 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.13 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.3 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.21 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 71.25 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 74.31 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 74.13 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 60.32 111.097 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 75.21 110.907 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.41 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.01 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.24 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.51 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.34 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.42 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 71.41 111.147 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.076 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 74.53 111.139 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 65.31 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.02 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.53 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 74.13 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 73.04 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.24 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 75.24 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.53 110.873 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 74.15 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.34 111.083 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 CA-C-O 120.798 0.249 . . . . 75.019999999999996 112.321 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.665 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 44.240000000000002 111.077 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 385' ' ' THR . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.123 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 71.099999999999994 110.876 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 75.420000000000002 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 376' ' ' ALA . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 111.153 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.487 ' C ' HD12 ' A' ' 336' ' ' ILE . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.155 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 41.310000000000002 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.039999999999999 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.030000000000001 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 328' ' ' ILE . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.141 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 359' ' ' ILE . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 61.420000000000002 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.439999999999998 110.897 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.799 0.333 . . . . 73.420000000000002 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.319999999999993 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 52.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 316' ' ' ILE . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 71.310000000000002 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.329999999999998 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 74.5 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 390' ' ' ALA . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.340000000000003 110.905 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.109999999999999 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.4 ' OE1' HD11 ' A' ' 360' ' ' LEU . 0.8 OUTLIER -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.450000000000003 110.925 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 338' ' ' ILE . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.732 HD13 HG22 ' A' ' 389' ' ' ILE . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 110.878 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.882 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.706 HG12 HG12 ' A' ' 388' ' ' ILE . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.400000000000006 111.163 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.631 ' HB3' HG23 ' A' ' 386' ' ' VAL . 2.1 p-10 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.916 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 32.329999999999998 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 64.420000000000002 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.019999999999996 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 362' ' ' VAL . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.982 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.510000000000005 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.319999999999993 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.129999999999995 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.42 ' HA ' HD13 ' A' ' 336' ' ' ILE . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.299999999999997 110.859 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 72.25 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.121 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 52.25 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 71.530000000000001 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 386' ' ' VAL . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.097 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.509999999999998 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.340000000000003 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 316' ' ' ILE . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 382' ' ' ALA . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 111.136 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.706 HG12 HG12 ' A' ' 362' ' ' VAL . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 111.13 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.732 HG22 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 44.009999999999998 111.1 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 64.439999999999998 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.530000000000001 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 54.140000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.239999999999995 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 CA-C-O 120.813 0.255 . . . . 75.019999999999996 112.353 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.612 HD12 HD23 ' A' ' 353' ' ' LEU . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 111.127 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 44.240000000000002 111.137 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 386' ' ' VAL . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.146 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.461 ' O ' HG12 ' A' ' 386' ' ' VAL . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 110.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 110.825 -179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 347' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.517 -0.233 . . . . 75.420000000000002 112.517 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.109999999999999 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 327' ' ' ILE . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 111.174 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.230000000000004 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 41.310000000000002 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.409999999999997 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 54.549999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.039999999999999 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.030000000000001 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.040000000000006 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 359' ' ' ILE . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.420000000000002 111.161 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.439999999999998 110.877 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.811 0.339 . . . . 73.420000000000002 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.319999999999993 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 52.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 324' ' ' GLY . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 111.104 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 316' ' ' ILE . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.814 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.329999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 314' ' ' ILE . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 74.5 110.908 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 388' ' ' ILE . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 41.200000000000003 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.593 ' HB2' HD13 ' A' ' 338' ' ' ILE . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.109999999999999 110.868 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 338' ' ' ILE . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 65.310000000000002 111.168 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 389' ' ' ILE . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.805 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.715 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.400000000000006 111.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 32.329999999999998 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 64.420000000000002 111.142 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 64.019999999999996 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 359' ' ' ILE . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.898 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.319999999999993 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.299999999999997 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 54.240000000000002 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 52.25 111.097 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.715 ' CD2' HG21 ' A' ' 362' ' ' VAL . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.96 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 316' ' ' ILE . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.420000000000002 111.081 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 55.240000000000002 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 111.129 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.425 HD12 ' OG ' ' A' ' 361' ' ' SER . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 44.009999999999998 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.530000000000001 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 54.140000000000001 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 61.039999999999999 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 75.019999999999996 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' A' ' 352' ' ' GLU . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.693 ' O ' HD13 ' A' ' 316' ' ' ILE . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.196 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 315' ' ' VAL . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.131 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 316' ' ' ILE . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.826 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 71.099999999999994 110.88 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.497 -0.241 . . . . 75.420000000000002 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.109999999999999 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 327' ' ' ILE . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.118 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 54.549999999999997 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.040000000000006 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 359' ' ' ILE . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 61.420000000000002 111.096 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.439999999999998 110.878 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 73.420000000000002 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.319999999999993 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 52.0 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.635 ' HB2' HD11 ' A' ' 314' ' ' ILE . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.856 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 314' ' ' ILE . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 74.5 110.884 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 41.200000000000003 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.109999999999999 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 338' ' ' ILE . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.08 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 389' ' ' ILE . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.329999999999998 110.894 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 HG13 ' A' ' 388' ' ' ILE . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.400000000000006 111.108 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 64.019999999999996 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 359' ' ' ILE . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.906 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.510000000000005 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.319999999999993 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.129999999999995 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.299999999999997 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.240000000000002 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 53.409999999999997 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 52.25 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.120000000000005 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 71.530000000000001 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.509999999999998 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 111.085 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 55.240000000000002 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.62 HG13 HG12 ' A' ' 362' ' ' VAL . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 111.155 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.651 HG22 HD12 ' A' ' 360' ' ' LEU . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 44.009999999999998 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 64.439999999999998 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.019999999999996 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.530000000000001 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 61.240000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 54.140000000000001 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.239999999999995 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 61.039999999999999 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.78 0.241 . . . . 75.019999999999996 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 71.140000000000001 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 352' ' ' GLU . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.121 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 44.240000000000002 111.179 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 314' ' ' ILE . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.179 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 110.85 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.851 -179.904 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.486 -0.246 . . . . 75.420000000000002 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.109999999999999 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 338' ' ' ILE . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 339' ' ' SER . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.128 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.513 ' CA ' HD12 ' A' ' 336' ' ' ILE . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.230000000000004 112.522 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 41.310000000000002 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.409999999999997 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 54.549999999999997 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.039999999999999 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.030000000000001 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.040000000000006 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.513 HD12 ' CA ' ' A' ' 329' ' ' GLY . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 111.134 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 359' ' ' ILE . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.112 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' SER . . . . . 0.639 ' HB2' HD12 ' A' ' 328' ' ' ILE . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.844 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.439999999999998 110.858 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 343' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.888 0.375 . . . . 73.420000000000002 110.91 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 342' ' ' LEU . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.105 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 52.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.209999999999994 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 71.310000000000002 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.745 ' CB ' HD11 ' A' ' 314' ' ' ILE . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.329999999999998 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 314' ' ' ILE . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 74.5 110.908 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 388' ' ' ILE . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 71.340000000000003 110.906 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 41.200000000000003 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.109999999999999 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 63.450000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 338' ' ' ILE . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 65.310000000000002 111.15 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.902 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 388' ' ' ILE . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.112 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 32.329999999999998 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 362' ' ' VAL . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.152 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 362' ' ' VAL . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.530000000000001 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.129999999999995 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.299999999999997 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.25 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 54.240000000000002 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 52.25 111.086 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 362' ' ' VAL . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 74.040000000000006 110.968 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.113 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.420000000000002 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.151 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 360' ' ' LEU . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 44.009999999999998 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.019999999999996 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.530000000000001 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 61.039999999999999 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PHE . . . . . 0.511 ' CG ' HG21 ' A' ' 328' ' ' ILE . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.855 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.340000000000003 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.340000000000003 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.712 0.213 . . . . 75.019999999999996 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 387' ' ' THR . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.878 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.687 HG21 ' HG ' ' A' ' 353' ' ' LEU . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 111.159 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.912 -179.91 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.46 -0.256 . . . . 75.420000000000002 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 110.893 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.140000000000001 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.791 HG23 ' HB2' ' A' ' 339' ' ' SER . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.162 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.230000000000004 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 41.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.409999999999997 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.549999999999997 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.039999999999999 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.030000000000001 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.121 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.706 ' CD1' HD11 ' A' ' 359' ' ' ILE . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.106 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' SER . . . . . 0.791 ' HB2' HG23 ' A' ' 328' ' ' ILE . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 110.907 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.439999999999998 110.872 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.733 0.301 . . . . 73.420000000000002 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.319999999999993 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 52.0 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.083 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 64.310000000000002 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.329999999999998 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.52 ' HB3' HD12 ' A' ' 314' ' ' ILE . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 74.5 110.928 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.687 ' HG ' HG21 ' A' ' 314' ' ' ILE . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 110.882 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 41.200000000000003 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.109999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.450000000000003 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.839 HG21 HD12 ' A' ' 367' ' ' LEU . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 64.329999999999998 110.908 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 389' ' ' ILE . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.835 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG1' HD11 ' A' ' 367' ' ' LEU . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.400000000000006 111.087 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.010000000000005 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.568 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.173 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 64.019999999999996 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 359' ' ' ILE . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.873 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.510000000000005 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.129999999999995 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.299999999999997 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 53.409999999999997 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 52.25 111.074 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 386' ' ' VAL . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 74.040000000000006 110.922 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.120000000000005 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.509999999999998 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 379' ' ' LEU . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.15 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 314' ' ' ILE . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 55.240000000000002 111.1 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.476 HG22 ' HB ' ' A' ' 362' ' ' VAL . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.077 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 361' ' ' SER . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 44.009999999999998 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 64.439999999999998 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 61.240000000000002 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 54.140000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 61.039999999999999 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 72.239999999999995 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.781 0.242 . . . . 75.019999999999996 112.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.726 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 71.140000000000001 110.936 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 353' ' ' LEU . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.329999999999998 111.05 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 315' ' ' VAL . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 44.240000000000002 111.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 385' ' ' THR . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.198 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 71.099999999999994 110.81 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.428 -0.269 . . . . 75.420000000000002 112.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.856 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.099999999999994 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.230000000000004 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 41.310000000000002 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 54.549999999999997 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.039999999999999 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.030000000000001 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.129999999999995 111.226 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 359' ' ' ILE . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.439999999999998 110.922 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.869 0.366 . . . . 73.420000000000002 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.319999999999993 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 52.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 353' ' ' LEU . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 111.101 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 64.310000000000002 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.329999999999998 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.5 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.923 HD22 HD11 ' A' ' 388' ' ' ILE . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.905 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 41.200000000000003 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 338' ' ' ILE . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 111.109 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 64.329999999999998 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.999 HG12 HG22 ' A' ' 388' ' ' ILE . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.400000000000006 111.144 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.010000000000005 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 32.329999999999998 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 64.420000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 64.019999999999996 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.747 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.916 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.530000000000001 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.747 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.319999999999993 111.094 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.129999999999995 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.25 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 54.240000000000002 111.12 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 53.409999999999997 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 382' ' ' ALA . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.948 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.239999999999995 111.111 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.509999999999998 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.340000000000003 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 316' ' ' ILE . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 388' ' ' ILE . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.12 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.999 HG22 HG12 ' A' ' 362' ' ' VAL . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.154 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 44.009999999999998 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.019999999999996 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.530000000000001 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 61.039999999999999 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.738 0.224 . . . . 75.019999999999996 112.397 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.755 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.858 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 353' ' ' LEU . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 111.154 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 386' ' ' VAL . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.196 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.439999999999998 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.843 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.515 -0.234 . . . . 75.420000000000002 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.915 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 72.340000000000003 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.230000000000004 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 41.310000000000002 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.409999999999997 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 54.549999999999997 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.030000000000001 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.040000000000006 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 336' ' ' ILE . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.109 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 357' ' ' ASP . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 61.420000000000002 111.162 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.439999999999998 110.884 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.319999999999993 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 52.0 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.329999999999998 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 74.5 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 390' ' ' ALA . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.944 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 41.200000000000003 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.813 ' HB2' HD12 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.109999999999999 110.883 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 359' ' ' ILE . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 111.165 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 389' ' ' ILE . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 64.329999999999998 110.882 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 1.025 HG12 HG22 ' A' ' 388' ' ' ILE . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 111.13 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 32.329999999999998 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 64.420000000000002 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.404 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 64.019999999999996 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.879 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.755 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.319999999999993 111.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.299999999999997 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 54.240000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.25 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.904 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.530000000000001 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.91 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.135 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.509999999999998 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.91 HG22 ' HB1' ' A' ' 382' ' ' ALA . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.067 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.142 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 1.025 HG22 HG12 ' A' ' 362' ' ' VAL . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.175 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 360' ' ' LEU . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 44.009999999999998 111.097 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 64.439999999999998 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 61.240000000000002 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.239999999999995 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 61.039999999999999 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 72.239999999999995 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.774 0.239 . . . . 75.019999999999996 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.895 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 353' ' ' LEU . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.450000000000003 111.131 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.425 ' N ' HG22 ' A' ' 316' ' ' ILE . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 110.859 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.099999999999994 110.915 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.435 -0.266 . . . . 75.420000000000002 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.109999999999999 110.882 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 376' ' ' ALA . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 111.121 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.74 ' O ' HD12 ' A' ' 336' ' ' ILE . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.099999999999994 111.15 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.230000000000004 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 41.310000000000002 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.409999999999997 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 54.549999999999997 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.039999999999999 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.030000000000001 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.040000000000006 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 328' ' ' ILE . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.114 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 357' ' ' ASP . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.09 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.439999999999998 110.949 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 52.0 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.453 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.087 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.329999999999998 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 74.5 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 388' ' ' ILE . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 110.96 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 338' ' ' ILE . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.109999999999999 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 63.450000000000003 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.310000000000002 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 64.329999999999998 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 110.877 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.659 HG22 HG22 ' A' ' 388' ' ' ILE . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.400000000000006 111.146 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.888 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 32.329999999999998 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 362' ' ' VAL . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 64.420000000000002 111.067 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 64.019999999999996 110.874 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.642 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 111.001 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.510000000000005 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.319999999999993 111.19 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.299999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 72.25 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 54.240000000000002 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.096 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 53.409999999999997 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 52.25 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 386' ' ' VAL . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.909 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.239999999999995 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.509999999999998 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.066 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 55.240000000000002 111.101 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 353' ' ' LEU . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 111.118 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 361' ' ' SER . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 44.009999999999998 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.019999999999996 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.530000000000001 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 54.140000000000001 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 61.039999999999999 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.530000000000001 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.466 -0.128 0 CA-C-O 120.738 0.224 . . . . 75.019999999999996 112.373 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.527 ' NE ' HD11 ' A' ' 389' ' ' ILE . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.842 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 44.240000000000002 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.573 HD11 ' HB ' ' A' ' 386' ' ' VAL . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 111.147 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 63.439999999999998 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.099999999999994 110.883 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.503 -0.239 . . . . 75.420000000000002 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 72.340000000000003 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.230000000000004 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.409999999999997 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.030000000000001 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.040000000000006 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 375' ' ' ALA . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.155 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.816 HD12 ' HB2' ' A' ' 357' ' ' ASP . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.136 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.439999999999998 110.841 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.882 0.373 . . . . 73.420000000000002 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 52.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.209999999999994 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 64.310000000000002 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.329999999999998 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 74.5 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 390' ' ' ALA . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.946 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 41.200000000000003 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.816 ' HB2' HD12 ' A' ' 338' ' ' ILE . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.109999999999999 110.875 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 63.450000000000003 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 367' ' ' LEU . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 65.310000000000002 111.082 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 389' ' ' ILE . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.876 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.494 HG22 ' OD1' ' A' ' 363' ' ' ASN . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.126 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.494 ' OD1' HG22 ' A' ' 362' ' ' VAL . 0.8 OUTLIER 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.881 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 32.329999999999998 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 378' ' ' ALA . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 111.143 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.019999999999996 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 359' ' ' ILE . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.129999999999995 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.478 ' OE1' HD12 ' A' ' 377' ' ' ILE . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.94 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 336' ' ' ILE . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 54.240000000000002 111.101 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' ILE . . . . . 0.478 HD12 ' OE1' ' A' ' 374' ' ' GLN . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 53.409999999999997 111.12 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 52.25 111.042 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.530000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.509999999999998 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.340000000000003 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.573 ' HB ' HD11 ' A' ' 316' ' ' ILE . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.173 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 55.240000000000002 111.182 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.54 HG23 HG23 ' A' ' 359' ' ' ILE . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 111.05 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.527 HD11 ' NE ' ' A' ' 313' ' ' ARG . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.74 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 44.009999999999998 111.103 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.019999999999996 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.530000000000001 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.240000000000002 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 54.140000000000001 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 61.039999999999999 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.340000000000003 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.825 0.26 . . . . 75.019999999999996 112.348 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 390' ' ' ALA . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 44.240000000000002 111.177 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 317' ' ' HIS . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.075 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.717 ' O ' HD12 ' A' ' 316' ' ' ILE . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.905 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 71.099999999999994 110.896 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.496 -0.242 . . . . 75.420000000000002 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.109999999999999 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.230000000000004 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 41.310000000000002 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.409999999999997 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.039999999999999 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.030000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 336' ' ' ILE . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 357' ' ' ASP . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 61.420000000000002 111.171 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 110.863 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.828 0.347 . . . . 73.420000000000002 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 52.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 71.310000000000002 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.329999999999998 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 74.5 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 338' ' ' ILE . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.109999999999999 110.86 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 389' ' ' ILE . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 64.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 389' ' ' ILE . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.806 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 367' ' ' LEU . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.400000000000006 111.151 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.579 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.010000000000005 110.861 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 32.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 64.420000000000002 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 367' ' ' LEU . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.019999999999996 110.882 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CB ' ' A' ' 370' ' ' ALA . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.959 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.685 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 111.049 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.129999999999995 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 72.25 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 54.240000000000002 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 53.409999999999997 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 52.25 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 110.899 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.081 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.509999999999998 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.340000000000003 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 363' ' ' ASN . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 111.081 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 55.240000000000002 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 312' ' ' ARG . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 44.009999999999998 111.084 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 360' ' ' LEU . 17.5 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.019999999999996 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 61.240000000000002 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 54.140000000000001 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 61.039999999999999 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 72.239999999999995 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 73.340000000000003 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.742 0.226 . . . . 75.019999999999996 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.497 ' NE ' ' HB3' ' A' ' 390' ' ' ALA . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.601 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.883 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 352' ' ' GLU . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.146 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 44.240000000000002 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 63.439999999999998 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.902 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.439 -0.264 . . . . 75.420000000000002 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.565 ' HZ ' HG11 ' A' ' 386' ' ' VAL . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.898 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 72.340000000000003 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 41.310000000000002 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.409999999999997 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 54.549999999999997 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.040000000000006 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.129999999999995 111.189 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.829 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.092 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.439999999999998 110.906 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 73.420000000000002 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.319999999999993 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 52.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.111 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.329999999999998 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.515 ' CB ' HD12 ' A' ' 314' ' ' ILE . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 74.5 110.903 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 338' ' ' ILE . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.949 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 41.200000000000003 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.829 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.109999999999999 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 63.450000000000003 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 367' ' ' LEU . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 111.169 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 391' ' ' GLN . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 64.329999999999998 110.866 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.140000000000001 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 367' ' ' LEU . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 362' ' ' VAL . 0.8 OUTLIER 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.010000000000005 110.925 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 32.329999999999998 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.541 HG21 ' HB1' ' A' ' 378' ' ' ALA . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.154 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.019999999999996 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.843 HD12 HG21 ' A' ' 359' ' ' ILE . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.923 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.319999999999993 111.153 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.129999999999995 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.299999999999997 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 72.25 110.953 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 54.240000000000002 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 73.420000000000002 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 53.409999999999997 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 52.25 111.027 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 379' ' ' LEU . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 74.040000000000006 110.935 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.509999999999998 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.565 HG11 ' HZ ' ' A' ' 325' ' ' PHE . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 55.240000000000002 111.148 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.44 HG23 HG23 ' A' ' 359' ' ' ILE . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.143 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.497 ' HB3' ' NE ' ' A' ' 312' ' ' ARG . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 44.009999999999998 111.032 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 360' ' ' LEU . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.019999999999996 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 61.240000000000002 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 61.039999999999999 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.863 0.276 . . . . 75.019999999999996 112.363 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ARG . . . . . 0.448 ' NE ' HD11 ' A' ' 314' ' ' ILE . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 352' ' ' GLU . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 111.091 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 44.240000000000002 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.558 ' CD1' HG13 ' A' ' 386' ' ' VAL . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 63.439999999999998 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.943 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 75.420000000000002 112.474 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.109999999999999 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.099999999999994 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.230000000000004 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 41.310000000000002 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 54.549999999999997 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.039999999999999 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.030000000000001 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.040000000000006 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.138 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.467 HD12 ' OD1' ' A' ' 357' ' ' ASP . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.420000000000002 111.155 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 110.911 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.908 0.385 . . . . 73.420000000000002 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.319999999999993 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 52.0 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 71.310000000000002 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.329999999999998 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 74.5 110.857 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 388' ' ' ILE . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.888 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 41.200000000000003 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.467 ' OD1' HD12 ' A' ' 338' ' ' ILE . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 63.450000000000003 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 359' ' ' ILE . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 65.310000000000002 111.113 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.816 HD12 HG21 ' A' ' 389' ' ' ILE . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 64.329999999999998 110.926 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 32.329999999999998 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 64.019999999999996 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.319999999999993 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.510000000000005 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.530000000000001 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.319999999999993 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.129999999999995 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.299999999999997 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.086 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 53.409999999999997 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 376' ' ' ALA . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.530000000000001 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.509999999999998 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.340000000000003 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 316' ' ' ILE . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.420000000000002 111.136 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 55.240000000000002 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 353' ' ' LEU . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 72.430000000000007 111.119 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 360' ' ' LEU . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 44.009999999999998 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 61.240000000000002 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 61.039999999999999 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 72.239999999999995 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.530000000000001 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 CA-C-O 120.783 0.243 . . . . 75.019999999999996 112.312 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 71.140000000000001 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 352' ' ' GLU . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.115 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 44.240000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.487 HD11 ' CD1' ' A' ' 353' ' ' LEU . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.138 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 316' ' ' ILE . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.439999999999998 110.867 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 71.099999999999994 110.863 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.406 -0.278 . . . . 75.420000000000002 112.406 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.577 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 110.864 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.230000000000004 112.507 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 41.310000000000002 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 54.549999999999997 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.039999999999999 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.030000000000001 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.040000000000006 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.443 HD12 ' HA3' ' A' ' 329' ' ' GLY . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 111.178 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 61.420000000000002 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.867 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 110.952 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.319999999999993 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 349' ' ' LEU . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 52.0 112.461 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.209999999999994 111.096 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 345' ' ' GLY . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.89 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HG2' HD12 ' A' ' 314' ' ' ILE . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 74.5 110.968 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 316' ' ' ILE . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.877 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 338' ' ' ILE . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.109999999999999 110.83 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' GLN . . . . . 0.457 ' OE1' HD11 ' A' ' 360' ' ' LEU . 1.1 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.954 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 388' ' ' ILE . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.126 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.457 HD11 ' OE1' ' A' ' 358' ' ' GLN . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 110.885 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 110.845 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 388' ' ' ILE . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.400000000000006 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.478 ' OD1' HG12 ' A' ' 362' ' ' VAL . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.010000000000005 110.911 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 32.329999999999998 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 64.420000000000002 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ASP . . . . . 0.423 ' C ' HD22 ' A' ' 367' ' ' LEU . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.019999999999996 110.856 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.675 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.897 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.530000000000001 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.675 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.319999999999993 111.105 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.129999999999995 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.514 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 72.25 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.502 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.131 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.409999999999997 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 52.25 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 362' ' ' VAL . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 386' ' ' VAL . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 111.114 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.509999999999998 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.340000000000003 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 382' ' ' ALA . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.096 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 359' ' ' ILE . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 111.135 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 361' ' ' SER . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 357' ' ' ASP . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 44.009999999999998 111.064 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.240000000000002 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 54.140000000000001 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.239999999999995 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 61.039999999999999 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.530000000000001 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.707 0.211 . . . . 75.019999999999996 112.414 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 387' ' ' THR . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.103 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 44.240000000000002 111.113 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 386' ' ' VAL . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.144 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 386' ' ' VAL . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.841 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.099999999999994 110.825 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.486 -0.246 . . . . 75.420000000000002 112.486 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 347' ' ' ALA . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 110.87 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 336' ' ' ILE . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.340000000000003 111.133 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.099999999999994 111.143 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.230000000000004 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 41.310000000000002 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 54.549999999999997 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.039999999999999 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.030000000000001 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.040000000000006 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 327' ' ' ILE . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.11 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 72.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 359' ' ' ILE . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 61.420000000000002 111.137 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.439999999999998 110.906 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 324' ' ' GLY . 67.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.746 0.308 . . . . 73.420000000000002 110.924 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 52.0 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 325' ' ' PHE . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.094 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.340000000000003 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.329999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.477 ' HG2' HD11 ' A' ' 314' ' ' ILE . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 74.5 110.934 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 71.340000000000003 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.120000000000005 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 41.200000000000003 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.528 ' HB3' HD13 ' A' ' 338' ' ' ILE . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.109999999999999 110.833 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 338' ' ' ILE . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 111.152 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 389' ' ' ILE . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 110.951 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 367' ' ' LEU . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.182 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 32.329999999999998 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 64.420000000000002 111.148 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 64.019999999999996 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 362' ' ' VAL . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.966 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.129999999999995 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 72.25 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 54.240000000000002 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 53.409999999999997 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 52.25 111.115 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 362' ' ' VAL . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 110.956 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.239999999999995 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.509999999999998 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.340000000000003 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 317' ' ' HIS . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 111.16 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 314' ' ' ILE . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 55.240000000000002 111.165 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 111.118 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 360' ' ' LEU . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 44.009999999999998 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 61.240000000000002 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.140000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 328' ' ' ILE . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.844 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.756 0.232 . . . . 75.019999999999996 112.275 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 387' ' ' THR . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.140000000000001 110.877 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 111.158 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 63.439999999999998 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.099999999999994 110.913 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.516 -0.234 . . . . 75.420000000000002 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.140000000000001 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.230000000000004 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 54.549999999999997 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.039999999999999 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.040000000000006 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.75 HD12 ' CB ' ' A' ' 357' ' ' ASP . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 61.420000000000002 111.087 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.529 ' H ' HG22 ' A' ' 338' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.911 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 52.0 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.908 ' HB1' HD12 ' A' ' 353' ' ' LEU . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.102 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 71.310000000000002 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 73.340000000000003 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.329999999999998 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.5 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.908 HD12 ' HB1' ' A' ' 347' ' ' ALA . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.913 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 71.430000000000007 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 41.200000000000003 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.75 ' CB ' HD12 ' A' ' 338' ' ' ILE . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.109999999999999 110.862 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 338' ' ' ILE . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.310000000000002 111.114 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.140000000000001 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.758 HG21 HD12 ' A' ' 379' ' ' LEU . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 111.181 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.010000000000005 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 32.329999999999998 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 362' ' ' VAL . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.1 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.589 HD13 HG12 ' A' ' 362' ' ' VAL . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.319999999999993 110.922 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.319999999999993 111.149 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.534 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.879 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 53.409999999999997 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 52.25 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.758 HD12 HG21 ' A' ' 362' ' ' VAL . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.897 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 71.530000000000001 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.509999999999998 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.340000000000003 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 55.240000000000002 111.094 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 362' ' ' VAL . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.161 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 64.439999999999998 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.019999999999996 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 54.140000000000001 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 61.039999999999999 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.239999999999995 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.530000000000001 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.746 0.228 . . . . 75.019999999999996 112.42 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 71.140000000000001 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 316' ' ' ILE . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 111.095 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 44.240000000000002 111.157 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.677 HD11 HG23 ' A' ' 314' ' ' ILE . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 111.126 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 316' ' ' ILE . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.903 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.099999999999994 110.781 -179.845 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.491 -0.243 . . . . 75.420000000000002 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.686 HG21 ' CE1' ' A' ' 397' ' ' TYR . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.099999999999994 111.075 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.230000000000004 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 41.310000000000002 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 54.549999999999997 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.039999999999999 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.030000000000001 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 336' ' ' ILE . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.040000000000006 112.516 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 335' ' ' GLY . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 111.107 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 328' ' ' ILE . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.892 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 357' ' ' ASP . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 61.420000000000002 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.420000000000002 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 342' ' ' LEU . 13.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 73.420000000000002 110.917 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.319999999999993 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 52.0 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.310000000000002 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.329999999999998 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 314' ' ' ILE . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 74.5 110.879 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 338' ' ' ILE . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 110.924 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 41.200000000000003 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.109999999999999 110.785 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.92 HD12 HG21 ' A' ' 388' ' ' ILE . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.310000000000002 111.109 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.721 HD13 HG22 ' A' ' 389' ' ' ILE . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.975 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 362' ' ' VAL . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.400000000000006 111.151 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.010000000000005 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 32.329999999999998 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.519 HG21 ' HB1' ' A' ' 378' ' ' ALA . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 64.420000000000002 111.133 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 64.019999999999996 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.584 HD12 HG21 ' A' ' 359' ' ' ILE . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.879 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.299999999999997 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 53.409999999999997 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 52.25 111.166 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 379' ' ' LEU . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.836 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.509999999999998 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.340000000000003 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 316' ' ' ILE . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 111.17 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 55.240000000000002 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.92 HG21 HD12 ' A' ' 359' ' ' ILE . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.072 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.721 HG22 HD13 ' A' ' 360' ' ' LEU . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 353' ' ' LEU . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 44.009999999999998 111.089 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.019999999999996 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.530000000000001 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 61.240000000000002 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' TYR . . . . . 0.686 ' CE1' HG21 ' A' ' 328' ' ' ILE . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 110.892 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 72.239999999999995 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.530000000000001 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.779 0.241 . . . . 75.019999999999996 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 387' ' ' THR . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 71.140000000000001 110.84 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 44.240000000000002 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.450000000000003 111.11 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 63.439999999999998 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.92 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.495 -0.242 . . . . 75.420000000000002 112.495 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.109999999999999 110.902 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.578 HD11 HG12 ' A' ' 336' ' ' ILE . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.219 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.696 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 111.129 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.230000000000004 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 41.310000000000002 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 54.549999999999997 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.039999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.030000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.040000000000006 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.578 HG12 HD11 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 111.114 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' A' ' 328' ' ' ILE . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.430000000000007 110.889 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 359' ' ' ILE . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 61.420000000000002 111.13 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.439999999999998 110.897 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.835 0.35 . . . . 73.420000000000002 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.319999999999993 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 52.0 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.209999999999994 111.069 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.329999999999998 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 74.5 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 390' ' ' ALA . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.87 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.430000000000007 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 41.200000000000003 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.109999999999999 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.450000000000003 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 327' ' ' ILE . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.164 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' SER . . . . . 0.652 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.808 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 388' ' ' ILE . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.400000000000006 111.151 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 32.329999999999998 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 370' ' ' ALA . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.898 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 367' ' ' LEU . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.319999999999993 111.135 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.129999999999995 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.25 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.073 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 111.122 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.409999999999997 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 52.25 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 376' ' ' ALA . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 74.040000000000006 110.899 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.530000000000001 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' A' ' 316' ' ' ILE . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.125 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 313' ' ' ARG . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.240000000000002 111.101 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.733 ' CG1' HG13 ' A' ' 362' ' ' VAL . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 111.109 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.652 HD12 ' OG ' ' A' ' 361' ' ' SER . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 44.009999999999998 111.086 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 64.439999999999998 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.019999999999996 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.530000000000001 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 61.240000000000002 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 54.140000000000001 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 61.039999999999999 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 328' ' ' ILE . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.887 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.794 0.248 . . . . 75.019999999999996 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 390' ' ' ALA . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.152 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 44.240000000000002 111.147 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.450000000000003 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 63.439999999999998 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.855 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.464 -0.255 . . . . 75.420000000000002 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.109999999999999 110.831 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ILE . . . . . 0.81 HG12 HD11 ' A' ' 336' ' ' ILE . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.135 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.099999999999994 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLY . . . . . 0.645 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.230000000000004 112.457 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 41.310000000000002 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.039999999999999 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.040000000000006 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.81 HD11 HG12 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.159 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 72.430000000000007 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.825 HD12 ' HB2' ' A' ' 357' ' ' ASP . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.106 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.439999999999998 110.892 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.859 0.361 . . . . 73.420000000000002 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.319999999999993 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 64.310000000000002 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 71.310000000000002 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.329999999999998 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 74.5 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.696 HD21 HD11 ' A' ' 388' ' ' ILE . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.914 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.120000000000005 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 41.200000000000003 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.825 ' HB2' HD12 ' A' ' 338' ' ' ILE . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.855 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.641 HG22 HD12 ' A' ' 367' ' ' LEU . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 111.145 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.757 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.919 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 367' ' ' LEU . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.400000000000006 111.106 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 32.329999999999998 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 359' ' ' ILE . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.847 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.530000000000001 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.129999999999995 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 54.240000000000002 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 53.409999999999997 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.120000000000005 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.509999999999998 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 316' ' ' ILE . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 111.115 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 55.240000000000002 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.696 HD11 HD21 ' A' ' 353' ' ' LEU . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.152 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.757 ' CG2' HD13 ' A' ' 360' ' ' LEU . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 357' ' ' ASP . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 44.009999999999998 111.139 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 64.439999999999998 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.019999999999996 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 61.039999999999999 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.530000000000001 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 311' ' ' PRO . . . . . 0.419 ' HB3' HD12 ' A' ' 360' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.845 0.269 . . . . 75.019999999999996 112.26 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ARG . . . . . 0.658 ' HA ' HD13 ' A' ' 389' ' ' ILE . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 352' ' ' GLU . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.166 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 44.240000000000002 111.156 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 315' ' ' VAL . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.068 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.439999999999998 110.868 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.915 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.453 -0.259 . . . . 75.420000000000002 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 379' ' ' LEU . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.109999999999999 110.934 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 41.310000000000002 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.409999999999997 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 54.549999999999997 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.039999999999999 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.030000000000001 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.040000000000006 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.153 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 359' ' ' ILE . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.116 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.439999999999998 110.914 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.785 0.326 . . . . 73.420000000000002 110.888 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.319999999999993 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 52.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 349' ' ' LEU . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 350' ' ' SER . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.909 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' SER . . . . . 0.588 ' N ' HD12 ' A' ' 349' ' ' LEU . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.859 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.329999999999998 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.725 ' HB3' HD13 ' A' ' 314' ' ' ILE . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 74.5 110.916 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 41.200000000000003 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.109999999999999 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 63.450000000000003 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 338' ' ' ILE . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.310000000000002 111.07 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 311' ' ' PRO . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 64.329999999999998 110.98 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 388' ' ' ILE . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.400000000000006 111.061 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.611 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.010000000000005 110.919 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 32.329999999999998 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 362' ' ' VAL . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.103 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.019999999999996 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 359' ' ' ILE . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.901 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.510000000000005 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 53.409999999999997 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 52.25 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 325' ' ' PHE . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 74.040000000000006 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.120000000000005 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.530000000000001 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ALA . . . . . 0.706 ' HB1' HG21 ' A' ' 386' ' ' VAL . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.137 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.509999999999998 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' VAL . . . . . 0.706 HG21 ' HB1' ' A' ' 382' ' ' ALA . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 55.240000000000002 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 359' ' ' ILE . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.148 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 313' ' ' ARG . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.5 ' HB3' HD11 ' A' ' 314' ' ' ILE . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 44.009999999999998 111.086 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.019999999999996 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 61.240000000000002 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 54.140000000000001 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 61.039999999999999 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 72.239999999999995 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.735 0.223 . . . . 75.019999999999996 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 388' ' ' ILE . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.102 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.639 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.240000000000002 111.149 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 315' ' ' VAL . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 111.105 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 63.439999999999998 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.891 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 324' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.457 -0.257 . . . . 75.420000000000002 112.457 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.109999999999999 110.922 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 72.340000000000003 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.099999999999994 111.095 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.230000000000004 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 41.310000000000002 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.409999999999997 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 54.549999999999997 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.039999999999999 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.030000000000001 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.040000000000006 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.129999999999995 111.154 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 357' ' ' ASP . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 61.420000000000002 111.161 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.420000000000002 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.934 -179.913 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 342' ' ' LEU . . . . . 0.547 HD12 ' HA2' ' A' ' 324' ' ' GLY . 46.2 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.785 0.326 . . . . 73.420000000000002 110.932 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 52.0 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.11 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.340000000000003 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.329999999999998 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 74.5 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 388' ' ' ILE . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 41.200000000000003 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ASP . . . . . 0.586 ' HB2' HD13 ' A' ' 338' ' ' ILE . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.109999999999999 110.901 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.450000000000003 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 64.329999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.672 HG22 HG22 ' A' ' 388' ' ' ILE . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 111.151 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 32.329999999999998 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.633 HD22 ' CG2' ' A' ' 362' ' ' VAL . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.913 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.25 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 53.409999999999997 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' ALA . . . . . 0.459 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 52.25 111.097 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 110.907 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.509999999999998 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.420000000000002 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 314' ' ' ILE . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 55.240000000000002 111.147 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 314' ' ' ILE . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.430000000000007 111.076 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.473 ' HB1' ' CG ' ' A' ' 357' ' ' ASP . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 44.009999999999998 111.139 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.439999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.019999999999996 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 61.240000000000002 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 54.140000000000001 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.039999999999999 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 328' ' ' ILE . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.873 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.340000000000003 111.083 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.917 0.389 . . . . 72.530000000000001 110.864 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.46 -64.88 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 51.520000000000003 110.882 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.94 -168.81 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 53.149999999999999 112.498 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -102.02 120.89 41.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 71.230000000000004 110.878 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -153.2 -176.9 5.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.140000000000001 110.899 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.93 -171.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.340000000000003 110.853 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 23.7 mt 64.27 77.12 0.31 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 74.430000000000007 111.116 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.19 18.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 72.420000000000002 112.307 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -54.4 101.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 52.100000000000001 110.895 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.08 160.06 71.86 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.010000000000005 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 145.38 56.85 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 75.019999999999996 112.321 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.665 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 44.240000000000002 111.077 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 385' ' ' THR . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.123 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -41.99 120.09 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 71.099999999999994 110.876 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.46 -27.06 16.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.239999999999995 112.511 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.1 m -51.24 -34.75 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.829 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -108.99 26.99 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 70.019999999999996 111.19 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.43 54.74 2.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 65.430000000000007 112.501 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 1.4 tp -93.63 -25.67 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 64.239999999999995 110.925 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.02 -37.25 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 75.420000000000002 112.452 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 376' ' ' ALA . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 111.153 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.487 ' C ' HD12 ' A' ' 336' ' ' ILE . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.155 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 41.310000000000002 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.039999999999999 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.030000000000001 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 328' ' ' ILE . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.141 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 359' ' ' ILE . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 61.420000000000002 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.92 155.76 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.439999999999998 110.897 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt -103.02 120.36 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 124.36 3.254 . . . . 73.420000000000002 110.925 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.319999999999993 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 52.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 316' ' ' ILE . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 71.310000000000002 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.329999999999998 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 74.5 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 390' ' ' ALA . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.340000000000003 110.905 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.109999999999999 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.4 ' OE1' HD11 ' A' ' 360' ' ' LEU . 0.8 OUTLIER -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.450000000000003 110.925 -179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 338' ' ' ILE . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.732 HD13 HG22 ' A' ' 389' ' ' ILE . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 110.878 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.882 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.706 HG12 HG12 ' A' ' 388' ' ' ILE . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.400000000000006 111.163 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.631 ' HB3' HG23 ' A' ' 386' ' ' VAL . 2.1 p-10 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.916 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 32.329999999999998 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 64.420000000000002 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.019999999999996 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 362' ' ' VAL . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.982 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.510000000000005 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.319999999999993 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.129999999999995 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.42 ' HA ' HD13 ' A' ' 336' ' ' ILE . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.299999999999997 110.859 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 72.25 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.121 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 52.25 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 71.530000000000001 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 386' ' ' VAL . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.097 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.509999999999998 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.340000000000003 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 316' ' ' ILE . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 382' ' ' ALA . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 111.136 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.706 HG12 HG12 ' A' ' 362' ' ' VAL . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 111.13 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.732 HG22 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 44.009999999999998 111.1 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 64.439999999999998 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.530000000000001 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 54.140000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.239999999999995 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 302' ' ' LEU . 39.5 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.877 0.37 . . . . 72.530000000000001 110.833 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 301' ' ' PHE . 12.9 mt -128.23 150.26 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 51.520000000000003 110.971 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -81.07 90.28 1.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.708 -0.758 . . . . 53.149999999999999 112.518 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -96.03 -49.22 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 71.230000000000004 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -52.43 -52.05 55.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.853 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -172.22 168.43 5.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 60.340000000000003 110.859 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.28 69.44 14.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.634 0.73 . . . . 74.430000000000007 111.114 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.725 2.283 . . . . 72.420000000000002 112.321 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.07 36.73 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 52.100000000000001 110.941 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -87.1 160.47 49.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 74.010000000000005 110.912 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 129.64 17.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 2.251 . . . . 75.019999999999996 112.353 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.612 HD12 HD23 ' A' ' 353' ' ' LEU . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 111.127 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 44.240000000000002 111.137 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 386' ' ' VAL . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.146 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.461 ' O ' HG12 ' A' ' 386' ' ' VAL . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 110.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -45.24 140.74 2.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 110.825 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -132.01 35.15 2.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 74.239999999999995 112.458 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 6.5 p -67.53 -35.82 79.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.403 . . . . 74.129999999999995 110.846 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.7 m -124.97 27.0 6.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 70.019999999999996 111.205 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -176.72 105.94 0.21 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.721 -0.752 . . . . 65.430000000000007 112.461 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.4 -46.74 7.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 64.239999999999995 110.862 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 347' ' ' ALA . . . 78.55 27.71 56.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 75.420000000000002 112.517 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.109999999999999 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 327' ' ' ILE . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 111.174 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.230000000000004 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 41.310000000000002 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.409999999999997 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 54.549999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.039999999999999 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.030000000000001 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.040000000000006 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 359' ' ' ILE . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.420000000000002 111.161 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -162.45 141.92 9.38 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.439999999999998 110.877 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt -89.28 131.76 35.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 124.415 3.28 . . . . 73.420000000000002 110.936 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.319999999999993 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 52.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 324' ' ' GLY . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 111.104 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 316' ' ' ILE . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.814 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.329999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 314' ' ' ILE . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 74.5 110.908 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 388' ' ' ILE . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 41.200000000000003 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.593 ' HB2' HD13 ' A' ' 338' ' ' ILE . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.109999999999999 110.868 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 338' ' ' ILE . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 65.310000000000002 111.168 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 389' ' ' ILE . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.805 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.715 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.400000000000006 111.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 32.329999999999998 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 64.420000000000002 111.142 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 64.019999999999996 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 359' ' ' ILE . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.898 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.319999999999993 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.299999999999997 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 54.240000000000002 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 52.25 111.097 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.715 ' CD2' HG21 ' A' ' 362' ' ' VAL . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.96 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 316' ' ' ILE . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.420000000000002 111.081 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 55.240000000000002 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 111.129 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.425 HD12 ' OG ' ' A' ' 361' ' ' SER . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 44.009999999999998 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.530000000000001 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 54.140000000000001 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 61.039999999999999 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 72.530000000000001 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.23 156.59 34.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 51.520000000000003 110.876 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -162.28 -176.43 34.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.749 . . . . 53.149999999999999 112.467 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -147.03 171.64 14.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.304 . . . . 71.230000000000004 110.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -175.71 147.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.140000000000001 110.835 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -58.87 -178.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 60.340000000000003 110.853 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 307' ' ' ILE . 4.0 tp -177.72 82.08 0.24 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.626 0.727 . . . . 74.430000000000007 111.08 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 175.43 8.11 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.739 2.293 . . . . 72.420000000000002 112.407 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -169.94 158.91 7.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 52.100000000000001 110.874 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.06 160.74 59.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 74.010000000000005 110.911 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 119.7 6.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.673 2.249 . . . . 75.019999999999996 112.323 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' A' ' 352' ' ' GLU . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.693 ' O ' HD13 ' A' ' 316' ' ' ILE . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.196 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 315' ' ' VAL . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.131 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 316' ' ' ILE . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.826 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -48.06 121.55 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 71.099999999999994 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -129.24 55.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 74.239999999999995 112.448 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.7 p -90.71 11.12 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.901 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.3 m -110.3 27.02 10.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 70.019999999999996 111.159 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.35 106.0 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 65.430000000000007 112.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 386' ' ' VAL . 9.5 mt -69.72 -33.12 72.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 64.239999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.47 50.63 2.52 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 75.420000000000002 112.497 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.109999999999999 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 327' ' ' ILE . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.118 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 54.549999999999997 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.040000000000006 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 359' ' ' ILE . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 61.420000000000002 111.096 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -148.39 167.57 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.439999999999998 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.0 139.63 58.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 124.363 3.256 . . . . 73.420000000000002 110.893 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.319999999999993 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 52.0 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.635 ' HB2' HD11 ' A' ' 314' ' ' ILE . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.856 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 314' ' ' ILE . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 74.5 110.884 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 41.200000000000003 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.109999999999999 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 338' ' ' ILE . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.08 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 389' ' ' ILE . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.329999999999998 110.894 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 HG13 ' A' ' 388' ' ' ILE . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.400000000000006 111.108 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 64.019999999999996 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 359' ' ' ILE . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.906 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.510000000000005 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.319999999999993 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.129999999999995 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.299999999999997 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.240000000000002 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 53.409999999999997 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 52.25 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.120000000000005 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 71.530000000000001 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.509999999999998 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.585 HG21 HD21 ' A' ' 323' ' ' LEU . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 111.085 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 55.240000000000002 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.62 HG13 HG12 ' A' ' 362' ' ' VAL . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 111.155 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.651 HG22 HD12 ' A' ' 360' ' ' LEU . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 44.009999999999998 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 64.439999999999998 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.019999999999996 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.530000000000001 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 61.240000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 54.140000000000001 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.239999999999995 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 61.039999999999999 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 302' ' ' LEU . 5.7 t80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.826 0.346 . . . . 72.530000000000001 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 301' ' ' PHE . 6.6 mt -129.22 177.65 7.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 51.520000000000003 110.936 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -106.17 -174.29 23.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.75 . . . . 53.149999999999999 112.434 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -108.64 -69.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 71.230000000000004 110.92 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -175.18 108.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 74.140000000000001 110.886 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.42 131.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 60.340000000000003 110.839 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 4.8 pt -124.72 67.65 51.04 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.613 0.721 . . . . 74.430000000000007 111.115 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.95 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.743 2.295 . . . . 72.420000000000002 112.337 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -89.06 -41.74 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 52.100000000000001 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.93 160.85 1.99 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.581 0.705 . . . . 74.010000000000005 110.935 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 126.69 13.64 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 75.019999999999996 112.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 71.140000000000001 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 352' ' ' GLU . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.121 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.586 HG21 HD22 ' A' ' 302' ' ' LEU . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 44.240000000000002 111.179 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 314' ' ' ILE . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.179 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 110.85 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -42.51 137.7 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.851 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -70.93 81.65 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 74.239999999999995 112.453 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.02 -33.86 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 74.129999999999995 110.881 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.802 HG23 ' HD3' ' A' ' 346' ' ' PRO . 8.9 t -126.19 27.21 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 70.019999999999996 111.093 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.65 -27.87 13.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 65.430000000000007 112.431 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 9.4 tp -52.7 -24.05 7.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 64.239999999999995 110.861 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -46.38 -36.1 7.43 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 75.420000000000002 112.486 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.109999999999999 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 338' ' ' ILE . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 339' ' ' SER . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.128 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.513 ' CA ' HD12 ' A' ' 336' ' ' ILE . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.230000000000004 112.522 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 41.310000000000002 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.409999999999997 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 54.549999999999997 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.039999999999999 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.030000000000001 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.040000000000006 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.513 HD12 ' CA ' ' A' ' 329' ' ' GLY . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 111.134 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 359' ' ' ILE . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.112 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' SER . . . . . 0.639 ' HB2' HD12 ' A' ' 328' ' ' ILE . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.844 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.9 167.63 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.439999999999998 110.858 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 343' ' ' ALA . 0.7 OUTLIER -107.43 147.58 30.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 124.399 3.272 . . . . 73.420000000000002 110.91 169.342 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 342' ' ' LEU . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.105 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 52.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' PRO . . . . . 0.802 ' HD3' HG23 ' A' ' 321' ' ' THR . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.209999999999994 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 71.310000000000002 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.745 ' CB ' HD11 ' A' ' 314' ' ' ILE . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.329999999999998 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 314' ' ' ILE . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 74.5 110.908 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 388' ' ' ILE . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 71.340000000000003 110.906 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 41.200000000000003 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.109999999999999 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 63.450000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 338' ' ' ILE . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 65.310000000000002 111.15 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.902 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 388' ' ' ILE . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.112 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 32.329999999999998 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 362' ' ' VAL . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.152 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 362' ' ' VAL . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.530000000000001 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.129999999999995 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.299999999999997 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.25 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 54.240000000000002 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 52.25 111.086 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 362' ' ' VAL . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 74.040000000000006 110.968 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.113 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.420000000000002 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.151 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 360' ' ' LEU . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 44.009999999999998 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.019999999999996 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.530000000000001 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 61.039999999999999 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PHE . . . . . 0.511 ' CG ' HG21 ' A' ' 328' ' ' ILE . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.855 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.340000000000003 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.340000000000003 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 72.530000000000001 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.01 -59.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 51.520000000000003 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -59.68 133.51 51.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 53.149999999999999 112.514 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.94 -46.58 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 71.230000000000004 110.931 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -89.23 57.27 3.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 74.140000000000001 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -122.65 -35.47 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 60.340000000000003 110.857 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 307' ' ' ILE . 1.3 pp -121.4 158.96 52.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.430000000000007 111.164 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -31.26 21.03 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.683 2.255 . . . . 72.420000000000002 112.324 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -89.86 74.45 7.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 52.100000000000001 110.87 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.33 121.41 84.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 74.010000000000005 110.871 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 158.59 56.45 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.701 2.267 . . . . 75.019999999999996 112.396 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 387' ' ' THR . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.878 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.687 HG21 ' HG ' ' A' ' 353' ' ' LEU . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 111.159 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -46.74 124.32 5.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -137.55 130.4 5.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 74.239999999999995 112.472 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.4 t -93.14 -39.98 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 110.825 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.5 p -132.02 17.4 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 70.019999999999996 111.207 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 47.54 36.64 12.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 65.430000000000007 112.439 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.1 mt -50.88 -30.72 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 64.239999999999995 110.896 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.05 -29.83 15.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 75.420000000000002 112.46 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 110.893 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.140000000000001 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.791 HG23 ' HB2' ' A' ' 339' ' ' SER . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.162 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.230000000000004 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 41.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.409999999999997 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.549999999999997 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.039999999999999 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.030000000000001 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.121 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.706 ' CD1' HD11 ' A' ' 359' ' ' ILE . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.106 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' SER . . . . . 0.791 ' HB2' HG23 ' A' ' 328' ' ' ILE . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 110.907 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -162.26 167.52 23.81 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.439999999999998 110.872 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.08 132.66 52.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 124.396 3.271 . . . . 73.420000000000002 110.981 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.319999999999993 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 52.0 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.083 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 64.310000000000002 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.329999999999998 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.52 ' HB3' HD12 ' A' ' 314' ' ' ILE . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 74.5 110.928 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.687 ' HG ' HG21 ' A' ' 314' ' ' ILE . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 110.882 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 41.200000000000003 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.109999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.450000000000003 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.839 HG21 HD12 ' A' ' 367' ' ' LEU . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 64.329999999999998 110.908 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 389' ' ' ILE . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.835 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG1' HD11 ' A' ' 367' ' ' LEU . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.400000000000006 111.087 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.010000000000005 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.568 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.173 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 64.019999999999996 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 359' ' ' ILE . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.873 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.510000000000005 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.129999999999995 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.299999999999997 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 53.409999999999997 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 52.25 111.074 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 386' ' ' VAL . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 74.040000000000006 110.922 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.120000000000005 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.509999999999998 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 379' ' ' LEU . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.15 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 314' ' ' ILE . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 55.240000000000002 111.1 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.476 HG22 ' HB ' ' A' ' 362' ' ' VAL . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.077 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 361' ' ' SER . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 44.009999999999998 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 64.439999999999998 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 61.240000000000002 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 54.140000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 61.039999999999999 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 72.239999999999995 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 6.1 t80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.373 . . . . 72.530000000000001 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 12.1 mt -133.95 93.39 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 51.520000000000003 110.908 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.2 178.3 45.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 53.149999999999999 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 60.72 56.46 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 71.230000000000004 110.877 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 37.64 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.942 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.561 ' O ' HD13 ' A' ' 307' ' ' ILE . 68.1 m-20 -113.31 -75.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 60.340000000000003 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 306' ' ' ASP . 26.7 mm -139.16 67.5 40.01 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 74.430000000000007 111.183 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 2.259 . . . . 72.420000000000002 112.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 32.5 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 52.100000000000001 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -87.43 160.28 48.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.649 0.738 . . . . 74.010000000000005 110.921 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 121.28 7.99 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.303 . . . . 75.019999999999996 112.362 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.726 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 71.140000000000001 110.936 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 353' ' ' LEU . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.329999999999998 111.05 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 315' ' ' VAL . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 44.240000000000002 111.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 385' ' ' THR . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.198 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -44.97 118.85 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 71.099999999999994 110.81 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.35 33.29 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 74.239999999999995 112.484 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.0 t -62.15 -36.25 81.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 18.1 p -101.98 26.99 6.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 70.019999999999996 111.069 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.51 101.34 0.16 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.745 -0.74 . . . . 65.430000000000007 112.493 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -94.59 -47.46 6.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 64.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 74.16 33.37 57.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 75.420000000000002 112.428 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.663 ' O ' HD12 ' A' ' 323' ' ' LEU . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.856 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.099999999999994 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.230000000000004 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 41.310000000000002 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 54.549999999999997 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.039999999999999 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.030000000000001 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.129999999999995 111.226 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 359' ' ' ILE . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -151.32 167.23 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.439999999999998 110.922 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.67 139.94 30.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 124.308 3.231 . . . . 73.420000000000002 110.918 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.319999999999993 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 52.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 353' ' ' LEU . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 111.101 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 64.310000000000002 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.329999999999998 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.5 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.923 HD22 HD11 ' A' ' 388' ' ' ILE . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.905 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 41.200000000000003 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 338' ' ' ILE . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 111.109 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 64.329999999999998 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.999 HG12 HG22 ' A' ' 388' ' ' ILE . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.400000000000006 111.144 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.010000000000005 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 32.329999999999998 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 64.420000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 64.019999999999996 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.747 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.916 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.530000000000001 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.747 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.319999999999993 111.094 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.129999999999995 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.25 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 54.240000000000002 111.12 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 53.409999999999997 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 382' ' ' ALA . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.948 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.239999999999995 111.111 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.509999999999998 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.340000000000003 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 316' ' ' ILE . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 388' ' ' ILE . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.12 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.999 HG22 HG12 ' A' ' 362' ' ' VAL . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.154 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 44.009999999999998 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.019999999999996 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.530000000000001 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 61.039999999999999 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.82 0.343 . . . . 72.530000000000001 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 tp -165.0 159.36 17.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 51.520000000000003 110.889 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -139.76 -174.52 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.818 -0.706 . . . . 53.149999999999999 112.508 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.86 155.76 7.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.913 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -175.52 156.18 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.866 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.38 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 60.340000000000003 110.911 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.427 HG22 ' HG3' ' A' ' 309' ' ' ARG . 30.6 mm -123.22 67.86 36.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 74.430000000000007 111.143 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -33.15 17.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.699 2.266 . . . . 72.420000000000002 112.257 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 307' ' ' ILE . 35.8 mtp180 54.11 34.01 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 52.100000000000001 110.83 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.29 160.18 49.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 74.010000000000005 110.86 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 119.47 6.41 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.726 2.284 . . . . 75.019999999999996 112.397 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.755 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.858 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 353' ' ' LEU . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 111.154 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 386' ' ' VAL . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.196 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.439999999999998 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -46.69 126.02 7.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.843 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -126.73 35.23 2.95 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.799 -0.715 . . . . 74.239999999999995 112.543 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.5 p -74.62 -39.72 61.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.391 . . . . 74.129999999999995 110.779 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -117.9 27.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 70.019999999999996 111.107 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.34 103.49 0.18 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 65.430000000000007 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 325' ' ' PHE . 4.1 mm? -88.54 -46.51 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 64.239999999999995 110.921 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.49 55.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 75.420000000000002 112.515 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.751 ' CZ ' HD12 ' A' ' 323' ' ' LEU . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.915 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 72.340000000000003 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.230000000000004 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 41.310000000000002 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.409999999999997 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 54.549999999999997 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.030000000000001 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.040000000000006 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.109 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 357' ' ' ASP . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 61.420000000000002 111.162 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -159.87 129.89 5.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.439999999999998 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt -93.65 115.68 28.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 124.324 3.238 . . . . 73.420000000000002 110.924 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.319999999999993 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 52.0 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.329999999999998 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 74.5 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 390' ' ' ALA . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.944 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 41.200000000000003 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.813 ' HB2' HD12 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.109999999999999 110.883 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 359' ' ' ILE . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 111.165 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 389' ' ' ILE . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 64.329999999999998 110.882 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 1.025 HG12 HG22 ' A' ' 388' ' ' ILE . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 111.13 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 32.329999999999998 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 64.420000000000002 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.404 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 64.019999999999996 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.879 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.755 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.319999999999993 111.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.299999999999997 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 54.240000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.25 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 323' ' ' LEU . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.530000000000001 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.91 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.135 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.509999999999998 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.91 HG22 ' HB1' ' A' ' 382' ' ' ALA . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.067 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.142 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 1.025 HG22 HG12 ' A' ' 362' ' ' VAL . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.175 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 360' ' ' LEU . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 44.009999999999998 111.097 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 64.439999999999998 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 61.240000000000002 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.239999999999995 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 61.039999999999999 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 72.239999999999995 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.896 0.379 . . . . 72.530000000000001 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 302' ' ' LEU . 15.4 mt -123.6 -74.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 51.520000000000003 110.932 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.34 41.54 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.759 -0.734 . . . . 53.149999999999999 112.527 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -168.91 166.43 11.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 71.230000000000004 110.883 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -127.09 68.13 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.909 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.35 -177.11 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 60.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.93 63.73 4.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 111.118 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -49.76 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 72.420000000000002 112.31 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -179.15 167.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.100000000000001 110.856 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.59 138.47 31.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.691 0.758 . . . . 74.010000000000005 110.847 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 147.11 61.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 75.019999999999996 112.322 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.895 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 353' ' ' LEU . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.450000000000003 111.131 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.425 ' N ' HG22 ' A' ' 316' ' ' ILE . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 110.859 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -47.91 128.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.099999999999994 110.915 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -107.89 105.29 2.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.783 -0.722 . . . . 74.239999999999995 112.487 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 93.6 p -94.94 -40.1 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 74.129999999999995 110.841 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 21.0 p -131.97 5.51 4.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 111.16 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.57 50.51 36.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 65.430000000000007 112.433 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.695 ' O ' HD12 ' A' ' 342' ' ' LEU . 11.4 mt -83.43 -34.08 25.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 64.239999999999995 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.76 -31.54 23.69 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 75.420000000000002 112.435 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.109999999999999 110.882 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 376' ' ' ALA . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 111.121 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.74 ' O ' HD12 ' A' ' 336' ' ' ILE . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.099999999999994 111.15 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.230000000000004 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 41.310000000000002 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.409999999999997 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 54.549999999999997 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.039999999999999 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.030000000000001 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.040000000000006 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 328' ' ' ILE . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.114 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 357' ' ' ASP . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.09 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -154.47 153.99 32.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.439999999999998 110.949 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 323' ' ' LEU . 13.7 mt -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 124.343 3.247 . . . . 73.420000000000002 110.908 169.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 52.0 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.453 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.087 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.329999999999998 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 74.5 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 388' ' ' ILE . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 110.96 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 338' ' ' ILE . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.109999999999999 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 63.450000000000003 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.310000000000002 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 64.329999999999998 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 110.877 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.659 HG22 HG22 ' A' ' 388' ' ' ILE . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.400000000000006 111.146 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.888 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 32.329999999999998 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 362' ' ' VAL . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 64.420000000000002 111.067 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 64.019999999999996 110.874 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.642 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 111.001 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.510000000000005 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.319999999999993 111.19 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.299999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 72.25 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 54.240000000000002 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.096 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 53.409999999999997 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 52.25 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 386' ' ' VAL . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.909 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.239999999999995 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.509999999999998 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.066 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 55.240000000000002 111.101 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 353' ' ' LEU . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 111.118 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 361' ' ' SER . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 44.009999999999998 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.019999999999996 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.530000000000001 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 54.140000000000001 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 61.039999999999999 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.530000000000001 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.866 0.365 . . . . 72.530000000000001 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.32 78.07 1.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 51.520000000000003 110.958 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -101.75 -33.21 4.8 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 53.149999999999999 112.543 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.96 155.51 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 71.230000000000004 110.912 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.05 -57.2 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.140000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 307' ' ' ILE . 3.1 p-10 -96.78 -176.07 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 60.340000000000003 110.917 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 306' ' ' ASP . 11.5 pt 35.58 74.12 0.59 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.604 0.716 . . . . 74.430000000000007 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 78.61 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 72.420000000000002 112.382 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.32 35.63 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 52.100000000000001 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -55.64 160.59 3.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 74.010000000000005 110.918 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 148.33 65.0 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 75.019999999999996 112.373 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.527 ' NE ' HD11 ' A' ' 389' ' ' ILE . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.842 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 44.240000000000002 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.573 HD11 ' HB ' ' A' ' 386' ' ' VAL . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 111.147 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 63.439999999999998 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -47.51 119.88 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.099999999999994 110.883 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -131.98 51.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 74.239999999999995 112.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 78.8 p -53.96 -39.9 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.819 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.9 p -130.28 26.97 5.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 70.019999999999996 111.091 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -138.47 41.59 1.35 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 65.430000000000007 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.88 -46.94 71.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 64.239999999999995 110.884 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 75.82 28.73 60.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 75.420000000000002 112.503 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 72.340000000000003 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.230000000000004 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.409999999999997 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.030000000000001 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.040000000000006 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 375' ' ' ALA . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.155 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.816 HD12 ' HB2' ' A' ' 357' ' ' ASP . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.136 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.66 167.59 21.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.439999999999998 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.54 114.81 5.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 124.407 3.276 . . . . 73.420000000000002 110.892 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 52.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.209999999999994 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 64.310000000000002 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.329999999999998 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 74.5 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 390' ' ' ALA . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.946 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 41.200000000000003 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.816 ' HB2' HD12 ' A' ' 338' ' ' ILE . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.109999999999999 110.875 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 63.450000000000003 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 367' ' ' LEU . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 65.310000000000002 111.082 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 389' ' ' ILE . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.876 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.494 HG22 ' OD1' ' A' ' 363' ' ' ASN . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.126 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.494 ' OD1' HG22 ' A' ' 362' ' ' VAL . 0.8 OUTLIER 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.881 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 32.329999999999998 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 378' ' ' ALA . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 111.143 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.019999999999996 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 359' ' ' ILE . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.129999999999995 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.478 ' OE1' HD12 ' A' ' 377' ' ' ILE . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.94 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 336' ' ' ILE . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 54.240000000000002 111.101 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' ILE . . . . . 0.478 HD12 ' OE1' ' A' ' 374' ' ' GLN . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 53.409999999999997 111.12 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 52.25 111.042 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.530000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.509999999999998 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.340000000000003 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.573 ' HB ' HD11 ' A' ' 316' ' ' ILE . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.173 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 55.240000000000002 111.182 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.54 HG23 HG23 ' A' ' 359' ' ' ILE . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 111.05 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.527 HD11 ' NE ' ' A' ' 313' ' ' ARG . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.74 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 44.009999999999998 111.103 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.019999999999996 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.530000000000001 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.240000000000002 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 54.140000000000001 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 61.039999999999999 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.340000000000003 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 72.530000000000001 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 303' ' ' GLY . 0.3 OUTLIER -131.81 133.31 44.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 51.520000000000003 110.892 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.585 ' N ' HD13 ' A' ' 302' ' ' LEU . . . -159.54 142.73 8.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 53.149999999999999 112.528 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -151.73 172.31 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.342 . . . . 71.230000000000004 110.873 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -101.82 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.898 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.28 174.37 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 60.340000000000003 110.879 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 307' ' ' ILE . 4.1 tp -126.79 80.87 70.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 74.430000000000007 111.089 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.85 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 72.420000000000002 112.288 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -61.9 95.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 52.100000000000001 110.935 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -86.92 137.33 33.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 74.010000000000005 110.899 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 158.59 56.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.662 2.241 . . . . 75.019999999999996 112.348 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 390' ' ' ALA . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 44.240000000000002 111.177 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 317' ' ' HIS . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.075 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.717 ' O ' HD12 ' A' ' 316' ' ' ILE . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.905 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.59 119.02 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 71.099999999999994 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.405 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -113.18 40.17 2.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 74.239999999999995 112.553 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.2 p -90.87 -38.4 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 74.129999999999995 110.83 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.2 m -113.44 27.01 9.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 70.019999999999996 111.103 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.37 106.83 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 65.430000000000007 112.49 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 379' ' ' LEU . 4.0 mt -93.02 -47.11 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 64.239999999999995 110.905 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.88 26.12 63.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 75.420000000000002 112.496 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.109999999999999 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.230000000000004 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 41.310000000000002 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.409999999999997 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.039999999999999 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.030000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 357' ' ' ASP . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 61.420000000000002 111.171 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -160.86 167.56 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 110.863 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.47 131.4 46.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 124.38 3.263 . . . . 73.420000000000002 110.925 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 52.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 71.310000000000002 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.329999999999998 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 74.5 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 338' ' ' ILE . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.109999999999999 110.86 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 389' ' ' ILE . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 64.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 389' ' ' ILE . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.806 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 367' ' ' LEU . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.400000000000006 111.151 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.579 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.010000000000005 110.861 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 32.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 64.420000000000002 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 367' ' ' LEU . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.019999999999996 110.882 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CB ' ' A' ' 370' ' ' ALA . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.959 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.685 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 111.049 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.129999999999995 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 72.25 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 54.240000000000002 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 53.409999999999997 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 52.25 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 323' ' ' LEU . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 110.899 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.081 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.509999999999998 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.340000000000003 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 363' ' ' ASN . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 111.081 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 55.240000000000002 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 312' ' ' ARG . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 44.009999999999998 111.084 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 360' ' ' LEU . 17.5 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.019999999999996 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 61.240000000000002 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 54.140000000000001 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 61.039999999999999 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 72.239999999999995 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 73.340000000000003 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.678 ' O ' HD22 ' A' ' 302' ' ' LEU . 29.8 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.881 0.372 . . . . 72.530000000000001 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 301' ' ' PHE . 4.4 mm? -130.27 122.97 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 51.520000000000003 110.875 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -130.17 -59.68 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.71 -0.757 . . . . 53.149999999999999 112.487 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.98 -176.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.334 . . . . 71.230000000000004 110.912 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -132.95 144.7 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.918 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 307' ' ' ILE . 2.3 m-20 64.14 50.9 2.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 60.340000000000003 110.89 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 306' ' ' ASP . 1.0 OUTLIER -161.98 67.31 2.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.603 0.716 . . . . 74.430000000000007 111.142 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 111.73 2.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.649 2.233 . . . . 72.420000000000002 112.331 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.401 HH11 HD13 ' A' ' 302' ' ' LEU . 0.0 OUTLIER -107.22 55.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 52.100000000000001 110.903 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -80.29 134.93 54.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.742 . . . . 74.010000000000005 110.874 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 75.019999999999996 112.378 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.497 ' NE ' ' HB3' ' A' ' 390' ' ' ALA . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.601 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.883 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 352' ' ' GLU . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.146 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 44.240000000000002 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 63.439999999999998 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -48.37 121.59 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.6 103.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 74.239999999999995 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 20.4 t -60.74 -39.95 90.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 74.129999999999995 110.859 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 24.3 p -132.03 4.53 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 70.019999999999996 111.158 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.4 52.31 28.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 65.430000000000007 112.521 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 342' ' ' LEU . 12.4 mt -51.1 -32.37 22.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 64.239999999999995 110.962 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.87 19.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 75.420000000000002 112.439 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.565 ' HZ ' HG11 ' A' ' 386' ' ' VAL . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.898 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 72.340000000000003 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 41.310000000000002 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.409999999999997 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 54.549999999999997 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.040000000000006 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.129999999999995 111.189 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.829 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.092 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.05 166.45 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.439999999999998 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 323' ' ' LEU . 4.1 mp -80.23 133.77 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.393 3.269 . . . . 73.420000000000002 110.883 169.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.319999999999993 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 52.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.111 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.329999999999998 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.515 ' CB ' HD12 ' A' ' 314' ' ' ILE . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 74.5 110.903 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 338' ' ' ILE . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.949 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 41.200000000000003 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.829 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.109999999999999 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 63.450000000000003 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 367' ' ' LEU . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 111.169 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 391' ' ' GLN . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 64.329999999999998 110.866 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.140000000000001 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 367' ' ' LEU . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.537 ' OD1' HG22 ' A' ' 362' ' ' VAL . 0.8 OUTLIER 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.010000000000005 110.925 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 32.329999999999998 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.541 HG21 ' HB1' ' A' ' 378' ' ' ALA . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.154 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.019999999999996 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.843 HD12 HG21 ' A' ' 359' ' ' ILE . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.923 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.319999999999993 111.153 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.129999999999995 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.299999999999997 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 72.25 110.953 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 54.240000000000002 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 73.420000000000002 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 53.409999999999997 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 52.25 111.027 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 379' ' ' LEU . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 74.040000000000006 110.935 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.509999999999998 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.565 HG11 ' HZ ' ' A' ' 325' ' ' PHE . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 55.240000000000002 111.148 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.44 HG23 HG23 ' A' ' 359' ' ' ILE . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.143 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.497 ' HB3' ' NE ' ' A' ' 312' ' ' ARG . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 44.009999999999998 111.032 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 360' ' ' LEU . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.019999999999996 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 61.240000000000002 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 61.039999999999999 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 30.0 t80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.896 0.379 . . . . 72.530000000000001 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 303' ' ' GLY . 4.0 pp -129.75 -39.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 51.520000000000003 110.904 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLY . . . . . 0.46 ' N ' HD12 ' A' ' 302' ' ' LEU . . . -89.03 163.27 31.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 53.149999999999999 112.541 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -149.18 161.95 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.327 . . . . 71.230000000000004 110.924 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -131.09 -73.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.927 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.2 56.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 60.340000000000003 110.896 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 31.9 mt 51.83 68.06 3.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 74.430000000000007 111.114 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.92 -170.68 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.708 2.272 . . . . 72.420000000000002 112.293 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.99 77.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 52.100000000000001 110.848 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -85.92 137.53 35.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.661 0.743 . . . . 74.010000000000005 110.823 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.602 2.202 . . . . 75.019999999999996 112.363 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ARG . . . . . 0.448 ' NE ' HD11 ' A' ' 314' ' ' ILE . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 352' ' ' GLU . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 111.091 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 44.240000000000002 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.558 ' CD1' HG13 ' A' ' 386' ' ' VAL . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 63.439999999999998 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -44.33 119.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.943 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.81 36.98 1.96 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 74.239999999999995 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.2 t -75.9 -36.29 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 110.927 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.2 p -102.69 27.05 7.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 70.019999999999996 111.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.37 107.42 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 65.430000000000007 112.485 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.681 HD22 HD22 ' A' ' 379' ' ' LEU . 6.4 mt -91.02 -46.54 8.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 110.909 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.68 61.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.792 -0.718 . . . . 75.420000000000002 112.474 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.109999999999999 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.099999999999994 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.230000000000004 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 41.310000000000002 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 54.549999999999997 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.039999999999999 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.030000000000001 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.040000000000006 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.138 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.467 HD12 ' OD1' ' A' ' 357' ' ' ASP . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.420000000000002 111.155 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -157.58 167.85 28.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.02 132.23 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 124.421 3.282 . . . . 73.420000000000002 110.893 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.319999999999993 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 52.0 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 71.310000000000002 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.329999999999998 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 74.5 110.857 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 388' ' ' ILE . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.888 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 41.200000000000003 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.467 ' OD1' HD12 ' A' ' 338' ' ' ILE . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 63.450000000000003 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 359' ' ' ILE . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 65.310000000000002 111.113 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.816 HD12 HG21 ' A' ' 389' ' ' ILE . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 64.329999999999998 110.926 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 32.329999999999998 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 64.019999999999996 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.319999999999993 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.510000000000005 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.530000000000001 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.319999999999993 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.129999999999995 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.299999999999997 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.086 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 53.409999999999997 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.681 HD22 HD22 ' A' ' 323' ' ' LEU . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.530000000000001 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.509999999999998 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.340000000000003 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 316' ' ' ILE . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.420000000000002 111.136 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 55.240000000000002 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 353' ' ' LEU . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 72.430000000000007 111.119 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 360' ' ' LEU . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 44.009999999999998 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 61.240000000000002 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 61.039999999999999 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 72.239999999999995 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.530000000000001 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' PHE . . . . . 0.56 ' C ' HD22 ' A' ' 302' ' ' LEU . 29.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.92 0.39 . . . . 72.530000000000001 110.897 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.56 HD22 ' C ' ' A' ' 301' ' ' PHE . 4.6 mm? -125.32 161.96 25.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.520000000000003 110.907 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -119.99 -79.92 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 53.149999999999999 112.47 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.64 -177.82 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 71.230000000000004 110.859 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -162.1 172.15 16.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.879 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.05 56.22 3.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 60.340000000000003 110.839 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.7 tp -175.65 131.52 0.42 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 74.430000000000007 111.127 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 75.15 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.262 . . . . 72.420000000000002 112.309 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -135.51 59.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 52.100000000000001 110.823 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.24 153.48 66.04 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.010000000000005 110.873 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 158.46 56.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 75.019999999999996 112.312 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 71.140000000000001 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 352' ' ' GLU . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.115 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 44.240000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.487 HD11 ' CD1' ' A' ' 353' ' ' LEU . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.138 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 316' ' ' ILE . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.439999999999998 110.867 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -47.25 119.76 2.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 71.099999999999994 110.863 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -120.58 117.89 3.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 74.239999999999995 112.507 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 70.2 p -93.08 -39.86 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.401 . . . . 74.129999999999995 110.895 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.02 -3.01 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 70.019999999999996 111.163 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.43 37.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.756 . . . . 65.430000000000007 112.504 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 342' ' ' LEU . 2.3 tp -51.44 -31.28 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 64.239999999999995 110.916 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.28 -31.98 20.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 75.420000000000002 112.406 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.577 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 110.864 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.230000000000004 112.507 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 41.310000000000002 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 54.549999999999997 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.039999999999999 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.030000000000001 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.040000000000006 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.443 HD12 ' HA3' ' A' ' 329' ' ' GLY . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 111.178 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 61.420000000000002 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -159.85 167.41 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.867 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 323' ' ' LEU . 26.7 mt -83.12 139.9 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.431 3.287 . . . . 73.420000000000002 110.952 169.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.319999999999993 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 349' ' ' LEU . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 52.0 112.461 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.209999999999994 111.096 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 345' ' ' GLY . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.89 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HG2' HD12 ' A' ' 314' ' ' ILE . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 74.5 110.968 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 316' ' ' ILE . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.877 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 338' ' ' ILE . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.109999999999999 110.83 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.457 ' OE1' HD11 ' A' ' 360' ' ' LEU . 1.1 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.954 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 388' ' ' ILE . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.126 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.457 HD11 ' OE1' ' A' ' 358' ' ' GLN . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 110.885 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 110.845 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 388' ' ' ILE . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.400000000000006 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.478 ' OD1' HG12 ' A' ' 362' ' ' VAL . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.010000000000005 110.911 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 32.329999999999998 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 64.420000000000002 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.423 ' C ' HD22 ' A' ' 367' ' ' LEU . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.019999999999996 110.856 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.675 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.897 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.530000000000001 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.675 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.319999999999993 111.105 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.129999999999995 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.514 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 72.25 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.502 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.131 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.409999999999997 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 52.25 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 362' ' ' VAL . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 386' ' ' VAL . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 111.114 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.509999999999998 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.340000000000003 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 382' ' ' ALA . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.096 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 359' ' ' ILE . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 111.135 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 361' ' ' SER . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 357' ' ' ASP . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 44.009999999999998 111.064 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.240000000000002 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 54.140000000000001 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.239999999999995 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 61.039999999999999 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.530000000000001 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.923 0.392 . . . . 72.530000000000001 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 1.3 mp -138.76 146.48 41.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 51.520000000000003 110.948 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -117.19 -35.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 53.149999999999999 112.432 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.99 156.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 71.230000000000004 110.86 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -157.52 101.98 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.916 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -174.47 150.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.340000000000003 110.858 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 24.4 mm 66.05 131.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 74.430000000000007 111.157 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.61 78.39 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 72.420000000000002 112.372 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -140.08 72.59 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 52.100000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.54 159.39 85.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.729 . . . . 74.010000000000005 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 156.68 62.65 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.642 2.228 . . . . 75.019999999999996 112.414 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 387' ' ' THR . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.103 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 44.240000000000002 111.113 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 386' ' ' VAL . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.144 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 386' ' ' VAL . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.841 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.66 136.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.099999999999994 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -147.05 92.46 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 74.239999999999995 112.497 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 33.0 t -95.0 -32.23 13.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.852 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.1 27.03 6.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 70.019999999999996 111.129 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -73.68 72.76 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 65.430000000000007 112.443 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.48 -4.81 50.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.893 0.377 . . . . 64.239999999999995 110.965 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . -46.93 -46.54 19.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.420000000000002 112.486 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 347' ' ' ALA . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 110.87 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 336' ' ' ILE . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.340000000000003 111.133 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.099999999999994 111.143 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.230000000000004 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 41.310000000000002 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 54.549999999999997 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.039999999999999 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.030000000000001 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.040000000000006 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 327' ' ' ILE . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.11 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 72.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 359' ' ' ILE . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 61.420000000000002 111.137 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.51 167.31 23.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.439999999999998 110.906 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 324' ' ' GLY . 67.2 mt -105.42 150.88 24.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.466 3.303 . . . . 73.420000000000002 110.924 169.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 52.0 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 325' ' ' PHE . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.094 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.340000000000003 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.329999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.477 ' HG2' HD11 ' A' ' 314' ' ' ILE . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 74.5 110.934 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 71.340000000000003 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.120000000000005 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 41.200000000000003 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.528 ' HB3' HD13 ' A' ' 338' ' ' ILE . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.109999999999999 110.833 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 338' ' ' ILE . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 111.152 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 389' ' ' ILE . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 110.951 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 367' ' ' LEU . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.182 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 32.329999999999998 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 64.420000000000002 111.148 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 64.019999999999996 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 362' ' ' VAL . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.966 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.129999999999995 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 72.25 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 54.240000000000002 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 53.409999999999997 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 52.25 111.115 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 362' ' ' VAL . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 110.956 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.239999999999995 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.509999999999998 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.340000000000003 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 317' ' ' HIS . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 111.16 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 314' ' ' ILE . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 55.240000000000002 111.165 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 111.118 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 360' ' ' LEU . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 44.009999999999998 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 61.240000000000002 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.140000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 328' ' ' ILE . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.844 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.79 0.329 . . . . 72.530000000000001 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.96 79.36 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 51.520000000000003 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -112.65 131.85 10.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 53.149999999999999 112.462 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -112.06 -71.34 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 71.230000000000004 110.948 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -107.96 63.63 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 110.891 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.21 171.18 16.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 60.340000000000003 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.5 pt -152.37 67.37 6.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.636 0.732 . . . . 74.430000000000007 111.099 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -171.5 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.6 2.2 . . . . 72.420000000000002 112.385 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -103.15 174.14 6.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 52.100000000000001 110.915 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.44 120.03 58.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 74.010000000000005 110.946 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.26 69.11 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 75.019999999999996 112.275 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 387' ' ' THR . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.140000000000001 110.877 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 111.158 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 63.439999999999998 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -49.37 119.73 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.099999999999994 110.913 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.26 47.76 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.5 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.0 t -51.8 -39.46 58.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.86 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -101.97 26.98 6.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 70.019999999999996 111.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.98 103.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.788 -0.72 . . . . 65.430000000000007 112.457 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.22 -29.62 15.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 64.239999999999995 110.95 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.97 -49.61 35.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.420000000000002 112.516 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.140000000000001 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.230000000000004 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 54.549999999999997 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.039999999999999 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.040000000000006 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.75 HD12 ' CB ' ' A' ' 357' ' ' ASP . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 61.420000000000002 111.087 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.529 ' H ' HG22 ' A' ' 338' ' ' ILE . 0.3 OUTLIER -67.82 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.911 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.71 132.19 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.445 3.293 . . . . 73.420000000000002 110.917 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 52.0 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.908 ' HB1' HD12 ' A' ' 353' ' ' LEU . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.102 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 71.310000000000002 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 73.340000000000003 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.329999999999998 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.5 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.908 HD12 ' HB1' ' A' ' 347' ' ' ALA . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.913 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 71.430000000000007 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 41.200000000000003 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.75 ' CB ' HD12 ' A' ' 338' ' ' ILE . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.109999999999999 110.862 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 338' ' ' ILE . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.310000000000002 111.114 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.140000000000001 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.758 HG21 HD12 ' A' ' 379' ' ' LEU . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 111.181 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.010000000000005 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 32.329999999999998 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 362' ' ' VAL . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.1 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.589 HD13 HG12 ' A' ' 362' ' ' VAL . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.319999999999993 110.922 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.319999999999993 111.149 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.534 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.879 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 53.409999999999997 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 52.25 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.758 HD12 HG21 ' A' ' 362' ' ' VAL . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.897 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 71.530000000000001 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.509999999999998 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.340000000000003 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 55.240000000000002 111.094 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 362' ' ' VAL . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.161 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 64.439999999999998 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.019999999999996 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 54.140000000000001 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 61.039999999999999 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.239999999999995 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.530000000000001 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.878 0.371 . . . . 72.530000000000001 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 10.5 mt -137.65 166.15 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 51.520000000000003 110.884 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.77 -176.54 42.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 53.149999999999999 112.548 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.59 -175.37 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 71.230000000000004 110.844 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -140.38 66.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 110.91 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -119.95 -49.99 2.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 60.340000000000003 110.901 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 308' ' ' PRO . 48.6 mm -51.62 133.1 36.0 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.645 0.736 . . . . 74.430000000000007 111.129 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 307' ' ' ILE . 53.5 Cg_endo -69.73 -42.23 3.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.724 2.283 . . . . 72.420000000000002 112.358 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -80.55 86.68 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 52.100000000000001 110.826 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -51.36 143.9 17.47 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.611 0.72 . . . . 74.010000000000005 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 158.6 56.48 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.629 2.219 . . . . 75.019999999999996 112.42 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 71.140000000000001 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 316' ' ' ILE . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 111.095 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 44.240000000000002 111.157 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.677 HD11 HG23 ' A' ' 314' ' ' ILE . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 111.126 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 316' ' ' ILE . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.903 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -46.46 136.07 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.099999999999994 110.781 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -122.61 122.57 5.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.738 . . . . 74.239999999999995 112.491 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 13.2 p -95.01 -40.02 9.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.99 0.424 . . . . 74.129999999999995 110.875 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.8 p -131.98 3.17 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 70.019999999999996 111.132 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.05 31.88 18.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 65.430000000000007 112.471 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.45 HD21 HD13 ' A' ' 342' ' ' LEU . 9.6 tt -55.82 -30.53 61.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 64.239999999999995 110.92 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.52 -30.31 12.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.420000000000002 112.491 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.686 HG21 ' CE1' ' A' ' 397' ' ' TYR . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.099999999999994 111.075 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.230000000000004 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 41.310000000000002 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 54.549999999999997 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.039999999999999 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.030000000000001 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 336' ' ' ILE . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.040000000000006 112.516 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 335' ' ' GLY . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 111.107 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 328' ' ' ILE . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.892 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 357' ' ' ASP . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 61.420000000000002 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.420000000000002 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -152.73 162.82 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 323' ' ' LEU . 13.0 mt -106.12 128.34 53.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 124.319 3.236 . . . . 73.420000000000002 110.917 169.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.319999999999993 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 52.0 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.310000000000002 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.329999999999998 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 314' ' ' ILE . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 74.5 110.879 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 338' ' ' ILE . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 110.924 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 41.200000000000003 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.109999999999999 110.785 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.92 HD12 HG21 ' A' ' 388' ' ' ILE . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.310000000000002 111.109 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.721 HD13 HG22 ' A' ' 389' ' ' ILE . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.975 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 362' ' ' VAL . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.400000000000006 111.151 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.010000000000005 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 32.329999999999998 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.519 HG21 ' HB1' ' A' ' 378' ' ' ALA . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 64.420000000000002 111.133 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 64.019999999999996 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.584 HD12 HG21 ' A' ' 359' ' ' ILE . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.879 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.299999999999997 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 53.409999999999997 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 52.25 111.166 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 379' ' ' LEU . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.836 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.509999999999998 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.340000000000003 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 316' ' ' ILE . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 111.17 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 55.240000000000002 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.92 HG21 HD12 ' A' ' 359' ' ' ILE . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.072 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.721 HG22 HD13 ' A' ' 360' ' ' LEU . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 353' ' ' LEU . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 44.009999999999998 111.089 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.019999999999996 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.530000000000001 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 61.240000000000002 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.686 ' CE1' HG21 ' A' ' 328' ' ' ILE . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 110.892 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 72.239999999999995 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.530000000000001 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.887 0.375 . . . . 72.530000000000001 110.878 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 3.0 tt -138.28 114.65 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 51.520000000000003 110.818 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.04 179.36 47.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 53.149999999999999 112.465 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.3 172.17 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 71.230000000000004 110.899 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -153.02 -179.54 7.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.925 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -68.74 -34.3 75.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 60.340000000000003 110.908 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 25.9 mt 65.07 67.86 0.77 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 74.430000000000007 111.09 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 119.03 6.04 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.723 2.282 . . . . 72.420000000000002 112.359 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -111.27 69.19 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 52.100000000000001 110.818 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -51.15 160.92 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.618 0.723 . . . . 74.010000000000005 110.839 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 121.18 7.87 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.618 2.212 . . . . 75.019999999999996 112.288 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 387' ' ' THR . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 71.140000000000001 110.84 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 44.240000000000002 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.450000000000003 111.11 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 63.439999999999998 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -46.5 122.68 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.92 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -92.76 55.09 2.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 74.239999999999995 112.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 77.4 p -90.43 11.13 22.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 74.129999999999995 110.86 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -117.32 27.05 9.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 70.019999999999996 111.146 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 103.97 144.11 13.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 65.430000000000007 112.515 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.627 ' CD1' HD13 ' A' ' 379' ' ' LEU . 6.5 mt -71.0 -39.96 72.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 64.239999999999995 110.951 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.15 25.78 50.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 75.420000000000002 112.495 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.109999999999999 110.902 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.578 HD11 HG12 ' A' ' 336' ' ' ILE . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.219 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.696 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 111.129 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.230000000000004 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 41.310000000000002 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 54.549999999999997 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.039999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.030000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.040000000000006 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.578 HG12 HD11 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 111.114 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' A' ' 328' ' ' ILE . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.430000000000007 110.889 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 359' ' ' ILE . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 61.420000000000002 111.13 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -161.91 167.39 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.439999999999998 110.897 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt -95.54 138.78 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 124.386 3.266 . . . . 73.420000000000002 110.955 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.319999999999993 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 52.0 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.209999999999994 111.069 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.329999999999998 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 74.5 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 390' ' ' ALA . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.87 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.430000000000007 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 41.200000000000003 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.109999999999999 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.450000000000003 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 327' ' ' ILE . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.164 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' SER . . . . . 0.652 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.808 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 388' ' ' ILE . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.400000000000006 111.151 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 32.329999999999998 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 370' ' ' ALA . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.898 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 367' ' ' LEU . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.319999999999993 111.135 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.129999999999995 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.25 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.073 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 111.122 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.409999999999997 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 52.25 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 376' ' ' ALA . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 74.040000000000006 110.899 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.530000000000001 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' A' ' 316' ' ' ILE . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.125 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 313' ' ' ARG . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.240000000000002 111.101 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.733 ' CG1' HG13 ' A' ' 362' ' ' VAL . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 111.109 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.652 HD12 ' OG ' ' A' ' 361' ' ' SER . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 44.009999999999998 111.086 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 64.439999999999998 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.019999999999996 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.530000000000001 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 61.240000000000002 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 54.140000000000001 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 61.039999999999999 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 328' ' ' ILE . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.887 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.879 0.371 . . . . 72.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 153.51 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 51.520000000000003 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -52.76 128.51 36.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.826 -0.702 . . . . 53.149999999999999 112.534 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -138.97 -177.89 5.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 71.230000000000004 110.902 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -108.12 -178.14 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.140000000000001 110.895 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.75 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 60.340000000000003 110.853 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 8.9 pt -153.34 73.57 6.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 74.430000000000007 111.079 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 156.61 62.92 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.761 2.307 . . . . 72.420000000000002 112.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.2 106.89 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 52.100000000000001 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.7 160.17 53.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 74.010000000000005 110.882 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 131.95 22.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.724 2.283 . . . . 75.019999999999996 112.256 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 390' ' ' ALA . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.152 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 44.240000000000002 111.147 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.450000000000003 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 63.439999999999998 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -47.78 119.81 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.855 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.6 48.88 3.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 74.239999999999995 112.481 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 41.2 t -94.93 10.98 33.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.384 . . . . 74.129999999999995 110.808 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.8 m -115.35 26.97 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.019999999999996 111.149 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 105.74 107.18 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 65.430000000000007 112.451 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 325' ' ' PHE . 0.0 OUTLIER -50.78 -48.23 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 64.239999999999995 110.902 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.77 36.32 58.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 75.420000000000002 112.464 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.58 ' O ' HD12 ' A' ' 323' ' ' LEU . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.109999999999999 110.831 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ILE . . . . . 0.81 HG12 HD11 ' A' ' 336' ' ' ILE . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.135 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.099999999999994 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLY . . . . . 0.645 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.230000000000004 112.457 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 41.310000000000002 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.039999999999999 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.040000000000006 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.81 HD11 HG12 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.159 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 72.430000000000007 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.825 HD12 ' HB2' ' A' ' 357' ' ' ASP . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.106 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.5 166.73 29.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.439999999999998 110.892 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt -108.24 129.41 55.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 124.377 3.262 . . . . 73.420000000000002 110.93 169.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.319999999999993 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 64.310000000000002 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 71.310000000000002 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.329999999999998 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 74.5 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.696 HD21 HD11 ' A' ' 388' ' ' ILE . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.914 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.120000000000005 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 41.200000000000003 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.825 ' HB2' HD12 ' A' ' 338' ' ' ILE . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.855 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.641 HG22 HD12 ' A' ' 367' ' ' LEU . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 111.145 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.757 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.919 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 367' ' ' LEU . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.400000000000006 111.106 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 32.329999999999998 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 359' ' ' ILE . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.847 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.530000000000001 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.129999999999995 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 54.240000000000002 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 53.409999999999997 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.120000000000005 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.509999999999998 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 316' ' ' ILE . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 111.115 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 55.240000000000002 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.696 HD11 HD21 ' A' ' 353' ' ' LEU . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.152 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.757 ' CG2' HD13 ' A' ' 360' ' ' LEU . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 357' ' ' ASP . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 44.009999999999998 111.139 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 64.439999999999998 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.019999999999996 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 61.039999999999999 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.530000000000001 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 72.530000000000001 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.67 -74.43 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 51.520000000000003 110.937 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.35 -176.72 44.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 53.149999999999999 112.501 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.17 -174.7 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 71.230000000000004 110.883 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLU . . . . . 0.602 ' HB3' HG22 ' A' ' 307' ' ' ILE . 4.4 tp10 -165.77 166.84 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -51.86 -35.22 44.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 60.340000000000003 110.921 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 305' ' ' GLU . 2.8 tp -51.4 131.49 34.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.154 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 -39.67 6.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 72.420000000000002 112.326 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -92.12 44.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 52.100000000000001 110.887 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.42 153.69 13.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.64 0.733 . . . . 74.010000000000005 110.894 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' PRO . . . . . 0.419 ' HB3' HD12 ' A' ' 360' ' ' LEU . 53.4 Cg_endo -69.84 127.26 14.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.25 . . . . 75.019999999999996 112.26 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ARG . . . . . 0.658 ' HA ' HD13 ' A' ' 389' ' ' ILE . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 352' ' ' GLU . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.166 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 44.240000000000002 111.156 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 315' ' ' VAL . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.068 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.439999999999998 110.868 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -44.74 122.85 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.42 -28.2 19.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 74.239999999999995 112.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.8 t -52.2 -35.59 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 74.129999999999995 110.866 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.1 m -103.13 26.97 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 70.019999999999996 111.131 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.62 32.54 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.509 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.87 -26.6 59.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 64.239999999999995 110.886 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -48.84 -40.68 26.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.721 . . . . 75.420000000000002 112.453 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 379' ' ' LEU . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.109999999999999 110.934 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 41.310000000000002 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.409999999999997 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 54.549999999999997 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.039999999999999 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.030000000000001 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.040000000000006 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.153 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 359' ' ' ILE . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.116 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -161.81 167.66 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.439999999999998 110.914 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.58 156.27 19.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 124.401 3.273 . . . . 73.420000000000002 110.888 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.319999999999993 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 52.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 349' ' ' LEU . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 350' ' ' SER . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.909 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' SER . . . . . 0.588 ' N ' HD12 ' A' ' 349' ' ' LEU . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.859 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.329999999999998 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.725 ' HB3' HD13 ' A' ' 314' ' ' ILE . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 74.5 110.916 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 41.200000000000003 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.109999999999999 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 63.450000000000003 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 338' ' ' ILE . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.310000000000002 111.07 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 311' ' ' PRO . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 64.329999999999998 110.98 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 388' ' ' ILE . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.400000000000006 111.061 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.611 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.010000000000005 110.919 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 32.329999999999998 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 362' ' ' VAL . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.103 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.019999999999996 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 359' ' ' ILE . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.901 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.510000000000005 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 53.409999999999997 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 52.25 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 325' ' ' PHE . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 74.040000000000006 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.120000000000005 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.530000000000001 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ALA . . . . . 0.706 ' HB1' HG21 ' A' ' 386' ' ' VAL . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.137 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.509999999999998 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' VAL . . . . . 0.706 HG21 ' HB1' ' A' ' 382' ' ' ALA . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 55.240000000000002 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 359' ' ' ILE . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.148 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 313' ' ' ARG . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.5 ' HB3' HD11 ' A' ' 314' ' ' ILE . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 44.009999999999998 111.086 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.019999999999996 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 61.240000000000002 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 54.140000000000001 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 61.039999999999999 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 72.239999999999995 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.932 0.396 . . . . 72.530000000000001 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.39 64.48 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 51.520000000000003 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -94.53 99.23 2.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 53.149999999999999 112.476 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -141.53 141.98 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 71.230000000000004 111.003 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.84 116.57 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.829 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 307' ' ' ILE . 0.1 OUTLIER -120.91 -74.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.340000000000003 110.927 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 306' ' ' ASP . 1.1 tt 35.28 79.67 0.29 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.576 0.703 . . . . 74.430000000000007 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 161.75 44.7 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 72.420000000000002 112.385 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -117.8 45.54 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 52.100000000000001 110.897 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.45 160.5 82.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.624 0.725 . . . . 74.010000000000005 110.936 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 158.61 56.39 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.696 2.264 . . . . 75.019999999999996 112.37 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 388' ' ' ILE . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.102 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.639 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.240000000000002 111.149 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 315' ' ' VAL . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 111.105 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 63.439999999999998 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -46.22 119.81 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.891 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.98 34.53 2.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.76 . . . . 74.239999999999995 112.483 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.5 t -58.86 -35.14 72.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.891 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.0 p -102.19 27.07 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 70.019999999999996 111.166 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.48 105.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.815 -0.707 . . . . 65.430000000000007 112.581 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 379' ' ' LEU . 11.0 mp -93.02 -46.84 7.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 64.239999999999995 110.895 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . 76.82 27.24 61.01 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.744 -0.741 . . . . 75.420000000000002 112.457 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 323' ' ' LEU . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.109999999999999 110.922 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 72.340000000000003 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.099999999999994 111.095 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.230000000000004 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 41.310000000000002 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.409999999999997 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 54.549999999999997 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.039999999999999 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.030000000000001 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.040000000000006 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.129999999999995 111.154 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 357' ' ' ASP . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 61.420000000000002 111.161 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.420000000000002 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -162.11 167.47 24.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.934 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.547 HD12 ' HA2' ' A' ' 324' ' ' GLY . 46.2 mt -108.31 142.93 37.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.476 3.307 . . . . 73.420000000000002 110.932 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 52.0 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.11 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.340000000000003 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.329999999999998 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 74.5 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 388' ' ' ILE . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 41.200000000000003 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ASP . . . . . 0.586 ' HB2' HD13 ' A' ' 338' ' ' ILE . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.109999999999999 110.901 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.450000000000003 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 64.329999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.672 HG22 HG22 ' A' ' 388' ' ' ILE . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 111.151 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 32.329999999999998 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.633 HD22 ' CG2' ' A' ' 362' ' ' VAL . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.913 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.25 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 53.409999999999997 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.459 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 52.25 111.097 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 323' ' ' LEU . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 110.907 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.509999999999998 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.420000000000002 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 314' ' ' ILE . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 55.240000000000002 111.147 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 314' ' ' ILE . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.430000000000007 111.076 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.473 ' HB1' ' CG ' ' A' ' 357' ' ' ASP . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 44.009999999999998 111.139 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.439999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.019999999999996 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 61.240000000000002 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 54.140000000000001 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.039999999999999 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 328' ' ' ILE . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.873 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.340000000000003 111.083 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.466 -0.115 0 CA-C-O 120.798 0.249 . . . . 75.019999999999996 112.321 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.665 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 44.240000000000002 111.077 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 385' ' ' THR . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.123 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 71.099999999999994 110.876 -179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.452 -0.259 . . . . 75.420000000000002 112.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 376' ' ' ALA . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 111.153 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.487 ' C ' HD12 ' A' ' 336' ' ' ILE . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.155 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 41.310000000000002 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.039999999999999 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.030000000000001 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 328' ' ' ILE . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.141 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 359' ' ' ILE . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 61.420000000000002 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.439999999999998 110.897 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.799 0.333 . . . . 73.420000000000002 110.925 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.319999999999993 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 52.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 316' ' ' ILE . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 71.310000000000002 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.329999999999998 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 74.5 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 390' ' ' ALA . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.340000000000003 110.905 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.109999999999999 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.693 HE21 HD11 ' A' ' 360' ' ' LEU . 3.1 pt20 -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.450000000000003 110.925 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 338' ' ' ILE . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.732 HD13 HG22 ' A' ' 389' ' ' ILE . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 110.878 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.882 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.706 HG12 HG12 ' A' ' 388' ' ' ILE . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.400000000000006 111.163 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.631 ' HB3' HG23 ' A' ' 386' ' ' VAL . 11.8 p30 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.916 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 32.329999999999998 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 64.420000000000002 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.019999999999996 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 362' ' ' VAL . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.982 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.510000000000005 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.319999999999993 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.129999999999995 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.42 ' HA ' HD13 ' A' ' 336' ' ' ILE . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.299999999999997 110.859 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 72.25 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.121 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 52.25 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 71.530000000000001 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 386' ' ' VAL . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.097 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.509999999999998 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.340000000000003 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 316' ' ' ILE . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 382' ' ' ALA . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 111.136 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.706 HG12 HG12 ' A' ' 362' ' ' VAL . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 111.13 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.732 HG22 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 44.009999999999998 111.1 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 64.439999999999998 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.530000000000001 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 54.140000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.239999999999995 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.465 -0.155 0 CA-C-O 120.813 0.255 . . . . 75.019999999999996 112.353 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.612 HD12 HD23 ' A' ' 353' ' ' LEU . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 111.127 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 44.240000000000002 111.137 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 386' ' ' VAL . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.146 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.461 ' O ' HG12 ' A' ' 386' ' ' VAL . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 110.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 110.825 -179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 347' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.517 -0.233 . . . . 75.420000000000002 112.517 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.109999999999999 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 327' ' ' ILE . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 111.174 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.230000000000004 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 41.310000000000002 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.409999999999997 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 54.549999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.039999999999999 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.030000000000001 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.040000000000006 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 359' ' ' ILE . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.420000000000002 111.161 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 . . . . . 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.439999999999998 110.877 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.811 0.339 . . . . 73.420000000000002 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.319999999999993 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 52.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 324' ' ' GLY . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 111.104 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 316' ' ' ILE . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.814 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.329999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 314' ' ' ILE . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 74.5 110.908 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 388' ' ' ILE . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 41.200000000000003 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.593 ' HB2' HD13 ' A' ' 338' ' ' ILE . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.109999999999999 110.868 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 338' ' ' ILE . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 65.310000000000002 111.168 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 389' ' ' ILE . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.805 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.715 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.400000000000006 111.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 32.329999999999998 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 64.420000000000002 111.142 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 64.019999999999996 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 359' ' ' ILE . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.898 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.319999999999993 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.299999999999997 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 54.240000000000002 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 52.25 111.097 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.715 ' CD2' HG21 ' A' ' 362' ' ' VAL . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.96 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 316' ' ' ILE . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.420000000000002 111.081 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 55.240000000000002 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 111.129 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.425 HD12 ' OG ' ' A' ' 361' ' ' SER . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 44.009999999999998 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.530000000000001 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 54.140000000000001 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 61.039999999999999 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.138 0 CA-C-O 120.766 0.236 . . . . 75.019999999999996 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' A' ' 352' ' ' GLU . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.693 ' O ' HD13 ' A' ' 316' ' ' ILE . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.196 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 315' ' ' VAL . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.131 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 316' ' ' ILE . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.826 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 71.099999999999994 110.88 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.497 -0.241 . . . . 75.420000000000002 112.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.109999999999999 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 327' ' ' ILE . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.118 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 54.549999999999997 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.040000000000006 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 359' ' ' ILE . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 61.420000000000002 111.096 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.439999999999998 110.878 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.751 0.31 . . . . 73.420000000000002 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.319999999999993 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 52.0 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.635 ' HB2' HD11 ' A' ' 314' ' ' ILE . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.856 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 314' ' ' ILE . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 74.5 110.884 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 41.200000000000003 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.109999999999999 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 338' ' ' ILE . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.08 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 389' ' ' ILE . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.329999999999998 110.894 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 HG13 ' A' ' 388' ' ' ILE . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.400000000000006 111.108 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 64.019999999999996 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 359' ' ' ILE . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.906 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.510000000000005 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.319999999999993 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.129999999999995 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.299999999999997 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.240000000000002 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 53.409999999999997 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 52.25 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.120000000000005 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 71.530000000000001 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.509999999999998 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 111.085 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 55.240000000000002 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.62 HG13 HG12 ' A' ' 362' ' ' VAL . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 111.155 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.651 HG22 HD12 ' A' ' 360' ' ' LEU . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 44.009999999999998 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 64.439999999999998 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.019999999999996 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.530000000000001 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 61.240000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 54.140000000000001 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.239999999999995 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 61.039999999999999 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--O 1.231 0.164 0 CA-C-O 120.78 0.241 . . . . 75.019999999999996 112.414 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 71.140000000000001 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 352' ' ' GLU . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.121 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 44.240000000000002 111.179 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 314' ' ' ILE . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.179 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 110.85 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.851 -179.904 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.486 -0.246 . . . . 75.420000000000002 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.109999999999999 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 338' ' ' ILE . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 339' ' ' SER . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.128 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.513 ' CA ' HD12 ' A' ' 336' ' ' ILE . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.230000000000004 112.522 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 41.310000000000002 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.409999999999997 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 54.549999999999997 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.039999999999999 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.030000000000001 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.040000000000006 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.513 HD12 ' CA ' ' A' ' 329' ' ' GLY . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 111.134 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 359' ' ' ILE . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.112 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . 0.639 ' HB2' HD12 ' A' ' 328' ' ' ILE . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.844 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.439999999999998 110.858 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 343' ' ' ALA . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.888 0.375 . . . . 73.420000000000002 110.91 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 342' ' ' LEU . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.105 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 52.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.209999999999994 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 71.310000000000002 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.745 ' CB ' HD11 ' A' ' 314' ' ' ILE . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.329999999999998 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 314' ' ' ILE . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 74.5 110.908 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 388' ' ' ILE . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 71.340000000000003 110.906 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 41.200000000000003 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.109999999999999 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 63.450000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 338' ' ' ILE . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 65.310000000000002 111.15 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.902 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 388' ' ' ILE . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.112 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 32.329999999999998 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 362' ' ' VAL . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.152 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 362' ' ' VAL . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.530000000000001 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.129999999999995 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.299999999999997 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.25 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 54.240000000000002 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 52.25 111.086 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 362' ' ' VAL . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 74.040000000000006 110.968 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.113 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.420000000000002 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.151 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 360' ' ' LEU . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 44.009999999999998 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.019999999999996 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.530000000000001 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 61.039999999999999 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . 0.511 ' CG ' HG21 ' A' ' 328' ' ' ILE . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.855 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.340000000000003 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.340000000000003 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.712 0.213 . . . . 75.019999999999996 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 387' ' ' THR . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.878 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.687 HG21 ' HG ' ' A' ' 353' ' ' LEU . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 111.159 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.912 -179.91 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.46 -0.256 . . . . 75.420000000000002 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 110.893 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.140000000000001 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.791 HG23 ' HB2' ' A' ' 339' ' ' SER . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.162 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.230000000000004 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 41.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.409999999999997 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.549999999999997 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.039999999999999 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.030000000000001 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.121 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.706 ' CD1' HD11 ' A' ' 359' ' ' ILE . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.106 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . 0.791 ' HB2' HG23 ' A' ' 328' ' ' ILE . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 110.907 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.439999999999998 110.872 -179.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.733 0.301 . . . . 73.420000000000002 110.981 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.319999999999993 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 52.0 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.083 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 64.310000000000002 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.329999999999998 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.52 ' HB3' HD12 ' A' ' 314' ' ' ILE . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 74.5 110.928 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.687 ' HG ' HG21 ' A' ' 314' ' ' ILE . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 110.882 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 41.200000000000003 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.109999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.450000000000003 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.839 HG21 HD12 ' A' ' 367' ' ' LEU . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 64.329999999999998 110.908 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 389' ' ' ILE . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.835 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG1' HD11 ' A' ' 367' ' ' LEU . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.400000000000006 111.087 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.010000000000005 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.568 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.173 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 64.019999999999996 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 359' ' ' ILE . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.873 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.510000000000005 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.129999999999995 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.299999999999997 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 53.409999999999997 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 52.25 111.074 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 386' ' ' VAL . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 74.040000000000006 110.922 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.120000000000005 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.509999999999998 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 379' ' ' LEU . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.15 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 314' ' ' ILE . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 55.240000000000002 111.1 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.476 HG22 ' HB ' ' A' ' 362' ' ' VAL . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.077 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 361' ' ' SER . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 44.009999999999998 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 64.439999999999998 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 61.240000000000002 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 54.140000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 61.039999999999999 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 72.239999999999995 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.192 0 CA-C-O 120.781 0.242 . . . . 75.019999999999996 112.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.726 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 71.140000000000001 110.936 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 353' ' ' LEU . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.329999999999998 111.05 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 315' ' ' VAL . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 44.240000000000002 111.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 385' ' ' THR . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.198 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 71.099999999999994 110.81 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.428 -0.269 . . . . 75.420000000000002 112.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.856 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.099999999999994 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.230000000000004 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 41.310000000000002 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 54.549999999999997 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.039999999999999 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.030000000000001 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.129999999999995 111.226 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 359' ' ' ILE . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.439999999999998 110.922 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.869 0.366 . . . . 73.420000000000002 110.918 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.319999999999993 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 52.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 353' ' ' LEU . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 111.101 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 64.310000000000002 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.329999999999998 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.5 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.923 HD22 HD11 ' A' ' 388' ' ' ILE . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.905 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 41.200000000000003 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 338' ' ' ILE . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 111.109 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 64.329999999999998 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.999 HG12 HG22 ' A' ' 388' ' ' ILE . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.400000000000006 111.144 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.010000000000005 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 32.329999999999998 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 64.420000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 64.019999999999996 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.747 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.916 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.530000000000001 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.747 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.319999999999993 111.094 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.129999999999995 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.25 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 54.240000000000002 111.12 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 53.409999999999997 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 382' ' ' ALA . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.948 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.239999999999995 111.111 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.509999999999998 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.340000000000003 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 316' ' ' ILE . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 388' ' ' ILE . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.12 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.999 HG22 HG12 ' A' ' 362' ' ' VAL . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.154 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 44.009999999999998 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.019999999999996 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.530000000000001 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 61.039999999999999 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.738 0.224 . . . . 75.019999999999996 112.397 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.755 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.858 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 353' ' ' LEU . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 111.154 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 386' ' ' VAL . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.196 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.439999999999998 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.843 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.515 -0.234 . . . . 75.420000000000002 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.915 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 72.340000000000003 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.230000000000004 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 41.310000000000002 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.409999999999997 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 54.549999999999997 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.030000000000001 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.040000000000006 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 336' ' ' ILE . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.109 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 357' ' ' ASP . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 61.420000000000002 111.162 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.439999999999998 110.884 -179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.319999999999993 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 52.0 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.329999999999998 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 74.5 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 390' ' ' ALA . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.944 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 41.200000000000003 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.813 ' HB2' HD12 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.109999999999999 110.883 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 359' ' ' ILE . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 111.165 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 389' ' ' ILE . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 64.329999999999998 110.882 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 1.025 HG12 HG22 ' A' ' 388' ' ' ILE . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 111.13 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 32.329999999999998 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 64.420000000000002 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.404 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 64.019999999999996 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.879 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.755 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.319999999999993 111.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.299999999999997 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 54.240000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.25 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.904 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.530000000000001 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.91 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.135 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.509999999999998 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.91 HG22 ' HB1' ' A' ' 382' ' ' ALA . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.067 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.142 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 1.025 HG22 HG12 ' A' ' 362' ' ' VAL . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.175 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 360' ' ' LEU . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 44.009999999999998 111.097 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 64.439999999999998 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 61.240000000000002 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.239999999999995 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 61.039999999999999 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 72.239999999999995 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.774 0.239 . . . . 75.019999999999996 112.322 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.895 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 353' ' ' LEU . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.450000000000003 111.131 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.425 ' N ' HG22 ' A' ' 316' ' ' ILE . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 110.859 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.099999999999994 110.915 -179.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.262 0 N-CA-C 112.435 -0.266 . . . . 75.420000000000002 112.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.109999999999999 110.882 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 376' ' ' ALA . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 111.121 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.74 ' O ' HD12 ' A' ' 336' ' ' ILE . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.099999999999994 111.15 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.230000000000004 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 41.310000000000002 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.409999999999997 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 54.549999999999997 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.039999999999999 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.030000000000001 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.040000000000006 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 328' ' ' ILE . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.114 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 357' ' ' ASP . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.09 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.439999999999998 110.949 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.805 0.336 . . . . 73.420000000000002 110.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 52.0 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.453 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.087 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.329999999999998 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 74.5 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 388' ' ' ILE . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 110.96 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 338' ' ' ILE . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.109999999999999 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 63.450000000000003 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.310000000000002 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 64.329999999999998 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 110.877 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.659 HG22 HG22 ' A' ' 388' ' ' ILE . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.400000000000006 111.146 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.633 HD22 HG12 ' A' ' 362' ' ' VAL . 12.1 p30 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.888 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 32.329999999999998 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 362' ' ' VAL . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 64.420000000000002 111.067 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 64.019999999999996 110.874 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.642 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 111.001 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.510000000000005 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.319999999999993 111.19 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.299999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 72.25 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 54.240000000000002 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.096 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 53.409999999999997 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 52.25 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 386' ' ' VAL . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.909 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.239999999999995 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.509999999999998 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.066 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 55.240000000000002 111.101 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 353' ' ' LEU . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 111.118 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 361' ' ' SER . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 44.009999999999998 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.019999999999996 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.530000000000001 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 54.140000000000001 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 61.039999999999999 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.530000000000001 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 N--CA 1.466 -0.128 0 CA-C-O 120.738 0.224 . . . . 75.019999999999996 112.373 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.527 ' NE ' HD11 ' A' ' 389' ' ' ILE . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.842 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 44.240000000000002 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.573 HD11 ' HB ' ' A' ' 386' ' ' VAL . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 111.147 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 63.439999999999998 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.099999999999994 110.883 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.503 -0.239 . . . . 75.420000000000002 112.503 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 72.340000000000003 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.230000000000004 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.409999999999997 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.030000000000001 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.040000000000006 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 375' ' ' ALA . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.155 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.816 HD12 ' HB2' ' A' ' 357' ' ' ASP . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.136 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.439999999999998 110.841 -179.93 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.882 0.373 . . . . 73.420000000000002 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 52.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.209999999999994 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 64.310000000000002 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.329999999999998 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 74.5 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 390' ' ' ALA . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.946 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 41.200000000000003 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.816 ' HB2' HD12 ' A' ' 338' ' ' ILE . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.109999999999999 110.875 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 63.450000000000003 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 367' ' ' LEU . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 65.310000000000002 111.082 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 389' ' ' ILE . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.876 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.664 HG22 HD22 ' A' ' 363' ' ' ASN . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.126 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.664 HD22 HG22 ' A' ' 362' ' ' VAL . 17.0 p30 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.881 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 32.329999999999998 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 378' ' ' ALA . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 111.143 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.019999999999996 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 359' ' ' ILE . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.129999999999995 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.478 ' OE1' HD12 ' A' ' 377' ' ' ILE . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.94 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 336' ' ' ILE . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 54.240000000000002 111.101 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . 0.478 HD12 ' OE1' ' A' ' 374' ' ' GLN . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 53.409999999999997 111.12 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 52.25 111.042 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.530000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.509999999999998 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.340000000000003 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.573 ' HB ' HD11 ' A' ' 316' ' ' ILE . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.173 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 55.240000000000002 111.182 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.54 HG23 HG23 ' A' ' 359' ' ' ILE . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 111.05 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.527 HD11 ' NE ' ' A' ' 313' ' ' ARG . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.74 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 44.009999999999998 111.103 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.019999999999996 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.530000000000001 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.240000000000002 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 54.140000000000001 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 61.039999999999999 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.340000000000003 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.825 0.26 . . . . 75.019999999999996 112.348 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 390' ' ' ALA . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 44.240000000000002 111.177 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 317' ' ' HIS . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.075 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.717 ' O ' HD12 ' A' ' 316' ' ' ILE . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.905 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 71.099999999999994 110.896 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.496 -0.242 . . . . 75.420000000000002 112.496 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.109999999999999 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.230000000000004 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 41.310000000000002 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.409999999999997 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.039999999999999 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.030000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 336' ' ' ILE . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 357' ' ' ASP . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 61.420000000000002 111.171 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 110.863 -179.917 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.828 0.347 . . . . 73.420000000000002 110.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 52.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 71.310000000000002 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.329999999999998 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 74.5 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 338' ' ' ILE . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.109999999999999 110.86 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 389' ' ' ILE . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 64.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 389' ' ' ILE . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.806 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 367' ' ' LEU . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.400000000000006 111.151 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.579 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.010000000000005 110.861 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 32.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 64.420000000000002 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 367' ' ' LEU . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.019999999999996 110.882 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CB ' ' A' ' 370' ' ' ALA . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.959 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.685 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 111.049 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.129999999999995 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 72.25 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 54.240000000000002 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 53.409999999999997 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 52.25 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 110.899 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.081 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.509999999999998 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.340000000000003 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 363' ' ' ASN . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 111.081 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 55.240000000000002 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 312' ' ' ARG . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 44.009999999999998 111.084 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 360' ' ' LEU . 4.2 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.019999999999996 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 61.240000000000002 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 54.140000000000001 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 61.039999999999999 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 72.239999999999995 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 73.340000000000003 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 C--O 1.232 0.19 0 CA-C-O 120.742 0.226 . . . . 75.019999999999996 112.378 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.497 ' NE ' ' HB3' ' A' ' 390' ' ' ALA . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.601 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.883 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 352' ' ' GLU . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.146 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 44.240000000000002 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 63.439999999999998 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.902 -179.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.439 -0.264 . . . . 75.420000000000002 112.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.565 ' HZ ' HG11 ' A' ' 386' ' ' VAL . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.898 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 72.340000000000003 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 41.310000000000002 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.409999999999997 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 54.549999999999997 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.040000000000006 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.129999999999995 111.189 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.829 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.092 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.439999999999998 110.906 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.78 0.324 . . . . 73.420000000000002 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.319999999999993 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 52.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.111 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.329999999999998 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.515 ' CB ' HD12 ' A' ' 314' ' ' ILE . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 74.5 110.903 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 338' ' ' ILE . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.949 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 41.200000000000003 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.829 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.109999999999999 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 63.450000000000003 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 367' ' ' LEU . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 111.169 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 391' ' ' GLN . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 64.329999999999998 110.866 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.140000000000001 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.689 HG22 ' ND2' ' A' ' 363' ' ' ASN . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.689 ' ND2' HG22 ' A' ' 362' ' ' VAL . 17.1 p30 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.010000000000005 110.925 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 32.329999999999998 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.541 HG21 ' HB1' ' A' ' 378' ' ' ALA . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.154 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.019999999999996 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.843 HD12 HG21 ' A' ' 359' ' ' ILE . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.923 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.319999999999993 111.153 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.129999999999995 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.299999999999997 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 72.25 110.953 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 54.240000000000002 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 73.420000000000002 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 53.409999999999997 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 52.25 111.027 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 379' ' ' LEU . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 74.040000000000006 110.935 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.509999999999998 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.565 HG11 ' HZ ' ' A' ' 325' ' ' PHE . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 55.240000000000002 111.148 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.44 HG23 HG23 ' A' ' 359' ' ' ILE . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.143 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.497 ' HB3' ' NE ' ' A' ' 312' ' ' ARG . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 44.009999999999998 111.032 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 360' ' ' LEU . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.019999999999996 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 61.240000000000002 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 61.039999999999999 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.15 0 CA-C-O 120.863 0.276 . . . . 75.019999999999996 112.363 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . 0.448 ' NE ' HD11 ' A' ' 314' ' ' ILE . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 352' ' ' GLU . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 111.091 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 44.240000000000002 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.558 ' CD1' HG13 ' A' ' 386' ' ' VAL . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 63.439999999999998 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.943 -179.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.474 -0.25 . . . . 75.420000000000002 112.474 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.109999999999999 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.099999999999994 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.230000000000004 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 41.310000000000002 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 54.549999999999997 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.039999999999999 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.030000000000001 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.040000000000006 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.138 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.467 HD12 ' OD1' ' A' ' 357' ' ' ASP . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.420000000000002 111.155 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 110.911 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.908 0.385 . . . . 73.420000000000002 110.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.319999999999993 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 52.0 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 71.310000000000002 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.329999999999998 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 74.5 110.857 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 388' ' ' ILE . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.888 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 41.200000000000003 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.467 ' OD1' HD12 ' A' ' 338' ' ' ILE . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 63.450000000000003 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 359' ' ' ILE . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 65.310000000000002 111.113 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.816 HD12 HG21 ' A' ' 389' ' ' ILE . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 64.329999999999998 110.926 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 32.329999999999998 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 64.019999999999996 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.319999999999993 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.510000000000005 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.530000000000001 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.319999999999993 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.129999999999995 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.299999999999997 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.086 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 53.409999999999997 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 376' ' ' ALA . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.530000000000001 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.509999999999998 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.340000000000003 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 316' ' ' ILE . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.420000000000002 111.136 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 55.240000000000002 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 353' ' ' LEU . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 72.430000000000007 111.119 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 360' ' ' LEU . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 44.009999999999998 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 61.240000000000002 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 61.039999999999999 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 72.239999999999995 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.530000000000001 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.466 -0.145 0 CA-C-O 120.783 0.243 . . . . 75.019999999999996 112.312 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 71.140000000000001 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 352' ' ' GLU . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.115 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 44.240000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.487 HD11 ' CD1' ' A' ' 353' ' ' LEU . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.138 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 316' ' ' ILE . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.439999999999998 110.867 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 71.099999999999994 110.863 -179.871 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.406 -0.278 . . . . 75.420000000000002 112.406 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.577 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 110.864 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.230000000000004 112.507 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 41.310000000000002 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 54.549999999999997 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.039999999999999 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.030000000000001 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.040000000000006 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.443 HD12 ' HA3' ' A' ' 329' ' ' GLY . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 111.178 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 61.420000000000002 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.867 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.7 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.8 0.333 . . . . 73.420000000000002 110.952 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.319999999999993 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 349' ' ' LEU . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 52.0 112.461 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.209999999999994 111.096 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 345' ' ' GLY . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.89 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HG2' HD12 ' A' ' 314' ' ' ILE . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 74.5 110.968 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 316' ' ' ILE . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.877 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 338' ' ' ILE . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.109999999999999 110.83 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . 0.616 ' NE2' HD11 ' A' ' 360' ' ' LEU . 3.7 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.954 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 388' ' ' ILE . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.126 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 358' ' ' GLN . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 110.885 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 110.845 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 388' ' ' ILE . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.400000000000006 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.478 ' OD1' HG12 ' A' ' 362' ' ' VAL . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.010000000000005 110.911 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 32.329999999999998 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 64.420000000000002 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . 0.423 ' C ' HD22 ' A' ' 367' ' ' LEU . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.019999999999996 110.856 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.675 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.897 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.530000000000001 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.675 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.319999999999993 111.105 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.129999999999995 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.514 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 72.25 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.502 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.131 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.409999999999997 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 52.25 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 362' ' ' VAL . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 386' ' ' VAL . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 111.114 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.509999999999998 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.340000000000003 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 382' ' ' ALA . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.096 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 359' ' ' ILE . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 111.135 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 361' ' ' SER . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 357' ' ' ASP . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 44.009999999999998 111.064 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.240000000000002 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 54.140000000000001 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.239999999999995 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 61.039999999999999 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.530000000000001 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.188 0 CA-C-O 120.707 0.211 . . . . 75.019999999999996 112.414 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 387' ' ' THR . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.103 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 44.240000000000002 111.113 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 386' ' ' VAL . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.144 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 386' ' ' VAL . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.841 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.099999999999994 110.825 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.486 -0.246 . . . . 75.420000000000002 112.486 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 347' ' ' ALA . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 110.87 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 336' ' ' ILE . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.340000000000003 111.133 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.099999999999994 111.143 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.230000000000004 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 41.310000000000002 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 54.549999999999997 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.039999999999999 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.030000000000001 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.040000000000006 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 327' ' ' ILE . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.11 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 72.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 359' ' ' ILE . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 61.420000000000002 111.137 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.439999999999998 110.906 -179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 324' ' ' GLY . 67.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.746 0.308 . . . . 73.420000000000002 110.924 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 52.0 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 325' ' ' PHE . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.094 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.340000000000003 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.329999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.477 ' HG2' HD11 ' A' ' 314' ' ' ILE . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 74.5 110.934 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 71.340000000000003 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.120000000000005 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 41.200000000000003 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.528 ' HB3' HD13 ' A' ' 338' ' ' ILE . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.109999999999999 110.833 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 338' ' ' ILE . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 111.152 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 389' ' ' ILE . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 110.951 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 367' ' ' LEU . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.182 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 32.329999999999998 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 64.420000000000002 111.148 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 64.019999999999996 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 362' ' ' VAL . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.966 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.129999999999995 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 72.25 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 54.240000000000002 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 53.409999999999997 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 52.25 111.115 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 362' ' ' VAL . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 110.956 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.239999999999995 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.509999999999998 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.340000000000003 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 317' ' ' HIS . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 111.16 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 314' ' ' ILE . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 55.240000000000002 111.165 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 111.118 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 360' ' ' LEU . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 44.009999999999998 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 61.240000000000002 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.140000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 328' ' ' ILE . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.844 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.231 0.145 0 CA-C-O 120.756 0.232 . . . . 75.019999999999996 112.275 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 387' ' ' THR . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.140000000000001 110.877 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 111.158 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 63.439999999999998 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.099999999999994 110.913 -179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.516 -0.234 . . . . 75.420000000000002 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.140000000000001 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.230000000000004 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 54.549999999999997 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.039999999999999 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.040000000000006 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.75 HD12 ' CB ' ' A' ' 357' ' ' ASP . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 61.420000000000002 111.087 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.529 ' H ' HG22 ' A' ' 338' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.911 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.76 0.314 . . . . 73.420000000000002 110.917 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 52.0 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.908 ' HB1' HD12 ' A' ' 353' ' ' LEU . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.102 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 71.310000000000002 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 73.340000000000003 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.329999999999998 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.5 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.908 HD12 ' HB1' ' A' ' 347' ' ' ALA . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.913 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 71.430000000000007 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 41.200000000000003 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.75 ' CB ' HD12 ' A' ' 338' ' ' ILE . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.109999999999999 110.862 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 338' ' ' ILE . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.310000000000002 111.114 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.140000000000001 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.758 HG21 HD12 ' A' ' 379' ' ' LEU . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 111.181 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.010000000000005 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 32.329999999999998 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 362' ' ' VAL . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.1 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.589 HD13 HG12 ' A' ' 362' ' ' VAL . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.319999999999993 110.922 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.319999999999993 111.149 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.534 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.879 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 53.409999999999997 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 52.25 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.758 HD12 HG21 ' A' ' 362' ' ' VAL . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.897 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 71.530000000000001 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.509999999999998 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.340000000000003 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 55.240000000000002 111.094 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 362' ' ' VAL . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.161 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 64.439999999999998 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.019999999999996 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 54.140000000000001 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 61.039999999999999 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.239999999999995 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.530000000000001 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo . . . . . 0 N--CA 1.465 -0.169 0 CA-C-O 120.746 0.228 . . . . 75.019999999999996 112.42 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 71.140000000000001 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 316' ' ' ILE . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 111.095 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 44.240000000000002 111.157 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.677 HD11 HG23 ' A' ' 314' ' ' ILE . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 111.126 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 316' ' ' ILE . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.903 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.099999999999994 110.781 -179.845 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 N-CA-C 112.491 -0.243 . . . . 75.420000000000002 112.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.686 HG21 ' CE1' ' A' ' 397' ' ' TYR . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.099999999999994 111.075 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.230000000000004 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 41.310000000000002 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 54.549999999999997 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.039999999999999 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.030000000000001 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 336' ' ' ILE . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.040000000000006 112.516 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 335' ' ' GLY . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 111.107 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 328' ' ' ILE . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.892 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 357' ' ' ASP . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 61.420000000000002 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.420000000000002 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 342' ' ' LEU . 13.0 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 73.420000000000002 110.917 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.319999999999993 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 52.0 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.310000000000002 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.329999999999998 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 314' ' ' ILE . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 74.5 110.879 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 338' ' ' ILE . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 110.924 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 41.200000000000003 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.109999999999999 110.785 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.92 HD12 HG21 ' A' ' 388' ' ' ILE . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.310000000000002 111.109 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.721 HD13 HG22 ' A' ' 389' ' ' ILE . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.975 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 362' ' ' VAL . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.400000000000006 111.151 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.010000000000005 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 32.329999999999998 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.519 HG21 ' HB1' ' A' ' 378' ' ' ALA . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 64.420000000000002 111.133 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 64.019999999999996 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.584 HD12 HG21 ' A' ' 359' ' ' ILE . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.879 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.299999999999997 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 53.409999999999997 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 52.25 111.166 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 379' ' ' LEU . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.836 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.509999999999998 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.340000000000003 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 316' ' ' ILE . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 111.17 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 55.240000000000002 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.92 HG21 HD12 ' A' ' 359' ' ' ILE . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.072 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.721 HG22 HD13 ' A' ' 360' ' ' LEU . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 353' ' ' LEU . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 44.009999999999998 111.089 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.019999999999996 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.530000000000001 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 61.240000000000002 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . 0.686 ' CE1' HG21 ' A' ' 328' ' ' ILE . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 110.892 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 72.239999999999995 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.530000000000001 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.779 0.241 . . . . 75.019999999999996 112.288 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 387' ' ' THR . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 71.140000000000001 110.84 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 44.240000000000002 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.450000000000003 111.11 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 63.439999999999998 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.92 -179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.495 -0.242 . . . . 75.420000000000002 112.495 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.109999999999999 110.902 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.578 HD11 HG12 ' A' ' 336' ' ' ILE . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.219 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.696 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 111.129 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.230000000000004 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 41.310000000000002 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 54.549999999999997 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.039999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.030000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.040000000000006 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.578 HG12 HD11 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 111.114 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' A' ' 328' ' ' ILE . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.430000000000007 110.889 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 359' ' ' ILE . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 61.420000000000002 111.13 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.439999999999998 110.897 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.835 0.35 . . . . 73.420000000000002 110.955 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.319999999999993 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 52.0 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.209999999999994 111.069 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.329999999999998 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 74.5 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 390' ' ' ALA . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.87 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.430000000000007 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 41.200000000000003 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.109999999999999 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.450000000000003 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 327' ' ' ILE . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.164 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . 0.652 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.808 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 388' ' ' ILE . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.400000000000006 111.151 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 32.329999999999998 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 370' ' ' ALA . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.898 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 367' ' ' LEU . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.319999999999993 111.135 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.129999999999995 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.25 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.073 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 111.122 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.409999999999997 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 52.25 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 376' ' ' ALA . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 74.040000000000006 110.899 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.530000000000001 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' A' ' 316' ' ' ILE . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.125 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 313' ' ' ARG . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.240000000000002 111.101 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.733 ' CG1' HG13 ' A' ' 362' ' ' VAL . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 111.109 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.652 HD12 ' OG ' ' A' ' 361' ' ' SER . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 44.009999999999998 111.086 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 64.439999999999998 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.019999999999996 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.530000000000001 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 61.240000000000002 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 54.140000000000001 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 61.039999999999999 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 328' ' ' ILE . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.887 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 120.794 0.248 . . . . 75.019999999999996 112.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 390' ' ' ALA . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.152 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 44.240000000000002 111.147 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.450000000000003 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 63.439999999999998 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.855 -179.886 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.464 -0.255 . . . . 75.420000000000002 112.464 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.109999999999999 110.831 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . 0.81 HG12 HD11 ' A' ' 336' ' ' ILE . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.135 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.099999999999994 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . 0.645 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.230000000000004 112.457 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 41.310000000000002 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.039999999999999 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.040000000000006 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.81 HD11 HG12 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.159 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 72.430000000000007 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.825 HD12 ' HB2' ' A' ' 357' ' ' ASP . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.106 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.439999999999998 110.892 -179.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.859 0.361 . . . . 73.420000000000002 110.93 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.319999999999993 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 64.310000000000002 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 71.310000000000002 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.329999999999998 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 74.5 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.696 HD21 HD11 ' A' ' 388' ' ' ILE . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.914 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.120000000000005 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 41.200000000000003 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.825 ' HB2' HD12 ' A' ' 338' ' ' ILE . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.855 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.641 HG22 HD12 ' A' ' 367' ' ' LEU . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 111.145 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.757 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.919 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 367' ' ' LEU . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.400000000000006 111.106 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 32.329999999999998 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 359' ' ' ILE . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.847 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.530000000000001 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.129999999999995 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 54.240000000000002 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 53.409999999999997 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.120000000000005 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.509999999999998 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 316' ' ' ILE . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 111.115 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 55.240000000000002 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.696 HD11 HD21 ' A' ' 353' ' ' LEU . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.152 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.757 ' CG2' HD13 ' A' ' 360' ' ' LEU . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 357' ' ' ASP . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 44.009999999999998 111.139 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 64.439999999999998 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.019999999999996 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 61.039999999999999 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.530000000000001 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . 0.419 ' HB3' HD12 ' A' ' 360' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.845 0.269 . . . . 75.019999999999996 112.26 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . 0.658 ' HA ' HD13 ' A' ' 389' ' ' ILE . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 352' ' ' GLU . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.166 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 44.240000000000002 111.156 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 315' ' ' VAL . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.068 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.439999999999998 110.868 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.915 -179.917 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 N-CA-C 112.453 -0.259 . . . . 75.420000000000002 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 379' ' ' LEU . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.109999999999999 110.934 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 41.310000000000002 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.409999999999997 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 54.549999999999997 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.039999999999999 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.030000000000001 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.040000000000006 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.153 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 359' ' ' ILE . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.116 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.439999999999998 110.914 -179.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.785 0.326 . . . . 73.420000000000002 110.888 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.319999999999993 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 52.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 349' ' ' LEU . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 350' ' ' SER . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.909 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . 0.588 ' N ' HD12 ' A' ' 349' ' ' LEU . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.859 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.329999999999998 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.725 ' HB3' HD13 ' A' ' 314' ' ' ILE . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 74.5 110.916 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 41.200000000000003 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.109999999999999 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 63.450000000000003 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 338' ' ' ILE . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.310000000000002 111.07 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 311' ' ' PRO . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 64.329999999999998 110.98 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 388' ' ' ILE . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.400000000000006 111.061 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.611 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.010000000000005 110.919 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 32.329999999999998 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 362' ' ' VAL . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.103 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.019999999999996 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 359' ' ' ILE . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.901 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.510000000000005 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 53.409999999999997 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 52.25 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 325' ' ' PHE . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 74.040000000000006 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.120000000000005 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.530000000000001 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . 0.706 ' HB1' HG21 ' A' ' 386' ' ' VAL . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.137 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.509999999999998 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . 0.706 HG21 ' HB1' ' A' ' 382' ' ' ALA . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 55.240000000000002 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 359' ' ' ILE . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.148 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 313' ' ' ARG . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.5 ' HB3' HD11 ' A' ' 314' ' ' ILE . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 44.009999999999998 111.086 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.019999999999996 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 61.240000000000002 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 54.140000000000001 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 61.039999999999999 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 72.239999999999995 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.735 0.223 . . . . 75.019999999999996 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 388' ' ' ILE . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.102 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.639 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.240000000000002 111.149 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 315' ' ' VAL . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 111.105 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 63.439999999999998 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.891 -179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.249 0 N-CA-C 112.457 -0.257 . . . . 75.420000000000002 112.457 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' PHE . . . . . 0.405 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.109999999999999 110.922 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 72.340000000000003 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.099999999999994 111.095 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.230000000000004 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 41.310000000000002 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.409999999999997 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 54.549999999999997 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.039999999999999 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.030000000000001 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.040000000000006 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.129999999999995 111.154 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 357' ' ' ASP . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 61.420000000000002 111.161 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.420000000000002 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.934 -179.913 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' LEU . . . . . 0.547 HD12 ' HA2' ' A' ' 324' ' ' GLY . 46.2 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.785 0.326 . . . . 73.420000000000002 110.932 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 52.0 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.11 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.340000000000003 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.329999999999998 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 74.5 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 388' ' ' ILE . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 41.200000000000003 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ASP . . . . . 0.586 ' HB2' HD13 ' A' ' 338' ' ' ILE . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.109999999999999 110.901 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.450000000000003 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 64.329999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.672 HG22 HG22 ' A' ' 388' ' ' ILE . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 111.151 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 32.329999999999998 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.633 HD22 ' CG2' ' A' ' 362' ' ' VAL . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.913 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.25 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 53.409999999999997 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' ALA . . . . . 0.459 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 52.25 111.097 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 110.907 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.509999999999998 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.420000000000002 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 314' ' ' ILE . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 55.240000000000002 111.147 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 314' ' ' ILE . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.430000000000007 111.076 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.473 ' HB1' ' CG ' ' A' ' 357' ' ' ASP . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 44.009999999999998 111.139 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.439999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.019999999999996 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 61.240000000000002 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 54.140000000000001 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.039999999999999 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 328' ' ' ILE . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.873 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.340000000000003 111.083 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.917 0.389 . . . . 72.530000000000001 110.864 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 8.8 tp -126.46 -64.88 1.0 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 51.520000000000003 110.882 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.94 -168.81 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 53.149999999999999 112.498 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -102.02 120.89 41.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.828 0.347 . . . . 71.230000000000004 110.878 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -153.2 -176.9 5.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.140000000000001 110.899 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -60.93 -171.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 60.340000000000003 110.853 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 23.7 mt 64.27 77.12 0.31 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.577 0.703 . . . . 74.430000000000007 111.116 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -32.19 18.86 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 72.420000000000002 112.307 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -54.4 101.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 52.100000000000001 110.895 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -79.08 160.06 71.86 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.010000000000005 110.891 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 145.38 56.85 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.64 2.227 . . . . 75.019999999999996 112.321 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 137.65 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 71.5 110.845 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 3.1 ptt85 -80.3 129.41 34.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.865 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 30.2 mm -106.0 135.94 42.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.189 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.665 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.5 p -79.54 131.7 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 44.240000000000002 111.077 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.679 ' O ' HG23 ' A' ' 385' ' ' THR . 25.8 mm -133.41 151.84 34.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.123 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -67.25 174.13 3.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.873 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -41.99 120.09 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 71.099999999999994 110.876 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.46 -27.06 16.39 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.239999999999995 112.511 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 58.1 m -51.24 -34.75 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.955 0.407 . . . . 74.129999999999995 110.829 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -108.99 26.99 9.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 70.019999999999996 111.19 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.43 54.74 2.41 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.742 -0.742 . . . . 65.430000000000007 112.501 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 1.4 tp -93.63 -25.67 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.922 0.391 . . . . 64.239999999999995 110.925 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.02 -37.25 22.42 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 75.420000000000002 112.452 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -98.84 159.81 14.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.856 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -127.45 165.83 19.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.89 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' A' ' 376' ' ' ALA . 25.0 pt -129.73 139.6 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 111.153 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.487 ' C ' HD12 ' A' ' 336' ' ' ILE . 15.3 tt -132.26 137.65 54.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.155 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.46 -156.32 7.65 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.509 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.81 -139.62 3.9 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.772 -0.728 . . . . 41.310000000000002 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -97.97 145.97 25.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 110.872 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 51.4 32.06 8.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.847 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.94 47.43 79.73 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.761 -0.733 . . . . 62.039999999999999 112.481 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -56.99 -30.06 63.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.94 0.4 . . . . 71.030000000000001 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.59 98.25 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.488 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 328' ' ' ILE . 1.9 tp -95.03 126.92 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.141 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -137.33 167.13 22.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.873 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 359' ' ' ILE . 49.1 mm -62.5 137.69 23.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.49 . . . . 61.420000000000002 111.075 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -68.99 0.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.856 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -159.92 155.76 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.344 0.593 . . . . 73.439999999999998 110.897 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 59.0 mt -103.02 120.36 40.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 124.36 3.254 . . . . 73.420000000000002 110.925 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -52.29 141.06 20.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 111.127 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 97.27 -22.94 38.05 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.726 -0.75 . . . . 73.319999999999993 112.466 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.24 163.73 38.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 52.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -43.28 2.74 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.652 2.235 . . . . 75.5 112.353 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.498 ' HA ' HG23 ' A' ' 316' ' ' ILE . . . -70.08 -29.56 66.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.209999999999994 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.34 -44.87 67.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.836 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.3 mt -80.28 -54.43 5.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.216 -0.447 . . . . 71.310000000000002 110.926 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.4 m -65.57 -46.28 80.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 73.340000000000003 110.83 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -100.14 155.57 19.56 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.724 -0.75 . . . . 70.329999999999998 112.493 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -102.5 20.69 16.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 74.5 110.882 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 390' ' ' ALA . 20.9 mt -68.8 146.81 52.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 71.340000000000003 110.905 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 -148.87 173.97 12.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.120000000000005 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 138.91 58.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.916 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 106.49 -29.18 11.36 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.466 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -67.01 147.39 53.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.804 0.335 . . . . 54.109999999999999 110.847 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.693 HE21 HD11 ' A' ' 360' ' ' LEU . 3.1 pt20 -105.72 145.05 31.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 63.450000000000003 110.925 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.879 HD11 HD11 ' A' ' 338' ' ' ILE . 37.3 mm -99.81 126.21 53.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 65.310000000000002 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.732 HD13 HG22 ' A' ' 389' ' ' ILE . 6.4 mp -99.98 -45.54 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 110.878 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.9 OUTLIER -155.61 152.15 28.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.882 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.706 HG12 HG12 ' A' ' 388' ' ' ILE . 27.2 m -129.27 128.98 67.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 70.400000000000006 111.163 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.631 ' HB3' HG23 ' A' ' 386' ' ' VAL . 11.8 p30 44.18 34.46 1.0 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.916 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.35 -70.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 32.329999999999998 112.491 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.8 m -48.66 131.25 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.845 0.355 . . . . 64.420000000000002 111.167 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -83.6 132.98 34.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.019999999999996 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.564 HD13 HG22 ' A' ' 362' ' ' VAL . 7.1 mp -113.71 33.06 5.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 71.319999999999993 110.982 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -69.13 -35.33 76.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 72.510000000000005 110.894 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -120.44 28.03 8.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 74.530000000000001 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.37 131.26 36.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 70.319999999999993 111.096 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.5 p -57.64 177.4 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 64.129999999999995 110.877 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.42 ' HA ' HD13 ' A' ' 336' ' ' ILE . 18.2 t-160 -60.67 -54.45 45.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 72.299999999999997 110.859 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -72.32 -35.02 68.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.905 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -54.53 -35.51 63.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.101 -0.5 . . . . 72.25 110.938 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.71 82.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 54.240000000000002 111.121 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -59.06 -34.5 72.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.121 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.56 -40.02 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 111.154 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.46 -35.44 73.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 52.25 111.098 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.01 -36.3 64.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 110.927 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 34.5 tttp -63.56 -42.52 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.929 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.72 18.05 10.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 71.530000000000001 110.915 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' A' ' 386' ' ' VAL . . . -51.36 -59.02 4.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.097 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 111.36 -135.62 12.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 61.509999999999998 112.507 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.74 -33.75 58.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 74.340000000000003 110.945 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 316' ' ' ILE . 84.8 m -157.07 139.22 14.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 62.43 111.144 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.662 ' HB ' ' HB1' ' A' ' 382' ' ' ALA . 4.0 p -123.63 122.7 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.420000000000002 111.136 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 52.9 p -83.82 105.13 14.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 55.240000000000002 111.097 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.706 HG12 HG12 ' A' ' 362' ' ' VAL . 11.5 mt -104.85 132.14 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 111.13 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.732 HG22 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -89.0 129.11 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.126 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -116.18 145.48 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 44.009999999999998 111.1 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -151.79 132.89 14.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 75.0 110.905 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -53.33 111.79 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 64.439999999999998 110.94 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -150.04 70.46 9.3 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.904 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -31.3 20.81 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.676 2.251 . . . . 73.530000000000001 112.344 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -74.72 -39.31 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 110.902 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -61.96 -47.63 84.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.125 -0.489 . . . . 54.140000000000001 110.888 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -75.03 -31.25 61.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.239999999999995 110.899 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -53.91 -25.23 19.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 61.039999999999999 110.888 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -59.61 -33.99 72.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 72.239999999999995 110.877 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -75.15 -47.95 25.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 110.918 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -86.92 105.08 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 73.340000000000003 110.889 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 111.098 179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.537 ' O ' HD23 ' A' ' 302' ' ' LEU . 39.5 m-85 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.877 0.37 . . . . 72.530000000000001 110.833 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 301' ' ' PHE . 12.9 mt -128.23 150.26 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 51.520000000000003 110.971 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -81.07 90.28 1.39 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.708 -0.758 . . . . 53.149999999999999 112.518 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -96.03 -49.22 5.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 71.230000000000004 110.898 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -52.43 -52.05 55.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.853 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -172.22 168.43 5.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 60.340000000000003 110.859 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 34.9 mt -120.28 69.44 14.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.634 0.73 . . . . 74.430000000000007 111.114 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.725 2.283 . . . . 72.420000000000002 112.321 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.07 36.73 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 52.100000000000001 110.941 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -87.1 160.47 49.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 74.010000000000005 110.912 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 129.64 17.96 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.677 2.251 . . . . 75.019999999999996 112.353 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -150.4 116.89 5.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 71.5 110.871 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.37 143.04 29.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 71.140000000000001 110.861 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.612 HD12 HD23 ' A' ' 353' ' ' LEU . 12.8 mt -104.09 123.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 111.127 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.614 ' O ' HD13 ' A' ' 316' ' ' ILE . 7.1 p -79.46 124.61 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 44.240000000000002 111.137 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 386' ' ' VAL . 21.5 mm -136.73 155.76 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 73.450000000000003 111.146 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.461 ' O ' HG12 ' A' ' 386' ' ' VAL . 1.9 t-160 -66.23 172.96 3.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 63.439999999999998 110.926 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -45.24 140.74 2.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 71.099999999999994 110.825 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -132.01 35.15 2.42 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.693 -0.765 . . . . 74.239999999999995 112.458 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 6.5 p -67.53 -35.82 79.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.403 . . . . 74.129999999999995 110.846 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.7 m -124.97 27.0 6.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 70.019999999999996 111.205 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -176.72 105.94 0.21 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.721 -0.752 . . . . 65.430000000000007 112.461 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.4 -46.74 7.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 64.239999999999995 110.862 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.579 ' O ' ' HB3' ' A' ' 347' ' ' ALA . . . 78.55 27.71 56.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.759 -0.734 . . . . 75.420000000000002 112.517 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -167.12 169.14 13.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.824 0.345 . . . . 75.109999999999999 110.939 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -112.08 168.57 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.888 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 327' ' ' ILE . 0.2 OUTLIER -142.04 139.69 30.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 111.174 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.5 tt -139.29 133.68 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 73.099999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -154.32 -151.62 5.85 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 70.230000000000004 112.503 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.96 -140.03 3.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.722 -0.751 . . . . 41.310000000000002 112.484 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.03 149.39 23.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.835 0.35 . . . . 71.409999999999997 110.926 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 50.8 31.84 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 54.549999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.05 55.76 28.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.782 -0.723 . . . . 62.039999999999999 112.435 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.29 -29.93 69.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.376 . . . . 71.030000000000001 110.913 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.39 100.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 74.040000000000006 112.482 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.83 118.78 45.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 73.129999999999995 111.196 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -133.29 166.65 22.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.938 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 359' ' ' ILE . 4.8 mp -71.83 137.19 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 61.420000000000002 111.161 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 6.7 t -102.01 -54.7 2.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 72.420000000000002 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -162.45 141.92 9.38 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.327 0.584 . . . . 73.439999999999998 110.877 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 21.9 mt -89.28 131.76 35.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 124.415 3.28 . . . . 73.420000000000002 110.936 169.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.3 143.7 40.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.006 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.4 12.14 84.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.755 -0.736 . . . . 73.319999999999993 112.499 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -105.63 -175.73 23.99 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.676 -0.773 . . . . 52.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.82 17.85 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 75.5 112.312 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 324' ' ' GLY . . . -71.07 -37.26 72.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 111.104 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -58.28 -45.3 88.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.83 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 37.6 mt -59.84 -47.64 84.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 110.994 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.45 ' OG ' HD12 ' A' ' 316' ' ' ILE . 0.7 OUTLIER -55.68 -41.08 73.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.814 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.89 43.31 99.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 70.329999999999998 112.505 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 314' ' ' ILE . 4.8 mt-10 -124.63 -52.51 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.846 0.355 . . . . 74.5 110.908 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.738 ' CD2' HD11 ' A' ' 388' ' ' ILE . 7.1 mt -69.31 124.93 25.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 11.1 mtp180 -144.65 166.43 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.832 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -64.61 139.59 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.897 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.53 -29.01 8.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.748 -0.739 . . . . 41.200000000000003 112.415 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.593 ' HB2' HD13 ' A' ' 338' ' ' ILE . 2.1 m-20 -72.69 149.25 43.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.844 0.354 . . . . 54.109999999999999 110.868 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -105.85 141.81 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.875 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.752 HD11 HD11 ' A' ' 338' ' ' ILE . 42.6 mm -99.58 112.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 65.310000000000002 111.168 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 68.9 mt -90.66 -39.17 12.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 110.865 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.425 ' OG ' HD12 ' A' ' 389' ' ' ILE . 4.9 p -154.45 158.56 40.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.805 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.715 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.7 p -138.66 116.29 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 70.400000000000006 111.217 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 10.0 t30 50.67 31.92 6.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.892 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.64 -69.43 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.78 -0.724 . . . . 32.329999999999998 112.482 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.3 m -50.41 124.48 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.843 0.354 . . . . 64.420000000000002 111.142 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.17 130.09 35.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 64.019999999999996 110.903 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 359' ' ' ILE . 51.3 mt -99.84 27.29 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 71.319999999999993 110.898 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -35.21 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 110.82 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -127.79 27.89 5.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.897 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.51 128.65 36.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 70.319999999999993 111.099 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.1 p -57.84 167.75 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 64.129999999999995 110.83 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -56.05 -55.27 34.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 72.299999999999997 110.816 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -73.74 -34.61 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 74.209999999999994 110.842 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -55.62 -38.9 70.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 72.25 110.851 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -37.77 76.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 54.240000000000002 111.096 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.39 -35.68 78.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 73.420000000000002 111.08 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 29.0 mt -61.62 -38.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 111.164 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -68.81 -44.87 72.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 52.25 111.097 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.715 ' CD2' HG21 ' A' ' 362' ' ' VAL . 1.3 mm? -64.22 -39.99 95.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.434 . . . . 74.040000000000006 110.96 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.0 ttpt -57.57 -34.71 69.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.120000000000005 110.879 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -104.98 17.68 23.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.909 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -50.94 -58.88 4.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.122 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.53 -135.05 7.98 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.736 -0.745 . . . . 61.509999999999998 112.497 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -107.52 21.45 17.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.885 0.374 . . . . 74.340000000000003 110.951 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m -163.2 126.52 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.152 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 316' ' ' ILE . 3.1 p -112.07 111.92 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 71.420000000000002 111.081 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 24.0 m -124.75 104.64 8.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 55.240000000000002 111.113 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.738 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.6 pp -113.87 142.34 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 72.430000000000007 111.129 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.425 HD12 ' OG ' ' A' ' 361' ' ' SER . 86.9 mt -82.91 121.23 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.157 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.1 129.83 56.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 44.009999999999998 111.125 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -137.61 133.43 34.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 75.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -53.31 111.54 0.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 64.439999999999998 110.943 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -150.08 67.32 8.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.814 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.82 -31.96 19.24 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.758 2.306 . . . . 73.530000000000001 112.307 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -65.77 -36.04 82.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 61.240000000000002 110.885 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -76.71 -47.83 20.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 54.140000000000001 110.871 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -66.8 -31.8 72.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 75.239999999999995 110.933 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.2 t -54.42 -25.11 22.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 61.039999999999999 110.823 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -33.2 71.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 72.239999999999995 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -75.9 -48.06 22.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.864 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -87.01 104.98 16.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.89 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.131 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 72.530000000000001 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.23 156.59 34.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 51.520000000000003 110.876 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -162.28 -176.43 34.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.726 -0.749 . . . . 53.149999999999999 112.467 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -147.03 171.64 14.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.304 . . . . 71.230000000000004 110.889 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -175.71 147.99 0.85 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.473 . . . . 74.140000000000001 110.835 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -58.87 -178.63 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.124 -0.489 . . . . 60.340000000000003 110.853 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 307' ' ' ILE . 4.0 tp -177.72 82.08 0.24 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.626 0.727 . . . . 74.430000000000007 111.08 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 175.43 8.11 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.739 2.293 . . . . 72.420000000000002 112.407 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -169.94 158.91 7.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 52.100000000000001 110.874 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.06 160.74 59.7 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.593 0.711 . . . . 74.010000000000005 110.911 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 119.7 6.6 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.673 2.249 . . . . 75.019999999999996 112.323 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 167.18 28.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 71.5 110.893 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.41 142.03 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.941 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.678 HD12 ' HB2' ' A' ' 352' ' ' GLU . 11.5 tt -104.95 124.01 59.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.693 ' O ' HD13 ' A' ' 316' ' ' ILE . 40.1 t -99.11 119.56 47.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.196 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.693 HD13 ' O ' ' A' ' 315' ' ' VAL . 16.4 mm -132.22 157.77 43.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 73.450000000000003 111.131 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.428 ' N ' HG22 ' A' ' 316' ' ' ILE . 31.1 m170 -66.74 172.59 4.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 63.439999999999998 110.826 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -48.06 121.55 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 71.099999999999994 110.88 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -129.24 55.48 0.76 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 74.239999999999995 112.448 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 15.7 p -90.71 11.12 23.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.901 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.3 m -110.3 27.02 10.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 70.019999999999996 111.159 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 101.35 106.0 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.764 -0.732 . . . . 65.430000000000007 112.506 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.585 HD21 HG21 ' A' ' 386' ' ' VAL . 9.5 mt -69.72 -33.12 72.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 64.239999999999995 110.87 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 92.47 50.63 2.52 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.751 . . . . 75.420000000000002 112.497 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -166.98 169.24 13.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 75.109999999999999 110.913 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -121.25 154.24 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.855 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 327' ' ' ILE . 2.7 pp -125.34 137.47 57.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.118 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 10.1 tt -119.59 140.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 73.099999999999994 111.097 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.67 -152.14 6.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.757 -0.735 . . . . 70.230000000000004 112.484 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.24 -140.01 2.79 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.752 -0.737 . . . . 41.310000000000002 112.478 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -96.14 146.65 24.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 71.409999999999997 110.835 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 52.09 27.77 4.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 54.549999999999997 110.887 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.56 49.88 38.2 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.56 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -54.96 -28.56 52.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.847 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 167.42 98.59 0.12 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.727 -0.749 . . . . 74.040000000000006 112.496 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.1 tt -91.29 130.67 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.087 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -137.96 167.19 22.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 72.430000000000007 110.932 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 359' ' ' ILE . 45.5 mm -74.94 139.46 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 61.420000000000002 111.096 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -94.6 -72.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 72.420000000000002 110.79 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -148.39 167.57 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.357 0.599 . . . . 73.439999999999998 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 43.4 mt -62.0 139.63 58.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 124.363 3.256 . . . . 73.420000000000002 110.893 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.51 155.3 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 111.061 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.87 13.03 82.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.732 -0.747 . . . . 73.319999999999993 112.475 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -112.06 165.15 12.06 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.712 -0.756 . . . . 52.0 112.459 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.36 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.711 2.274 . . . . 75.5 112.302 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -54.15 -44.64 71.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.169 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -71.96 -47.48 51.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 64.310000000000002 110.839 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.75 -38.12 71.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.962 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.635 ' HB2' HD11 ' A' ' 314' ' ' ILE . 4.2 p -54.34 -37.5 64.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.856 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.18 51.95 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.801 -0.714 . . . . 70.329999999999998 112.466 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' A' ' 314' ' ' ILE . 0.8 OUTLIER -121.37 -53.43 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 74.5 110.884 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 79.2 mt -86.34 114.67 23.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -140.82 174.07 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.926 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.06 130.66 47.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 71.430000000000007 110.908 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.21 -29.09 9.52 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.736 -0.745 . . . . 41.200000000000003 112.513 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -63.84 148.91 48.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 54.109999999999999 110.837 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -110.29 117.02 32.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 110.941 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 1.097 HD11 HD11 ' A' ' 338' ' ' ILE . 42.1 mm -71.35 126.36 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.08 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.651 HD12 HG22 ' A' ' 389' ' ' ILE . 82.1 mt -102.76 -38.98 7.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 64.329999999999998 110.894 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.16 162.08 37.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.822 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.62 HG12 HG13 ' A' ' 388' ' ' ILE . 2.6 m -138.75 108.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 70.400000000000006 111.108 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.46 34.52 24.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 75.010000000000005 110.896 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.56 -75.72 0.25 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.498 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.13 129.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.112 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -83.36 140.38 32.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 64.019999999999996 110.87 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 359' ' ' ILE . 29.0 mt -109.08 32.65 4.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.906 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -72.3 -33.69 67.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 72.510000000000005 110.835 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -129.42 28.41 5.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 110.957 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.03 128.61 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 70.319999999999993 111.102 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -58.63 175.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 64.129999999999995 110.827 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 14.0 t-160 -61.19 -54.32 45.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.504 . . . . 72.299999999999997 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -71.51 -33.28 69.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.859 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -55.29 -42.04 73.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 72.25 110.892 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.56 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.240000000000002 111.111 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.77 75.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 111.123 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.49 -44.05 88.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 53.409999999999997 111.111 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.51 -35.55 73.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 52.25 111.102 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 3.3 tt -58.66 -47.7 83.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 74.040000000000006 110.951 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -61.27 -35.33 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.120000000000005 110.915 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.48 18.63 16.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 71.530000000000001 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.13 -58.41 6.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.075 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.83 -134.1 8.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 61.509999999999998 112.468 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -117.38 26.93 9.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 74.340000000000003 110.9 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -155.53 161.8 40.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 62.43 111.137 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.585 HG21 HD21 ' A' ' 323' ' ' LEU . 98.6 t -124.91 109.62 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 71.420000000000002 111.085 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.56 104.88 7.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.476 . . . . 55.240000000000002 111.146 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.62 HG13 HG12 ' A' ' 362' ' ' VAL . 3.7 mp -124.8 139.82 49.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 111.155 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.651 HG22 HD12 ' A' ' 360' ' ' LEU . 3.4 mp -112.35 110.88 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 74.25 111.155 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -138.26 167.36 22.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 44.009999999999998 111.058 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -144.27 149.03 35.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 75.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -52.1 111.11 0.56 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 64.439999999999998 110.995 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -150.06 75.05 9.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 75.019999999999996 110.859 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -26.87 27.11 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.731 2.287 . . . . 73.530000000000001 112.356 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -73.54 -40.88 63.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.256 -0.429 . . . . 61.240000000000002 110.911 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -62.96 -47.87 81.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 54.140000000000001 110.888 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -69.22 -31.2 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 75.239999999999995 110.891 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 2.6 m -54.0 -24.65 17.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 61.039999999999999 110.884 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -58.95 -33.49 70.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.852 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -76.7 -47.99 20.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.871 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.14 104.82 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 73.340000000000003 110.948 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.109 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.743 ' O ' HD23 ' A' ' 302' ' ' LEU . 5.7 t80 . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.826 0.346 . . . . 72.530000000000001 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 301' ' ' PHE . 6.6 mt -129.22 177.65 7.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.449 . . . . 51.520000000000003 110.936 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -106.17 -174.29 23.46 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.75 . . . . 53.149999999999999 112.434 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -108.64 -69.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 71.230000000000004 110.92 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -175.18 108.54 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 74.140000000000001 110.886 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.42 131.93 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 60.340000000000003 110.839 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 4.8 pt -124.72 67.65 51.04 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.613 0.721 . . . . 74.430000000000007 111.115 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.95 0.42 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.743 2.295 . . . . 72.420000000000002 112.337 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -89.06 -41.74 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.273 -0.421 . . . . 52.100000000000001 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.93 160.85 1.99 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.581 0.705 . . . . 74.010000000000005 110.935 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 126.69 13.64 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 75.019999999999996 112.414 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 162.9 31.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 71.5 110.931 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.03 142.4 31.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 71.140000000000001 110.851 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 352' ' ' GLU . 16.2 tt -104.72 147.5 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 111.121 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.586 HG21 HD22 ' A' ' 302' ' ' LEU . 4.8 p -116.97 118.16 57.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 44.240000000000002 111.179 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.51 HD11 ' CG2' ' A' ' 314' ' ' ILE . 2.0 mp -137.94 160.32 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.179 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 12.5 m170 -65.5 173.66 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 63.439999999999998 110.85 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -42.51 137.7 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 71.099999999999994 110.851 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -70.93 81.65 0.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 74.239999999999995 112.453 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.02 -33.86 12.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.983 0.421 . . . . 74.129999999999995 110.881 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.802 HG23 ' HD3' ' A' ' 346' ' ' PRO . 8.9 t -126.19 27.21 6.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.121 -0.49 . . . . 70.019999999999996 111.093 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.65 -27.87 13.91 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.74 -0.743 . . . . 65.430000000000007 112.431 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 9.4 tp -52.7 -24.05 7.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 64.239999999999995 110.861 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -46.38 -36.1 7.43 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 75.420000000000002 112.486 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -101.93 150.58 23.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 75.109999999999999 110.896 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -112.42 159.71 18.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.46 . . . . 72.140000000000001 110.898 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.608 HG22 ' HA ' ' A' ' 338' ' ' ILE . 17.7 pt -143.35 158.22 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 72.340000000000003 111.099 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 339' ' ' SER . 1.4 mp -116.7 123.66 71.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.128 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.513 ' CA ' HD12 ' A' ' 336' ' ' ILE . . . -127.95 -164.38 11.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 70.230000000000004 112.522 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -160.11 -140.04 2.8 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.686 -0.769 . . . . 41.310000000000002 112.429 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -99.95 141.99 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 71.409999999999997 110.941 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 50.95 31.23 6.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 54.549999999999997 110.86 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.82 51.13 35.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.802 -0.713 . . . . 62.039999999999999 112.473 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -55.58 -30.03 60.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.873 0.368 . . . . 71.030000000000001 110.837 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 165.54 96.0 0.11 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.801 -0.714 . . . . 74.040000000000006 112.529 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.513 HD12 ' CA ' ' A' ' 329' ' ' GLY . 0.8 OUTLIER -89.35 134.4 28.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 111.134 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -137.97 167.18 22.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 72.430000000000007 110.865 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 359' ' ' ILE . 35.1 mm -76.94 138.84 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.112 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . 0.639 ' HB2' HD12 ' A' ' 328' ' ' ILE . 29.9 t -95.66 -66.74 0.89 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.844 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -161.9 167.63 24.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.334 0.588 . . . . 73.439999999999998 110.858 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.501 HD23 ' N ' ' A' ' 343' ' ' ALA . 0.7 OUTLIER -107.43 147.58 30.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 124.399 3.272 . . . . 73.420000000000002 110.91 169.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.501 ' N ' HD23 ' A' ' 342' ' ' LEU . . . -55.87 143.43 31.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.105 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 94.84 -22.32 38.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 73.319999999999993 112.575 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.14 176.36 54.55 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.687 -0.768 . . . . 52.0 112.526 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . 0.802 ' HD3' HG23 ' A' ' 321' ' ' THR . 54.2 Cg_endo -69.7 -31.59 20.51 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.716 2.277 . . . . 75.5 112.393 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -61.42 -51.12 70.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.209999999999994 111.153 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -72.11 -38.43 69.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 64.310000000000002 110.866 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.97 -53.5 57.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 71.310000000000002 110.857 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.745 ' CB ' HD11 ' A' ' 314' ' ' ILE . 6.6 t -65.51 -36.3 83.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.340000000000003 110.923 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.77 33.1 56.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.728 -0.748 . . . . 70.329999999999998 112.465 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.747 ' HB2' HD12 ' A' ' 314' ' ' ILE . 9.4 mm-40 -124.65 -47.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.892 0.377 . . . . 74.5 110.908 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.695 ' CD2' HD11 ' A' ' 388' ' ' ILE . 16.7 mt -74.72 125.21 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.506 . . . . 71.340000000000003 110.906 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -148.83 161.97 40.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.869 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.49 139.29 15.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.842 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 100.23 -28.8 14.05 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.761 -0.733 . . . . 41.200000000000003 112.474 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -59.79 148.99 32.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.746 0.308 . . . . 54.109999999999999 110.872 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -111.57 140.9 45.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 63.450000000000003 110.882 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.869 HD11 HD11 ' A' ' 338' ' ' ILE . 52.2 mm -99.18 126.81 52.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 65.310000000000002 111.15 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.717 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -107.48 -32.43 7.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 110.902 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 78.5 p -157.44 161.47 38.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 73.140000000000001 110.893 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.677 ' HA ' HG22 ' A' ' 388' ' ' ILE . 5.2 p -139.07 116.62 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.112 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.3 t30 50.37 32.34 6.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 75.010000000000005 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 113.15 -69.37 0.23 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.681 -0.771 . . . . 32.329999999999998 112.497 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.513 HG23 HG13 ' A' ' 362' ' ' VAL . 3.6 m -51.56 124.73 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.152 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -72.05 138.96 48.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 64.019999999999996 110.874 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 362' ' ' VAL . 62.2 mt -108.26 30.91 5.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 110.883 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -72.25 -33.18 67.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.912 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -127.89 27.91 5.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.11 -0.495 . . . . 74.530000000000001 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -94.28 128.52 40.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 111.135 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.3 p -58.16 177.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 64.129999999999995 110.843 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 -63.24 -54.44 37.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 72.299999999999997 110.917 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.18 -34.34 68.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.937 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -55.33 -40.94 71.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.25 110.912 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.28 80.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 54.240000000000002 111.145 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.69 -36.59 84.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.114 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.7 mt -58.81 -40.3 79.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 53.409999999999997 111.177 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.422 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.63 -34.44 72.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 52.25 111.086 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 362' ' ' VAL . 1.9 mp -73.49 -39.61 64.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 74.040000000000006 110.968 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp -61.11 -46.53 90.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.929 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -102.12 18.78 19.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.259 -0.428 . . . . 71.530000000000001 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -54.04 -36.93 63.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.113 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 127.85 -133.76 7.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.552 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -114.6 26.41 10.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.914 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.53 165.69 35.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 62.43 111.16 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 97.8 t -132.02 110.97 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 71.420000000000002 111.137 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.22 103.61 7.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.111 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.695 HD11 ' CD2' ' A' ' 353' ' ' LEU . 2.8 pp -132.18 142.57 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.430000000000007 111.151 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.717 ' CG2' HD13 ' A' ' 360' ' ' LEU . 77.3 mt -85.54 114.83 26.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.037 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 44.009999999999998 111.101 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -134.12 128.98 35.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 75.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -53.13 111.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 64.439999999999998 110.912 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.0 tptt -149.97 64.11 6.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.64 0.733 . . . . 75.019999999999996 110.969 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.94 24.88 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.663 2.242 . . . . 73.530000000000001 112.344 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -81.67 -53.59 6.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.922 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -65.5 -36.33 83.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 54.140000000000001 110.887 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.56 -31.69 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.214 -0.448 . . . . 75.239999999999995 110.826 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.6 t -53.89 -24.74 17.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 61.039999999999999 110.908 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -59.07 -33.91 71.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.873 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . 0.511 ' CG ' HG21 ' A' ' 328' ' ' ILE . 20.8 m-85 -78.4 -48.0 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.855 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.39 104.47 16.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.340000000000003 110.935 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 74.340000000000003 111.057 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.931 0.396 . . . . 72.530000000000001 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 51.8 mt -127.01 -59.93 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 51.520000000000003 110.941 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -59.68 133.51 51.53 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.715 -0.755 . . . . 53.149999999999999 112.514 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -128.94 -46.58 1.25 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 71.230000000000004 110.931 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -89.23 57.27 3.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 74.140000000000001 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -122.65 -35.47 3.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 60.340000000000003 110.857 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 307' ' ' ILE . 1.3 pp -121.4 158.96 52.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.593 0.711 . . . . 74.430000000000007 111.164 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -31.26 21.03 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.683 2.255 . . . . 72.420000000000002 112.324 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -89.86 74.45 7.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 52.100000000000001 110.87 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.33 121.41 84.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.629 0.728 . . . . 74.010000000000005 110.871 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 158.59 56.45 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.701 2.267 . . . . 75.019999999999996 112.396 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.23 137.11 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.887 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 387' ' ' THR . 11.1 tpp85 -78.88 130.25 35.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 71.140000000000001 110.878 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.687 HG21 ' HG ' ' A' ' 353' ' ' LEU . 30.4 mm -105.89 146.09 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 111.159 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.1 p -106.45 128.0 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.106 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.09 149.35 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 111.166 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -66.96 172.74 4.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 110.876 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -46.74 124.32 5.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 71.099999999999994 110.912 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -137.55 130.4 5.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 74.239999999999995 112.472 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.4 t -93.14 -39.98 10.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 110.825 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 74.5 p -132.02 17.4 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 70.019999999999996 111.207 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 47.54 36.64 12.22 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.743 -0.742 . . . . 65.430000000000007 112.439 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 5.1 mt -50.88 -30.72 15.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.35 . . . . 64.239999999999995 110.896 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.05 -29.83 15.44 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.752 -0.737 . . . . 75.420000000000002 112.46 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.608 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.2 p90 -137.12 151.66 49.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.844 0.354 . . . . 75.109999999999999 110.893 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -87.53 139.87 30.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.452 . . . . 72.140000000000001 110.894 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 5.6 pt -126.84 147.06 31.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.054 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.791 HG23 ' HB2' ' A' ' 339' ' ' SER . 2.2 pt -116.89 123.29 71.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.162 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -131.53 155.0 21.15 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.689 -0.767 . . . . 70.230000000000004 112.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -118.3 -140.01 6.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 41.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -100.01 142.18 31.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 71.409999999999997 110.922 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 51.03 31.58 6.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 54.549999999999997 110.822 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.3 48.78 46.76 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.707 -0.759 . . . . 62.039999999999999 112.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -59.3 -29.91 67.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.381 . . . . 71.030000000000001 110.914 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.88 107.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.733 -0.746 . . . . 74.040000000000006 112.502 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -106.46 125.23 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.121 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -137.51 167.92 20.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.869 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.706 ' CD1' HD11 ' A' ' 359' ' ' ILE . 37.0 mm -66.76 130.79 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.106 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . 0.791 ' HB2' HG23 ' A' ' 328' ' ' ILE . 30.2 t -88.56 -59.05 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 72.420000000000002 110.907 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -162.26 167.52 23.81 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.319 0.58 . . . . 73.439999999999998 110.872 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 17.9 mt -107.08 132.66 52.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 124.396 3.271 . . . . 73.420000000000002 110.981 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.39 145.26 39.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.251 -0.431 . . . . 72.120000000000005 111.038 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.66 -23.95 31.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.693 -0.765 . . . . 73.319999999999993 112.473 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.45 -173.26 48.92 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.75 -0.738 . . . . 52.0 112.498 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -33.46 16.76 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 75.5 112.302 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.608 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -57.58 -42.87 83.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 111.083 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.29 -41.74 85.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.274 -0.421 . . . . 64.310000000000002 110.897 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.04 -43.72 82.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 71.310000000000002 110.965 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -37.5 83.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 73.340000000000003 110.913 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.46 58.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 70.329999999999998 112.48 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.52 ' HB3' HD12 ' A' ' 314' ' ' ILE . 28.0 mt-10 -128.56 -50.65 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.925 0.393 . . . . 74.5 110.928 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.687 ' HG ' HG21 ' A' ' 314' ' ' ILE . 63.9 mt -69.19 128.02 35.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 110.882 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -146.62 174.13 11.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.120000000000005 110.884 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.7 139.3 58.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 105.28 -28.99 12.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.695 -0.764 . . . . 41.200000000000003 112.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -65.55 149.69 49.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.784 0.326 . . . . 54.109999999999999 110.846 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -115.71 143.53 45.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.450000000000003 110.981 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.839 HG21 HD12 ' A' ' 367' ' ' LEU . 3.1 mp -99.59 126.61 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 65.310000000000002 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.456 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.0 mp -104.16 -34.98 8.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.103 -0.498 . . . . 64.329999999999998 110.908 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 389' ' ' ILE . 12.8 t -158.95 160.45 36.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 73.140000000000001 110.835 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG1' HD11 ' A' ' 367' ' ' LEU . 5.5 p -138.29 115.62 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 70.400000000000006 111.087 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 m120 51.35 30.84 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 75.010000000000005 110.851 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.65 -69.94 0.27 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.735 -0.745 . . . . 32.329999999999998 112.489 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.568 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.0 m -50.48 123.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.173 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.71 134.62 39.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 64.019999999999996 110.884 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.839 HD12 HG21 ' A' ' 359' ' ' ILE . 15.3 mt -110.15 28.83 8.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.873 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -69.28 -33.73 73.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 72.510000000000005 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -122.77 27.96 7.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.873 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -90.34 129.0 36.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.319999999999993 111.041 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.36 177.69 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 64.129999999999995 110.842 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -55.15 -54.37 44.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.063 -0.517 . . . . 72.299999999999997 110.864 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -72.44 -32.5 66.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.455 . . . . 74.209999999999994 110.884 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -55.18 -40.64 70.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.942 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.45 75.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.119 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.105 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 34.3 mt -60.39 -52.36 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 53.409999999999997 111.151 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.568 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -63.96 -48.59 75.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 52.25 111.074 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.491 HD11 ' CG1' ' A' ' 386' ' ' VAL . 9.3 tp -57.28 -35.26 69.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.451 . . . . 74.040000000000006 110.922 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -69.3 -35.21 75.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 72.120000000000005 110.895 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -99.49 18.18 18.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.916 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -71.61 -35.11 70.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.078 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 116.07 -135.28 12.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.781 -0.724 . . . . 61.509999999999998 112.475 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -110.16 28.12 8.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 74.340000000000003 110.87 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.0 m -161.96 119.0 2.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.124 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.491 ' CG1' HD11 ' A' ' 379' ' ' LEU . 98.4 t -100.95 111.96 32.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.15 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 314' ' ' ILE . 0.2 OUTLIER -123.01 103.06 8.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 55.240000000000002 111.1 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.476 HG22 ' HB ' ' A' ' 362' ' ' VAL . 14.1 pt -113.04 142.61 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.430000000000007 111.077 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 361' ' ' SER . 5.3 mp -82.32 129.33 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 74.25 111.158 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.31 145.07 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 44.009999999999998 111.115 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -152.12 139.22 19.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 75.0 110.86 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -53.34 111.18 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 64.439999999999998 110.911 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -150.0 66.41 7.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.612 0.72 . . . . 75.019999999999996 110.99 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.72 -35.09 13.39 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.344 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -68.33 -47.1 68.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 61.240000000000002 110.898 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -61.63 -47.64 84.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 54.140000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -69.8 -32.14 70.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 75.239999999999995 110.988 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -55.12 -24.42 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 61.039999999999999 110.941 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.07 -35.15 72.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.015 -0.539 . . . . 72.239999999999995 110.817 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -84.09 -48.56 9.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.902 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.35 103.27 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 73.340000000000003 110.844 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 74.340000000000003 111.122 179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 6.1 t80 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.884 0.373 . . . . 72.530000000000001 110.896 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 12.1 mt -133.95 93.39 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 51.520000000000003 110.908 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.2 178.3 45.23 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 53.149999999999999 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 60.72 56.46 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.796 0.331 . . . . 71.230000000000004 110.877 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 37.64 2.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.942 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.561 ' O ' HD13 ' A' ' 307' ' ' ILE . 68.1 m-20 -113.31 -75.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.121 -0.49 . . . . 60.340000000000003 110.869 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 306' ' ' ASP . 26.7 mm -139.16 67.5 40.01 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.672 0.749 . . . . 74.430000000000007 111.183 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 92.42 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.689 2.259 . . . . 72.420000000000002 112.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.55 32.5 4.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 52.100000000000001 110.868 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -87.43 160.28 48.42 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.649 0.738 . . . . 74.010000000000005 110.921 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 121.28 7.99 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.755 2.303 . . . . 75.019999999999996 112.362 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.12 135.77 39.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 71.5 110.907 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.726 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.5 OUTLIER -80.72 141.62 34.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 71.140000000000001 110.936 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 353' ' ' LEU . 5.3 mp -106.58 121.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 73.329999999999998 111.05 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 315' ' ' VAL . 7.2 p -93.38 124.79 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.132 -0.486 . . . . 44.240000000000002 111.174 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 385' ' ' THR . 1.2 pp -138.42 159.99 31.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 111.198 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -67.24 172.62 4.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 63.439999999999998 110.883 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -44.97 118.85 1.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 71.099999999999994 110.81 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.35 33.29 2.45 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 74.239999999999995 112.484 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.0 t -62.15 -36.25 81.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.87 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 18.1 p -101.98 26.99 6.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 70.019999999999996 111.069 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.51 101.34 0.16 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.745 -0.74 . . . . 65.430000000000007 112.493 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 325' ' ' PHE . 0.1 OUTLIER -94.59 -47.46 6.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 64.239999999999995 110.909 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 74.16 33.37 57.05 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.775 -0.726 . . . . 75.420000000000002 112.428 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.663 ' O ' HD12 ' A' ' 323' ' ' LEU . 9.2 p90 -166.75 169.38 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.856 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -117.2 167.87 10.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.875 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 32.2 pt -141.8 139.06 31.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 72.340000000000003 111.077 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.7 tt -130.95 136.67 57.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 73.099999999999994 111.137 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -149.78 -160.22 9.11 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 70.230000000000004 112.541 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.85 -139.76 3.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 41.310000000000002 112.458 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -99.98 146.04 27.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.932 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 51.3 33.48 9.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.499 . . . . 54.549999999999997 110.836 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.56 48.9 54.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.721 -0.752 . . . . 62.039999999999999 112.524 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -62.19 -30.05 70.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.877 0.37 . . . . 71.030000000000001 110.892 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.8 109.27 0.22 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.427 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -109.74 125.73 66.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 73.129999999999995 111.226 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -137.07 167.39 21.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.908 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 359' ' ' ILE . 46.4 mm -67.11 139.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.121 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.77 -70.46 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 72.420000000000002 110.856 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -151.32 167.23 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.329 0.585 . . . . 73.439999999999998 110.922 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 8.9 mt -92.67 139.94 30.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 124.308 3.231 . . . . 73.420000000000002 110.918 169.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -66.88 139.67 57.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.473 . . . . 72.120000000000005 111.155 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 79.12 14.06 82.25 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 73.319999999999993 112.474 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -98.3 165.5 21.64 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.73 . . . . 52.0 112.509 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 -34.45 14.74 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.689 2.259 . . . . 75.5 112.348 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.605 ' HB1' ' HB2' ' A' ' 353' ' ' LEU . . . -58.04 -41.53 83.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.209999999999994 111.101 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.47 -53.94 52.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 64.310000000000002 110.83 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.8 mt -64.52 -44.7 90.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 52.4 p -54.55 -37.27 65.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 73.340000000000003 110.9 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 69.98 33.0 69.76 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.683 -0.77 . . . . 70.329999999999998 112.482 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -119.96 -53.24 2.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.5 110.952 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.923 HD22 HD11 ' A' ' 388' ' ' ILE . 4.2 mt -84.06 115.33 22.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.340000000000003 110.905 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -147.38 174.04 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.866 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 71.430000000000007 110.863 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.33 -29.0 12.77 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 41.200000000000003 112.51 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -70.11 148.84 48.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.777 0.322 . . . . 54.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -114.55 141.72 47.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.874 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 338' ' ' ILE . 34.3 mt -99.52 124.74 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 65.310000000000002 111.109 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 89.7 mt -100.11 -32.61 10.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 64.329999999999998 110.962 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.5 m -158.94 157.8 32.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.999 HG12 HG22 ' A' ' 388' ' ' ILE . 27.3 m -135.34 126.68 45.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 70.400000000000006 111.144 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.16 34.99 1.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 75.010000000000005 110.86 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.1 -73.11 0.2 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.707 -0.759 . . . . 32.329999999999998 112.401 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.4 m -46.15 132.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.8 0.333 . . . . 64.420000000000002 111.143 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.7 139.41 40.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 64.019999999999996 110.853 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.747 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.9 OUTLIER -116.63 27.08 9.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 71.319999999999993 110.916 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 24.0 mtp180 -73.02 -39.44 65.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 72.510000000000005 110.926 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -115.14 28.47 8.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.530000000000001 110.898 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.747 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.12 128.62 40.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 70.319999999999993 111.094 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.2 p -64.35 175.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 64.129999999999995 110.786 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -58.77 -54.54 45.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.852 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.63 -31.96 65.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.229 -0.442 . . . . 74.209999999999994 110.907 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -54.94 -42.68 72.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 72.25 110.921 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.23 -35.73 72.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 54.240000000000002 111.12 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.52 -33.99 75.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 111.072 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.77 -50.35 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 53.409999999999997 111.054 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.43 -34.72 72.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.154 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 382' ' ' ALA . 16.0 mt -69.74 -36.09 75.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 74.040000000000006 110.948 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -58.66 -50.7 72.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.895 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -100.69 18.72 18.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 71.530000000000001 110.885 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 379' ' ' LEU . . . -58.85 -48.37 81.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 75.239999999999995 111.111 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.1 -133.86 7.23 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.754 -0.736 . . . . 61.509999999999998 112.495 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.75 -71.3 0.77 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.895 0.379 . . . . 74.340000000000003 110.944 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . 0.536 HG23 ' O ' ' A' ' 316' ' ' ILE . 55.6 m -77.92 86.39 4.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.43 111.144 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.509 HG12 HG23 ' A' ' 388' ' ' ILE . 59.4 t -75.65 111.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.420000000000002 111.138 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.726 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -94.41 104.88 16.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 111.12 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.999 HG22 HG12 ' A' ' 362' ' ' VAL . 2.5 pp -112.72 140.79 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.154 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 5.2 mp -91.91 120.22 40.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.25 111.09 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.49 143.11 45.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 44.009999999999998 111.146 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -150.95 135.37 17.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 75.0 110.96 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -53.53 111.71 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.439999999999998 110.925 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -150.02 67.52 8.47 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.58 0.705 . . . . 75.019999999999996 110.882 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.68 -28.4 25.66 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.675 2.25 . . . . 73.530000000000001 112.356 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.99 -48.51 29.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 110.95 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -61.77 -47.7 84.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 54.140000000000001 110.858 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -68.02 -31.96 71.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.888 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -24.9 23.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.496 . . . . 61.039999999999999 110.843 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -59.78 -32.58 70.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.87 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -74.83 -47.78 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.530000000000001 110.833 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -86.68 105.19 16.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 73.340000000000003 110.898 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 111.099 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.82 0.343 . . . . 72.530000000000001 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 tp -165.0 159.36 17.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 51.520000000000003 110.889 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -139.76 -174.52 13.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.818 -0.706 . . . . 53.149999999999999 112.508 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.86 155.76 7.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.913 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -175.52 156.18 1.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.866 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.38 -74.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 60.340000000000003 110.911 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.427 HG22 ' HG3' ' A' ' 309' ' ' ARG . 30.6 mm -123.22 67.86 36.03 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.575 0.702 . . . . 74.430000000000007 111.143 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -33.15 17.07 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.699 2.266 . . . . 72.420000000000002 112.257 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.427 ' HG3' HG22 ' A' ' 307' ' ' ILE . 35.8 mtp180 54.11 34.01 19.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.285 -0.416 . . . . 52.100000000000001 110.83 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.29 160.18 49.04 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 74.010000000000005 110.86 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 119.47 6.41 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.726 2.284 . . . . 75.019999999999996 112.397 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.92 150.47 37.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.5 110.932 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.755 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -92.42 141.38 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 71.140000000000001 110.858 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 353' ' ' LEU . 74.7 mt -106.91 118.72 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 111.154 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.3 t -79.61 128.5 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 44.240000000000002 111.105 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.62 HD11 ' HB ' ' A' ' 386' ' ' VAL . 4.9 pt -137.96 159.57 33.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 111.196 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -67.44 172.86 4.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 63.439999999999998 110.828 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -46.69 126.02 7.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.843 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -126.73 35.23 2.95 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.799 -0.715 . . . . 74.239999999999995 112.543 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.5 p -74.62 -39.72 61.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.922 0.391 . . . . 74.129999999999995 110.779 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -117.9 27.02 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.084 -0.507 . . . . 70.019999999999996 111.107 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.34 103.49 0.18 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 65.430000000000007 112.461 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.751 HD12 ' CZ ' ' A' ' 325' ' ' PHE . 4.1 mm? -88.54 -46.51 9.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 64.239999999999995 110.921 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 79.25 27.49 55.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.745 -0.741 . . . . 75.420000000000002 112.515 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.751 ' CZ ' HD12 ' A' ' 323' ' ' LEU . 10.3 p90 -167.14 169.16 12.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.915 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.5 155.72 22.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.89 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 15.3 pt -135.18 132.58 52.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 72.340000000000003 111.094 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.1 tt -119.62 137.49 53.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 73.099999999999994 111.116 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -155.35 -146.64 4.49 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.833 -0.699 . . . . 70.230000000000004 112.52 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -161.13 -139.94 2.77 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.8 -0.714 . . . . 41.310000000000002 112.527 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -99.73 148.41 24.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.816 0.341 . . . . 71.409999999999997 110.891 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 55.09 24.42 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 54.549999999999997 110.871 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.09 46.8 55.95 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.769 -0.729 . . . . 62.039999999999999 112.473 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -55.2 -28.91 56.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.9 0.381 . . . . 71.030000000000001 110.902 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 169.31 94.94 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.804 -0.712 . . . . 74.040000000000006 112.541 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -94.81 123.62 47.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 73.129999999999995 111.109 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -136.32 167.64 20.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 72.430000000000007 110.863 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.813 HD12 ' HB2' ' A' ' 357' ' ' ASP . 42.2 mt -70.29 142.33 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 61.420000000000002 111.162 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.41 -64.57 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 72.420000000000002 110.836 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -159.87 129.89 5.46 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.377 0.608 . . . . 73.439999999999998 110.884 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.8 mt -93.65 115.68 28.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 124.324 3.238 . . . . 73.420000000000002 110.924 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -56.33 140.54 44.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 72.120000000000005 111.029 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 81.7 10.83 83.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.723 -0.751 . . . . 73.319999999999993 112.469 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -95.15 165.46 25.28 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.797 -0.716 . . . . 52.0 112.437 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -47.26 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 2.226 . . . . 75.5 112.41 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -66.97 -32.75 74.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 74.209999999999994 111.09 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.57 -36.18 68.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 64.310000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.58 -54.48 5.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 71.310000000000002 110.884 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 m -68.36 -34.91 76.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.873 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -103.83 157.05 17.47 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.782 -0.723 . . . . 70.329999999999998 112.455 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -108.58 20.57 18.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 74.5 110.857 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.756 HD21 ' HB2' ' A' ' 390' ' ' ALA . 11.9 mt -69.19 144.04 53.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.944 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -148.88 174.41 12.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.883 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.39 133.52 29.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 71.430000000000007 110.863 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.21 -29.27 8.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.723 -0.751 . . . . 41.200000000000003 112.494 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.813 ' HB2' HD12 ' A' ' 338' ' ' ILE . 0.9 OUTLIER -64.97 147.88 52.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.771 0.32 . . . . 54.109999999999999 110.883 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -118.53 140.82 49.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 63.450000000000003 110.98 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 359' ' ' ILE . 2.7 mp -99.41 124.98 53.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 65.310000000000002 111.165 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.872 HD12 HG21 ' A' ' 389' ' ' ILE . 68.8 mt -93.28 -35.84 12.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.193 -0.458 . . . . 64.329999999999998 110.882 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.4 m -159.7 157.06 28.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.841 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 1.025 HG12 HG22 ' A' ' 388' ' ' ILE . 27.0 m -130.83 130.74 64.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 70.400000000000006 111.13 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 43.8 35.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.886 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 104.95 -69.65 0.25 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 32.329999999999998 112.446 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 18.6 m -48.32 138.14 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 64.420000000000002 111.155 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.404 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.4 p30 -78.78 140.33 38.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 64.019999999999996 110.837 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.755 HD13 ' CB ' ' A' ' 370' ' ' ALA . 0.6 OUTLIER -119.1 26.22 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.319999999999993 110.879 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -72.89 -35.45 67.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.843 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -119.42 28.78 7.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.849 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.755 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.18 128.29 40.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 70.319999999999993 111.124 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.4 172.75 0.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 64.129999999999995 110.84 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.81 -54.33 47.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 72.299999999999997 110.837 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.58 -33.19 70.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 110.874 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -55.39 -43.57 75.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 72.25 110.852 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.544 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.54 -40.02 81.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 54.240000000000002 111.135 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -63.24 -32.22 73.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.121 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.38 -50.77 77.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.138 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.4 -36.74 74.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.25 111.155 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 323' ' ' LEU . 40.8 mt -57.48 -35.43 70.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -73.49 -35.0 65.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -94.88 18.4 11.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 71.530000000000001 110.912 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.91 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -58.66 -59.07 5.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.135 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 119.48 -135.31 11.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 61.509999999999998 112.491 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -98.11 3.39 49.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 74.340000000000003 110.903 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.6 m -160.95 135.67 7.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 62.43 111.124 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.91 HG22 ' HB1' ' A' ' 382' ' ' ALA . 19.9 t -121.7 112.47 35.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 111.067 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -92.11 104.93 17.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.142 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 1.025 HG22 HG12 ' A' ' 362' ' ' VAL . 11.4 pt -112.84 142.14 26.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.175 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.872 HG21 HD12 ' A' ' 360' ' ' LEU . 18.0 mm -91.94 130.27 41.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 74.25 111.129 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.756 ' HB2' HD21 ' A' ' 353' ' ' LEU . . . -115.84 130.34 56.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 44.009999999999998 111.097 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -146.68 128.03 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.964 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -53.46 111.71 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.992 0.425 . . . . 64.439999999999998 110.901 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -150.03 68.23 8.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.592 0.71 . . . . 75.019999999999996 110.871 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -30.91 21.89 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.726 2.284 . . . . 73.530000000000001 112.357 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -66.46 -35.43 80.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 61.240000000000002 110.878 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -73.39 -47.47 41.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 54.140000000000001 110.89 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.45 -31.65 70.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 75.239999999999995 110.917 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.3 t -54.27 -25.05 21.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 61.039999999999999 110.86 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -59.9 -33.22 71.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.136 -0.483 . . . . 72.239999999999995 110.917 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.9 -45.95 39.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 110.873 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 104.97 16.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 73.340000000000003 110.878 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.093 179.908 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.896 0.379 . . . . 72.530000000000001 110.859 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 302' ' ' LEU . 15.4 mt -123.6 -74.63 0.61 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 51.520000000000003 110.932 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -175.94 -173.34 41.54 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.759 -0.734 . . . . 53.149999999999999 112.527 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -168.91 166.43 11.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.803 0.335 . . . . 71.230000000000004 110.883 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -127.09 68.13 1.28 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.909 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.35 -177.11 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 60.340000000000003 110.855 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 1.1 pp -152.93 63.73 4.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 111.118 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -49.76 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.673 2.248 . . . . 72.420000000000002 112.31 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -179.15 167.14 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 52.100000000000001 110.856 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.59 138.47 31.71 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.691 0.758 . . . . 74.010000000000005 110.847 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 147.11 61.94 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.729 2.286 . . . . 75.019999999999996 112.322 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 137.27 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 110.856 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.737 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -78.33 141.37 38.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.895 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.27 140.01 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.329999999999998 111.145 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 92.9 t -89.19 130.01 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 44.240000000000002 111.148 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.662 HD11 ' CD1' ' A' ' 353' ' ' LEU . 14.3 mt -138.11 157.68 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 73.450000000000003 111.131 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.425 ' N ' HG22 ' A' ' 316' ' ' ILE . 58.0 m170 -66.9 172.57 4.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 63.439999999999998 110.859 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -47.91 128.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 71.099999999999994 110.915 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -107.89 105.29 2.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.783 -0.722 . . . . 74.239999999999995 112.487 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 93.6 p -94.94 -40.1 9.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.948 0.404 . . . . 74.129999999999995 110.841 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 21.0 p -131.97 5.51 4.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 111.16 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.57 50.51 36.03 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 65.430000000000007 112.433 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.695 ' O ' HD12 ' A' ' 342' ' ' LEU . 11.4 mt -83.43 -34.08 25.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 64.239999999999995 110.931 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.76 -31.54 23.69 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 75.420000000000002 112.435 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 9.6 p90 -136.78 154.48 50.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 75.109999999999999 110.882 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -100.56 168.2 9.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 72.140000000000001 110.93 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.406 HD11 ' HB2' ' A' ' 376' ' ' ALA . 26.3 pt -145.34 139.13 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 111.121 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.74 ' O ' HD12 ' A' ' 336' ' ' ILE . 20.7 tt -133.85 131.38 56.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 73.099999999999994 111.15 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -146.87 -159.27 8.2 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.786 -0.721 . . . . 70.230000000000004 112.554 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -137.19 -137.2 3.59 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 41.310000000000002 112.517 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -99.9 143.25 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 71.409999999999997 110.875 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 51.47 33.15 9.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 54.549999999999997 110.879 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.39 55.52 24.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.674 -0.774 . . . . 62.039999999999999 112.477 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -68.42 -29.94 68.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.856 0.36 . . . . 71.030000000000001 110.889 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.68 92.19 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.73 -0.748 . . . . 74.040000000000006 112.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.74 HD12 ' O ' ' A' ' 328' ' ' ILE . 7.3 tp -95.25 121.36 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.114 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -136.97 167.4 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.430000000000007 110.907 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 357' ' ' ASP . 60.2 mt -68.51 144.03 14.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 61.420000000000002 111.09 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.0 t -105.96 -67.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 72.420000000000002 110.881 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -154.47 153.99 32.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.332 0.587 . . . . 73.439999999999998 110.949 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 323' ' ' LEU . 13.7 mt -107.9 145.07 34.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 124.343 3.247 . . . . 73.420000000000002 110.908 169.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -74.57 128.92 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 72.120000000000005 111.113 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.11 -23.66 33.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 112.436 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.77 177.29 14.05 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.75 . . . . 52.0 112.543 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.7 -33.56 16.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.363 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.453 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -59.92 -36.82 77.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.209999999999994 111.087 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -59.4 -37.54 78.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.832 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 73.4 mt -57.35 -50.05 74.19 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.915 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.41 -36.11 66.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 110.878 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 52.28 33.22 38.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.802 -0.713 . . . . 70.329999999999998 112.42 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.59 -37.61 2.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.971 0.415 . . . . 74.5 110.904 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 388' ' ' ILE . 14.8 mt -84.84 124.78 31.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 71.340000000000003 110.96 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.63 173.39 13.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 74.120000000000005 110.839 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 139.26 26.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 71.430000000000007 110.892 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.13 -29.21 12.47 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.583 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.815 ' HB2' HD12 ' A' ' 338' ' ' ILE . 27.2 m-20 -63.24 148.91 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.756 0.312 . . . . 54.109999999999999 110.84 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.96 143.81 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 63.450000000000003 110.876 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 48.7 mm -95.42 126.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 65.310000000000002 111.081 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 7.1 mt -105.5 -50.77 3.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.154 -0.475 . . . . 64.329999999999998 110.938 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.5 ' O ' HD12 ' A' ' 389' ' ' ILE . 0.8 OUTLIER -147.63 142.67 27.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 110.877 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.659 HG22 HG22 ' A' ' 388' ' ' ILE . 11.1 t -125.87 125.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 70.400000000000006 111.146 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.633 HD22 HG12 ' A' ' 362' ' ' VAL . 12.1 p30 44.48 33.92 0.99 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.888 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.53 -68.99 0.22 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.75 -0.738 . . . . 32.329999999999998 112.411 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 362' ' ' VAL . 22.8 m -49.18 140.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 64.420000000000002 111.067 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.454 ' O ' HD22 ' A' ' 367' ' ' LEU . 2.3 p30 -82.48 147.08 28.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 64.019999999999996 110.874 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.642 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.4 mm? -119.37 26.44 9.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 111.001 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -73.09 -42.47 62.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.510000000000005 110.917 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.73 28.36 8.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 110.859 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -93.6 129.01 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 70.319999999999993 111.19 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -61.65 177.24 0.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.447 . . . . 64.129999999999995 110.896 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -64.21 -54.56 31.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.299999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -72.29 -36.26 68.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -55.52 -43.69 75.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 72.25 110.879 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.59 -41.59 86.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 54.240000000000002 111.139 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.406 ' HB2' HD11 ' A' ' 327' ' ' ILE . . . -61.12 -32.25 71.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 111.096 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 56.1 mt -58.32 -45.16 89.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 53.409999999999997 111.214 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.36 -46.88 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 52.25 111.11 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 386' ' ' VAL . 0.2 OUTLIER -57.43 -40.6 78.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.909 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -62.69 -35.95 81.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.902 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -100.12 18.46 18.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 71.530000000000001 110.827 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.72 -59.38 4.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 75.239999999999995 111.076 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 125.76 -141.71 13.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.688 -0.768 . . . . 61.509999999999998 112.546 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -77.7 -22.31 50.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 74.340000000000003 110.916 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 91.9 m -150.67 132.46 15.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.125 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 379' ' ' LEU . 3.6 p -112.4 113.0 42.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.066 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.737 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -93.33 105.03 17.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 55.240000000000002 111.101 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 353' ' ' LEU . 21.9 pt -111.79 134.84 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 111.118 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 361' ' ' SER . 5.0 mp -88.1 125.16 41.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.112 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.5 129.87 56.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 44.009999999999998 111.099 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -131.68 131.19 42.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -53.4 109.69 0.47 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.939 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -150.04 75.05 9.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.713 . . . . 75.019999999999996 110.916 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -32.51 18.32 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.699 2.266 . . . . 73.530000000000001 112.338 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.27 -44.18 76.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.151 -0.477 . . . . 61.240000000000002 110.888 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -62.65 -47.54 83.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 54.140000000000001 110.889 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -71.62 -31.6 67.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.469 . . . . 75.239999999999995 110.865 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 4.0 t -54.12 -25.12 20.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 61.039999999999999 110.799 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -33.51 71.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 110.864 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -76.42 -48.03 21.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 75.530000000000001 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -87.16 104.99 16.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.069 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.866 0.365 . . . . 72.530000000000001 110.884 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.32 78.07 1.83 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 51.520000000000003 110.958 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -101.75 -33.21 4.8 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 53.149999999999999 112.543 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -80.96 155.51 26.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 71.230000000000004 110.912 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -132.05 -57.2 0.97 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.140000000000001 110.869 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 307' ' ' ILE . 3.1 p-10 -96.78 -176.07 3.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 60.340000000000003 110.917 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.421 ' C ' ' O ' ' A' ' 306' ' ' ASP . 11.5 pt 35.58 74.12 0.59 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.604 0.716 . . . . 74.430000000000007 111.13 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 78.61 1.0 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.695 2.263 . . . . 72.420000000000002 112.382 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -133.32 35.63 3.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 52.100000000000001 110.875 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -55.64 160.59 3.88 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.565 0.698 . . . . 74.010000000000005 110.918 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 148.33 65.0 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.639 2.226 . . . . 75.019999999999996 112.373 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.48 137.63 42.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 71.5 110.872 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.527 ' NE ' HD11 ' A' ' 389' ' ' ILE . 13.2 tpp85 -82.29 136.26 35.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.842 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 50.7 mm -110.16 118.86 57.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 73.329999999999998 111.119 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.0 p -103.29 123.95 57.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.107 -0.497 . . . . 44.240000000000002 111.118 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.573 HD11 ' HB ' ' A' ' 386' ' ' VAL . 16.6 pt -138.1 159.82 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 111.147 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.35 172.98 4.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 63.439999999999998 110.843 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -47.51 119.88 2.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 71.099999999999994 110.883 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -131.98 51.52 0.85 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 74.239999999999995 112.498 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 78.8 p -53.96 -39.9 66.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.819 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.9 p -130.28 26.97 5.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 70.019999999999996 111.091 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -138.47 41.59 1.35 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.771 -0.728 . . . . 65.430000000000007 112.502 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 27.5 mt -53.88 -46.94 71.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.857 0.361 . . . . 64.239999999999995 110.884 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 75.82 28.73 60.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 75.420000000000002 112.503 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -167.1 169.31 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.836 0.35 . . . . 75.109999999999999 110.868 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -115.09 167.86 10.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 110.843 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.92 141.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 72.340000000000003 111.133 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.59 134.92 51.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.032 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -142.2 -166.77 11.08 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 70.230000000000004 112.531 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -128.11 -139.99 4.94 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.525 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -100.06 143.7 29.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.861 0.362 . . . . 71.409999999999997 110.885 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 51.17 31.74 7.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.886 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 56.21 36.27 68.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.716 -0.754 . . . . 62.039999999999999 112.493 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -55.29 -30.0 59.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.392 . . . . 71.030000000000001 110.893 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 176.46 109.02 0.23 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.778 -0.725 . . . . 74.040000000000006 112.508 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.426 HD13 ' HB2' ' A' ' 375' ' ' ALA . 2.8 tt -112.88 125.21 70.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.155 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -135.07 167.03 21.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 110.879 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.816 HD12 ' HB2' ' A' ' 357' ' ' ASP . 52.5 mt -63.85 146.24 13.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.136 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.3 t -101.78 -73.23 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 110.813 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.66 167.59 21.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.324 0.583 . . . . 73.439999999999998 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 56.4 mt -65.54 114.81 5.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 124.407 3.276 . . . . 73.420000000000002 110.892 169.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -58.43 136.8 57.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 72.120000000000005 111.093 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.6 14.69 81.83 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.501 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -88.31 163.62 32.93 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 52.0 112.447 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -45.22 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 75.5 112.28 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.17 -29.02 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 74.209999999999994 111.146 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -69.33 -46.02 68.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 64.310000000000002 110.891 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.17 -54.32 5.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.918 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 12.3 m -64.36 -46.38 83.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 73.340000000000003 110.839 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . -99.16 155.7 19.95 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.773 -0.727 . . . . 70.329999999999998 112.49 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -94.92 20.39 8.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 74.5 110.923 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.74 HD23 ' HB2' ' A' ' 390' ' ' ALA . 8.4 mt -68.9 119.92 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.946 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -137.88 174.18 10.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.120000000000005 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 139.36 57.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 110.936 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 101.77 -29.16 13.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.693 -0.765 . . . . 41.200000000000003 112.481 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.816 ' HB2' HD12 ' A' ' 338' ' ' ILE . 1.7 m-20 -66.38 149.3 50.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.698 0.285 . . . . 54.109999999999999 110.875 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -110.47 144.94 38.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 63.450000000000003 110.897 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.636 HG21 HD12 ' A' ' 367' ' ' LEU . 77.9 mt -99.85 127.09 53.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 65.310000000000002 111.082 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 94.1 mt -97.38 -36.09 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.892 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.495 ' OG ' HD13 ' A' ' 389' ' ' ILE . 57.6 p -161.9 159.49 26.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.876 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.664 HG22 HD22 ' A' ' 363' ' ' ASN . 6.8 p -137.2 125.66 33.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.126 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.664 HD22 HG22 ' A' ' 362' ' ' VAL . 17.0 p30 45.41 30.98 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.881 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 111.62 -67.99 0.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 32.329999999999998 112.536 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.572 HG21 ' HB1' ' A' ' 378' ' ' ALA . 6.6 m -50.91 126.42 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.824 0.345 . . . . 64.420000000000002 111.143 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.34 137.69 41.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 64.019999999999996 110.863 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.636 HD12 HG21 ' A' ' 359' ' ' ILE . 83.1 mt -108.66 30.97 6.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 71.319999999999993 110.888 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -72.33 -43.66 63.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 72.510000000000005 110.84 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -117.23 28.07 8.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.952 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.75 128.89 38.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.124 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.3 p -59.78 177.01 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 64.129999999999995 110.87 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -62.73 -54.63 36.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.299999999999997 110.872 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -72.51 -34.28 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.934 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.478 ' OE1' HD12 ' A' ' 377' ' ' ILE . 11.5 mm100 -55.28 -41.92 72.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.94 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.426 ' HB2' HD13 ' A' ' 336' ' ' ILE . . . -58.84 -35.72 73.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 54.240000000000002 111.101 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -68.57 -35.02 76.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 73.420000000000002 111.127 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . 0.478 HD12 ' OE1' ' A' ' 374' ' ' GLN . 36.0 mt -59.24 -45.83 92.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 53.409999999999997 111.12 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.572 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -64.65 -48.36 75.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 52.25 111.042 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -39.07 75.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.040000000000006 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -64.2 -35.79 81.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.896 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -98.56 18.12 17.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 71.530000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -62.33 -56.22 20.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.065 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.84 -135.32 8.31 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.792 -0.718 . . . . 61.509999999999998 112.504 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -105.12 26.03 9.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.922 0.391 . . . . 74.340000000000003 110.908 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.8 m -162.65 116.89 1.75 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 62.43 111.176 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.573 ' HB ' HD11 ' A' ' 316' ' ' ILE . 92.8 t -100.14 112.24 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.173 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 313' ' ' ARG . 0.2 OUTLIER -118.83 104.53 10.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 55.240000000000002 111.182 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.54 HG23 HG23 ' A' ' 359' ' ' ILE . 15.5 mt -120.65 141.98 38.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 111.05 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.527 HD11 ' NE ' ' A' ' 313' ' ' ARG . 3.6 mp -89.19 140.63 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 74.25 111.11 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.74 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -125.19 133.42 52.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 44.009999999999998 111.103 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -140.3 134.42 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -60.57 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.932 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -150.0 69.94 9.23 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.608 0.718 . . . . 75.019999999999996 110.871 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -31.48 20.12 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.751 2.301 . . . . 73.530000000000001 112.325 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -67.62 -36.09 80.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.240000000000002 110.875 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -76.28 -47.84 22.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 54.140000000000001 110.823 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -67.22 -30.93 70.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.198 -0.455 . . . . 75.239999999999995 110.947 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 9.9 t -53.95 -24.6 17.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.091 -0.504 . . . . 61.039999999999999 110.896 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -59.09 -32.7 70.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.239999999999995 110.873 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -74.77 -47.75 29.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.530000000000001 110.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.88 105.32 16.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.906 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 74.340000000000003 111.068 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 72.530000000000001 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 303' ' ' GLY . 0.3 OUTLIER -131.81 133.31 44.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 51.520000000000003 110.892 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.585 ' N ' HD13 ' A' ' 302' ' ' LEU . . . -159.54 142.73 8.51 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.771 -0.728 . . . . 53.149999999999999 112.528 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -151.73 172.31 16.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.342 . . . . 71.230000000000004 110.873 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -101.82 -74.68 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 74.140000000000001 110.898 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -85.28 174.37 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 60.340000000000003 110.879 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 307' ' ' ILE . 4.1 tp -126.79 80.87 70.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.641 0.734 . . . . 74.430000000000007 111.089 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -170.85 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.705 2.27 . . . . 72.420000000000002 112.288 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -61.9 95.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 52.100000000000001 110.935 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -86.92 137.33 33.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.613 0.721 . . . . 74.010000000000005 110.899 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 158.59 56.44 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.662 2.241 . . . . 75.019999999999996 112.348 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' A' ' 390' ' ' ALA . 25.2 ttt180 -141.99 117.01 9.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 71.5 110.925 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.0 117.58 30.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.824 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -106.03 119.7 55.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 73.329999999999998 111.158 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -80.5 121.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 44.240000000000002 111.177 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.717 HD12 ' O ' ' A' ' 317' ' ' HIS . 1.2 pp -138.32 160.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.075 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.717 ' O ' HD12 ' A' ' 316' ' ' ILE . 38.4 m170 -66.85 173.71 3.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 63.439999999999998 110.905 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -43.59 119.02 1.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 71.099999999999994 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.405 ' H ' HG23 ' A' ' 386' ' ' VAL . . . -113.18 40.17 2.6 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 74.239999999999995 112.553 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.2 p -90.87 -38.4 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.02 0.438 . . . . 74.129999999999995 110.83 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 2.2 m -113.44 27.01 9.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 70.019999999999996 111.103 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -178.37 106.83 0.22 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.731 -0.747 . . . . 65.430000000000007 112.49 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.749 HD13 HD23 ' A' ' 379' ' ' LEU . 4.0 mt -93.02 -47.11 7.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 64.239999999999995 110.905 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 76.88 26.12 63.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.733 . . . . 75.420000000000002 112.496 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -167.5 169.08 12.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.922 0.391 . . . . 75.109999999999999 110.849 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -106.95 147.79 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 110.908 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.1 pt -124.88 132.4 71.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 72.340000000000003 111.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 15.0 tt -123.05 139.92 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 111.124 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.55 -171.54 18.89 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 70.230000000000004 112.543 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -126.22 -135.19 4.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.767 -0.73 . . . . 41.310000000000002 112.482 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -99.9 145.67 27.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.85 0.357 . . . . 71.409999999999997 110.894 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 51.0 31.36 6.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 54.549999999999997 110.808 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.37 46.87 63.63 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 62.039999999999999 112.541 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.55 -29.92 64.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 71.030000000000001 110.896 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.63 107.12 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.464 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.5 tp -96.35 127.25 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 73.129999999999995 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -138.2 167.93 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 110.923 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 357' ' ' ASP . 56.5 mt -79.39 142.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 61.420000000000002 111.171 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.7 t -107.7 -40.26 5.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 72.420000000000002 110.835 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -160.86 167.56 26.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 110.863 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.47 131.4 46.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 124.38 3.263 . . . . 73.420000000000002 110.925 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -75.65 147.13 39.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 72.120000000000005 111.119 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 88.82 -14.95 58.89 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.491 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -81.7 -176.03 50.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.745 -0.741 . . . . 52.0 112.494 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 -39.31 6.63 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 75.5 112.321 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -67.37 -49.44 63.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.124 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -58.52 -36.04 73.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.908 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 11.4 mt -56.61 -35.68 68.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 71.310000000000002 110.89 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.18 -38.4 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.832 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 73.8 34.03 56.89 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.779 -0.724 . . . . 70.329999999999998 112.423 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -122.04 -34.48 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 74.5 110.806 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.15 121.0 15.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 110.852 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -136.9 158.71 43.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.120000000000005 110.89 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.62 139.89 58.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.896 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 111.42 -28.99 9.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.714 -0.755 . . . . 41.200000000000003 112.511 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.479 ' HB2' HD12 ' A' ' 338' ' ' ILE . 14.8 m-20 -58.7 139.67 55.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 54.109999999999999 110.86 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -99.94 118.09 35.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 63.450000000000003 110.931 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.03 109.95 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.158 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.56 HD13 HG21 ' A' ' 389' ' ' ILE . 4.8 mp -78.6 -36.17 44.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 64.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.429 ' O ' HD12 ' A' ' 389' ' ' ILE . 1.0 OUTLIER -158.41 159.72 36.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 73.140000000000001 110.806 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.549 HG22 ' CD2' ' A' ' 367' ' ' LEU . 26.9 m -135.58 130.3 49.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.091 -0.504 . . . . 70.400000000000006 111.151 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.579 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.52 34.12 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 75.010000000000005 110.861 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.91 -71.64 0.21 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 32.329999999999998 112.485 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 12.4 m -46.17 138.29 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.733 0.301 . . . . 64.420000000000002 111.221 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 367' ' ' LEU . 6.1 m-20 -80.01 138.7 37.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 64.019999999999996 110.882 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.685 HD13 ' CB ' ' A' ' 370' ' ' ALA . 2.2 mm? -122.68 23.57 9.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.959 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -73.22 -40.85 64.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.882 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -109.57 28.12 8.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.837 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.685 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -94.41 128.57 41.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 111.049 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -59.17 177.21 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 64.129999999999995 110.858 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -64.63 -55.33 20.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.807 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -73.1 -37.9 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.841 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -55.39 -41.0 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 72.25 110.927 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.85 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 54.240000000000002 111.144 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -64.94 -34.53 78.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.098 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 27.6 mt -63.93 -47.12 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 53.409999999999997 111.157 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.17 -40.8 74.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 52.25 111.147 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.749 HD23 HD13 ' A' ' 323' ' ' LEU . 7.8 tp -57.5 -42.76 83.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 74.040000000000006 110.899 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -59.62 -35.36 74.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 110.875 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -103.96 19.1 20.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.265 -0.425 . . . . 71.530000000000001 110.908 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.411 ' HB1' HG22 ' A' ' 386' ' ' VAL . . . -49.11 -59.18 3.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.081 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.71 -165.43 12.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 61.509999999999998 112.503 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -86.46 138.5 31.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.344 . . . . 74.340000000000003 110.901 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.1 m 67.34 58.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 62.43 111.12 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 363' ' ' ASN . 90.5 t -75.8 110.46 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 71.420000000000002 111.081 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 7.4 p -89.23 104.97 17.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 55.240000000000002 111.139 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 12.9 mt -95.64 121.87 46.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 111.131 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 360' ' ' LEU . 5.3 mp -82.68 137.17 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.117 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 312' ' ' ARG . . . -116.21 129.68 56.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 44.009999999999998 111.084 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 360' ' ' LEU . 4.2 tt0 -137.94 118.22 13.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.0 110.943 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -53.32 111.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 64.439999999999998 110.94 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 24.5 tptt -149.97 66.14 7.85 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.571 0.7 . . . . 75.019999999999996 110.878 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -30.83 21.58 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.295 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -66.61 -49.97 64.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 61.240000000000002 110.887 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -61.93 -47.72 83.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 54.140000000000001 110.881 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -67.67 -31.87 72.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 75.239999999999995 110.885 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.49 -25.88 28.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 61.039999999999999 110.842 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -59.87 -32.8 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 72.239999999999995 110.862 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -76.06 -47.97 22.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -86.92 105.0 16.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 73.340000000000003 110.915 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 111.08 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.678 ' O ' HD22 ' A' ' 302' ' ' LEU . 29.8 t80 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.881 0.372 . . . . 72.530000000000001 110.895 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.678 HD22 ' O ' ' A' ' 301' ' ' PHE . 4.4 mm? -130.27 122.97 29.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 51.520000000000003 110.875 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -130.17 -59.68 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.71 -0.757 . . . . 53.149999999999999 112.487 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -58.98 -176.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.8 0.334 . . . . 71.230000000000004 110.912 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -132.95 144.7 50.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.918 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 307' ' ' ILE . 2.3 m-20 64.14 50.9 2.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 60.340000000000003 110.89 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 306' ' ' ASP . 1.0 OUTLIER -161.98 67.31 2.08 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.603 0.716 . . . . 74.430000000000007 111.142 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 111.73 2.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.649 2.233 . . . . 72.420000000000002 112.331 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.401 HH11 HD13 ' A' ' 302' ' ' LEU . 0.0 OUTLIER -107.22 55.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 52.100000000000001 110.903 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -80.29 134.93 54.56 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.659 0.742 . . . . 74.010000000000005 110.874 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 119.62 6.54 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.661 2.241 . . . . 75.019999999999996 112.378 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.497 ' NE ' ' HB3' ' A' ' 390' ' ' ALA . 0.0 OUTLIER -140.02 135.18 32.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 71.5 110.832 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.601 ' HB2' HG22 ' A' ' 387' ' ' THR . 0.0 OUTLIER -82.84 141.63 32.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.883 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.515 HD12 ' CB ' ' A' ' 352' ' ' GLU . 27.6 mm -105.58 122.4 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 111.146 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.5 123.62 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.137 -0.483 . . . . 44.240000000000002 111.063 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 19.8 mt -137.99 154.67 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 111.128 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -66.92 172.31 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 63.439999999999998 110.848 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -48.37 121.59 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 71.099999999999994 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.6 103.28 0.43 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.756 -0.735 . . . . 74.239999999999995 112.525 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 20.4 t -60.74 -39.95 90.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.898 0.38 . . . . 74.129999999999995 110.859 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 24.3 p -132.03 4.53 4.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 70.019999999999996 111.158 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.4 52.31 28.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.703 -0.761 . . . . 65.430000000000007 112.521 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 342' ' ' LEU . 12.4 mt -51.1 -32.37 22.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.845 0.355 . . . . 64.239999999999995 110.962 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.42 -30.87 19.96 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.72 -0.752 . . . . 75.420000000000002 112.439 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.565 ' HZ ' HG11 ' A' ' 386' ' ' VAL . 11.9 p90 -133.07 169.48 16.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.957 0.408 . . . . 75.109999999999999 110.898 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.52 167.72 11.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.874 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.8 pt -144.23 140.86 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.472 . . . . 72.340000000000003 111.127 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.0 tt -133.78 134.72 56.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 73.099999999999994 111.124 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.42 -165.28 12.52 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.515 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -138.11 -139.98 3.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 41.310000000000002 112.502 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -99.99 147.34 25.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 71.409999999999997 110.88 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.01 29.26 4.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.098 -0.501 . . . . 54.549999999999997 110.873 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 52.18 56.97 14.42 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.748 -0.739 . . . . 62.039999999999999 112.511 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.77 -28.32 64.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.915 0.388 . . . . 71.030000000000001 110.892 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.32 103.56 0.17 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.766 -0.73 . . . . 74.040000000000006 112.463 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.418 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.8 tt -111.94 121.86 65.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 73.129999999999995 111.189 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -137.34 166.99 22.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 72.430000000000007 110.918 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.829 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.7 mt -62.6 138.62 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 61.420000000000002 111.092 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -96.95 -72.02 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.847 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -154.05 166.45 33.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.345 0.593 . . . . 73.439999999999998 110.906 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 323' ' ' LEU . 4.1 mp -80.23 133.77 36.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.393 3.269 . . . . 73.420000000000002 110.883 169.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.07 141.66 41.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 111.11 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.12 -22.41 38.63 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.746 -0.74 . . . . 73.319999999999993 112.401 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -76.01 -175.77 39.61 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.779 -0.724 . . . . 52.0 112.493 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -32.71 18.09 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 75.5 112.381 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.534 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -55.26 -41.9 72.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.111 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.74 -40.42 83.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 64.310000000000002 110.894 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 94.9 mt -56.45 -52.5 64.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.4 t -63.11 -45.29 92.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.803 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 62.27 50.79 61.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 70.329999999999998 112.534 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.515 ' CB ' HD12 ' A' ' 314' ' ' ILE . 64.4 mm-40 -128.65 -53.56 1.24 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 74.5 110.903 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.634 HD22 HD11 ' A' ' 338' ' ' ILE . 96.0 mt -72.02 119.15 15.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 110.949 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -135.88 171.54 14.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.16 139.21 58.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 71.430000000000007 110.863 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.25 -29.14 13.12 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.778 -0.725 . . . . 41.200000000000003 112.507 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.829 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.9 m-20 -65.38 148.89 50.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.71 0.29 . . . . 54.109999999999999 110.915 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -111.43 143.18 42.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 63.450000000000003 110.943 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.843 HG21 HD12 ' A' ' 367' ' ' LEU . 68.5 mt -99.32 112.87 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 111.169 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 391' ' ' GLN . 4.1 mp -89.72 -35.7 15.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 64.329999999999998 110.866 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 3.1 m -157.13 151.58 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 73.140000000000001 110.903 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.689 HG22 ' ND2' ' A' ' 363' ' ' ASN . 7.4 p -136.1 123.12 33.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 70.400000000000006 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.689 ' ND2' HG22 ' A' ' 362' ' ' VAL . 17.1 p30 44.99 31.72 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 75.010000000000005 110.925 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 112.01 -69.96 0.22 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.724 -0.75 . . . . 32.329999999999998 112.472 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.541 HG21 ' HB1' ' A' ' 378' ' ' ALA . 4.5 m -49.11 129.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.154 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -83.52 128.5 34.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.019999999999996 110.854 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.843 HD12 HG21 ' A' ' 359' ' ' ILE . 34.9 mt -101.84 30.72 4.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 71.319999999999993 110.923 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -33.32 68.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.842 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -128.34 28.04 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.530000000000001 110.908 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.441 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.52 128.79 41.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 70.319999999999993 111.153 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.1 p -63.55 177.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 64.129999999999995 110.794 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -61.67 -54.43 42.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 72.299999999999997 110.82 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -72.68 -35.69 67.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.85 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.441 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 29.8 tp60 -55.44 -42.32 74.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 72.25 110.953 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.35 86.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 54.240000000000002 111.105 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.22 73.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 73.420000000000002 111.147 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 52.1 mt -58.42 -42.63 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 53.409999999999997 111.133 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.541 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -70.51 -48.79 53.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 52.25 111.027 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 379' ' ' LEU . 3.4 tt -57.41 -36.5 71.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.312 -0.403 . . . . 74.040000000000006 110.935 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 18.4 mtpt -58.16 -35.34 71.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 72.120000000000005 110.93 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -103.27 18.15 22.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 110.823 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.23 -58.96 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 111.122 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 129.46 -135.11 8.24 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.783 -0.722 . . . . 61.509999999999998 112.407 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.14 25.07 11.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.932 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 16.9 m -161.39 121.58 2.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 62.43 111.165 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.565 HG11 ' HZ ' ' A' ' 325' ' ' PHE . 22.6 t -100.18 112.29 32.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 111.12 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -117.99 104.7 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 55.240000000000002 111.148 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.44 HG23 HG23 ' A' ' 359' ' ' ILE . 22.4 mt -116.37 141.57 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.143 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 60.0 mt -87.76 142.16 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.149 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.497 ' HB3' ' NE ' ' A' ' 312' ' ' ARG . . . -116.17 140.91 48.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 44.009999999999998 111.032 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.619 ' HB2' HD11 ' A' ' 360' ' ' LEU . 1.4 tt0 -152.27 118.13 5.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.922 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -53.29 111.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 110.959 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 1.1 tptp -150.0 66.53 8.04 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.522 0.677 . . . . 75.019999999999996 110.912 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 -31.81 19.76 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.705 2.27 . . . . 73.530000000000001 112.303 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -63.25 -42.43 99.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 61.240000000000002 110.906 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -76.18 -48.06 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.140000000000001 110.881 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.27 -31.61 72.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 110.861 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.4 t -54.23 -25.27 22.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 61.039999999999999 110.809 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 ptt85 -60.13 -33.18 71.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.895 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -75.18 -47.79 26.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.530000000000001 110.907 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.99 105.16 16.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.849 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.086 179.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 30.0 t80 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.896 0.379 . . . . 72.530000000000001 110.858 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.46 HD12 ' N ' ' A' ' 303' ' ' GLY . 4.0 pp -129.75 -39.54 1.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 51.520000000000003 110.904 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . 0.46 ' N ' HD12 ' A' ' 302' ' ' LEU . . . -89.03 163.27 31.69 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.733 -0.746 . . . . 53.149999999999999 112.541 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -149.18 161.95 40.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.327 . . . . 71.230000000000004 110.924 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -131.09 -73.63 0.54 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.927 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.2 56.45 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 60.340000000000003 110.896 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 31.9 mt 51.83 68.06 3.55 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 74.430000000000007 111.114 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.92 -170.68 0.42 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.708 2.272 . . . . 72.420000000000002 112.293 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.99 77.31 1.23 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 52.100000000000001 110.848 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -85.92 137.53 35.54 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.661 0.743 . . . . 74.010000000000005 110.823 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.602 2.202 . . . . 75.019999999999996 112.363 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . 0.448 ' NE ' HD11 ' A' ' 314' ' ' ILE . 30.4 ttp180 -108.34 117.25 33.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 71.5 110.864 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 11.6 tpp85 -95.99 114.51 26.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 71.140000000000001 110.81 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 352' ' ' GLU . 43.2 mm -105.57 139.64 26.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 73.329999999999998 111.091 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.32 132.19 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 44.240000000000002 111.129 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.558 ' CD1' HG13 ' A' ' 386' ' ' VAL . 2.2 pt -135.65 160.31 39.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 111.13 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -66.5 173.4 3.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 63.439999999999998 110.886 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -44.33 119.74 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.943 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.81 36.98 1.96 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 74.239999999999995 112.487 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 1.2 t -75.9 -36.29 59.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.949 0.404 . . . . 74.129999999999995 110.927 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 32.2 p -102.69 27.05 7.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 70.019999999999996 111.166 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -177.37 107.42 0.23 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.752 -0.737 . . . . 65.430000000000007 112.485 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.681 HD22 HD22 ' A' ' 379' ' ' LEU . 6.4 mt -91.02 -46.54 8.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 110.909 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 77.97 25.68 61.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.792 -0.718 . . . . 75.420000000000002 112.474 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -167.53 156.6 9.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.907 0.384 . . . . 75.109999999999999 110.85 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -91.5 167.89 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 72.140000000000001 110.94 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 24.0 pt -141.07 138.75 33.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 111.101 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 19.8 tt -135.69 134.65 51.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 73.099999999999994 111.123 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -147.24 -166.88 12.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.724 -0.751 . . . . 70.230000000000004 112.484 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -129.5 -140.02 4.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 41.310000000000002 112.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -100.01 149.15 23.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 71.409999999999997 110.891 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 50.84 30.32 5.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 54.549999999999997 110.909 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 57.08 42.92 93.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.774 -0.727 . . . . 62.039999999999999 112.501 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -57.0 -29.89 63.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 71.030000000000001 110.881 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 172.31 118.05 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 74.040000000000006 112.503 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.6 OUTLIER -113.91 120.28 63.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.138 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -136.39 167.44 21.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.965 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.467 HD12 ' OD1' ' A' ' 357' ' ' ASP . 61.4 mt -73.42 139.55 19.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.454 . . . . 61.420000000000002 111.155 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.2 t -108.14 -36.07 6.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 72.420000000000002 110.859 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -157.58 167.85 28.97 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 26.1 mt -96.02 132.23 41.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 124.421 3.282 . . . . 73.420000000000002 110.893 169.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.49 141.36 41.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.120000000000005 111.098 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 96.4 -20.33 50.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.806 -0.712 . . . . 73.319999999999993 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -69.3 -177.58 17.04 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.691 -0.766 . . . . 52.0 112.443 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.81 2.47 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.662 2.241 . . . . 75.5 112.375 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -65.91 -50.66 63.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.088 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.63 -36.99 74.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.856 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.58 -52.62 64.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 71.310000000000002 110.896 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.84 -39.34 69.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.883 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 78.45 58.65 3.05 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.793 -0.717 . . . . 70.329999999999998 112.53 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -124.99 -33.34 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.35 . . . . 74.5 110.857 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 388' ' ' ILE . 45.3 mt -97.41 128.74 44.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 71.340000000000003 110.888 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -148.92 166.34 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.868 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -64.59 136.9 57.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 110.851 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.81 -29.19 9.14 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.769 -0.729 . . . . 41.200000000000003 112.504 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.467 ' OD1' HD12 ' A' ' 338' ' ' ILE . 1.9 p-10 -77.35 149.71 35.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.779 0.323 . . . . 54.109999999999999 110.862 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -112.28 114.68 27.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 63.450000000000003 110.951 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 359' ' ' ILE . 3.3 mp -70.76 108.76 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 65.310000000000002 111.113 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.816 HD12 HG21 ' A' ' 389' ' ' ILE . 12.0 mt -72.98 -40.03 65.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 64.329999999999998 110.926 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 163.55 39.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 73.140000000000001 110.889 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 128.24 35.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 70.400000000000006 111.107 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.18 34.85 1.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.857 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 107.01 -70.89 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.812 -0.709 . . . . 32.329999999999998 112.469 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 15.8 m -46.66 135.34 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.869 0.366 . . . . 64.420000000000002 111.1 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -82.87 147.96 28.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 64.019999999999996 110.786 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 53.4 mt -124.85 31.35 5.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 71.319999999999993 110.859 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 29.7 ttt180 -71.95 -35.88 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.510000000000005 110.866 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -123.01 27.59 7.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 74.530000000000001 110.852 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.95 128.98 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 70.319999999999993 111.067 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.4 p -56.96 177.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.466 . . . . 64.129999999999995 110.888 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -61.06 -54.37 45.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.472 . . . . 72.299999999999997 110.809 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -71.59 -34.47 69.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.83 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -55.21 -37.52 67.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.454 . . . . 72.25 110.919 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -63.82 -43.71 95.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 111.068 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -59.34 -33.13 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 73.420000000000002 111.086 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.4 -41.77 82.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 53.409999999999997 111.203 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.77 -34.95 72.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 52.25 111.071 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.681 HD22 HD22 ' A' ' 323' ' ' LEU . 12.7 mt -58.66 -47.67 83.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 74.040000000000006 110.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -69.93 -31.29 68.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.908 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -92.86 18.2 9.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 71.530000000000001 110.9 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -64.08 -58.93 5.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 118.01 -146.63 18.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.683 -0.77 . . . . 61.509999999999998 112.449 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 -88.61 8.41 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.819 0.342 . . . . 74.340000000000003 110.926 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 3.2 m -162.05 106.17 1.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 62.43 111.174 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.558 HG13 ' CD1' ' A' ' 316' ' ' ILE . 4.1 p -99.72 112.61 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 71.420000000000002 111.136 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 104.19 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 55.240000000000002 111.145 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 353' ' ' LEU . 8.5 mt -104.31 142.09 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 72.430000000000007 111.119 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.816 HG21 HD12 ' A' ' 360' ' ' LEU . 80.9 mt -94.94 142.42 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 74.25 111.135 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.58 138.38 51.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 44.009999999999998 111.116 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -152.12 105.55 3.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -53.21 110.98 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 64.439999999999998 110.864 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.07 69.18 9.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.912 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -30.69 21.55 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.618 2.212 . . . . 73.530000000000001 112.326 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.57 -39.61 91.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 61.240000000000002 110.833 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -76.71 -48.09 19.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.921 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -63.99 -31.44 72.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.871 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -25.29 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.486 . . . . 61.039999999999999 110.844 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.8 ptt85 -59.48 -32.9 70.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 72.239999999999995 110.844 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.69 -47.73 30.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 75.530000000000001 110.811 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -86.71 105.25 16.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 73.340000000000003 110.88 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.134 179.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . 0.56 ' C ' HD22 ' A' ' 302' ' ' LEU . 29.0 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.92 0.39 . . . . 72.530000000000001 110.897 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.56 HD22 ' C ' ' A' ' 301' ' ' PHE . 4.6 mm? -125.32 161.96 25.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 51.520000000000003 110.907 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -119.99 -79.92 0.61 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.739 -0.743 . . . . 53.149999999999999 112.47 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.64 -177.82 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.799 0.333 . . . . 71.230000000000004 110.859 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -162.1 172.15 16.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.879 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.05 56.22 3.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 60.340000000000003 110.839 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 2.7 tp -175.65 131.52 0.42 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.639 0.733 . . . . 74.430000000000007 111.127 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 75.15 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.692 2.262 . . . . 72.420000000000002 112.309 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -135.51 59.81 1.71 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 52.100000000000001 110.823 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -83.24 153.48 66.04 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.645 0.736 . . . . 74.010000000000005 110.873 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 158.46 56.9 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.709 2.273 . . . . 75.019999999999996 112.312 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -150.7 116.95 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 71.5 110.943 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.8 mtm180 -89.44 140.51 29.44 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.166 -0.47 . . . . 71.140000000000001 110.841 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.542 HD12 ' HG2' ' A' ' 352' ' ' GLU . 25.6 mm -112.29 123.42 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 111.115 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 7.5 p -79.78 126.91 39.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 44.240000000000002 111.135 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.487 HD11 ' CD1' ' A' ' 353' ' ' LEU . 17.0 mt -137.97 156.13 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 73.450000000000003 111.138 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.4 ' N ' HG22 ' A' ' 316' ' ' ILE . 2.8 t-80 -66.86 172.93 3.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 63.439999999999998 110.867 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -47.25 119.76 2.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.426 . . . . 71.099999999999994 110.863 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -120.58 117.89 3.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.718 -0.753 . . . . 74.239999999999995 112.507 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 70.2 p -93.08 -39.86 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.401 . . . . 74.129999999999995 110.895 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.02 -3.01 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 70.019999999999996 111.163 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.43 37.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.711 -0.756 . . . . 65.430000000000007 112.504 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 342' ' ' LEU . 2.3 tp -51.44 -31.28 22.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.837 0.351 . . . . 64.239999999999995 110.916 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -50.28 -31.98 20.91 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 75.420000000000002 112.406 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.577 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 12.1 p90 -133.07 168.19 18.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 110.864 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -113.09 168.17 9.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.5 pt -144.41 131.27 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 72.340000000000003 111.18 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.84 133.02 69.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.099999999999994 111.136 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -145.41 -157.41 7.24 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 70.230000000000004 112.507 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -136.04 -139.88 4.06 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.732 -0.747 . . . . 41.310000000000002 112.464 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -99.76 144.74 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 71.409999999999997 110.877 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 51.54 29.96 5.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 54.549999999999997 110.887 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 59.64 39.63 95.4 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.67 -0.776 . . . . 62.039999999999999 112.528 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -55.1 -29.94 58.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.849 0.357 . . . . 71.030000000000001 110.892 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 171.31 98.64 0.11 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 74.040000000000006 112.534 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.443 HD12 ' HA3' ' A' ' 329' ' ' GLY . 0.6 OUTLIER -101.56 125.08 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.842 0.353 . . . . 73.129999999999995 111.178 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -134.97 167.59 20.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.858 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 357' ' ' ASP . 59.8 mt -67.25 142.57 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 61.420000000000002 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.06 -67.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.851 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -159.85 167.41 28.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.867 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 323' ' ' LEU . 26.7 mt -83.12 139.9 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.431 3.287 . . . . 73.420000000000002 110.952 169.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.02 149.13 35.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 111.128 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 82.69 13.68 77.51 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 73.319999999999993 112.489 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . 0.481 ' O ' HD12 ' A' ' 349' ' ' LEU . . . -113.83 -177.24 19.28 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.759 -0.734 . . . . 52.0 112.461 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -36.39 11.01 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.772 2.315 . . . . 75.5 112.306 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -60.69 -35.77 77.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 74.209999999999994 111.096 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.16 -50.93 71.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.904 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 345' ' ' GLY . 4.5 mp -59.37 -36.44 75.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.89 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.06 -38.34 67.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.813 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 53.58 32.88 47.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.524 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HG2' HD12 ' A' ' 314' ' ' ILE . 3.9 tp10 -128.62 -53.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 74.5 110.968 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.487 ' CD1' HD11 ' A' ' 316' ' ' ILE . 90.2 mt -70.02 126.14 28.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.340000000000003 110.877 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -148.87 172.29 14.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 74.120000000000005 110.863 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.25 139.18 57.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.842 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.12 -29.11 9.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 41.200000000000003 112.477 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 338' ' ' ILE . 31.2 m-20 -68.49 148.92 49.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.79 0.328 . . . . 54.109999999999999 110.83 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.616 ' NE2' HD11 ' A' ' 360' ' ' LEU . 3.7 pt20 -114.4 142.83 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 63.450000000000003 110.954 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.739 HD12 HG21 ' A' ' 388' ' ' ILE . 23.3 mm -82.97 126.87 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 65.310000000000002 111.126 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.616 HD11 ' NE2' ' A' ' 358' ' ' GLN . 1.9 mp -108.84 -47.97 3.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 110.885 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.649 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -152.46 142.42 22.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.140000000000001 110.845 -179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 388' ' ' ILE . 18.9 t -129.61 124.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 70.400000000000006 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.478 ' OD1' HG12 ' A' ' 362' ' ' VAL . 4.9 p-10 43.58 35.56 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.010000000000005 110.911 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 106.9 -70.08 0.22 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.694 -0.765 . . . . 32.329999999999998 112.513 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.6 m -49.03 137.56 4.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.924 0.392 . . . . 64.420000000000002 111.069 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.423 ' C ' HD22 ' A' ' 367' ' ' LEU . 74.5 m-20 -79.85 147.63 31.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 64.019999999999996 110.856 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.675 HD13 ' CB ' ' A' ' 370' ' ' ALA . 3.6 mm? -118.15 25.51 10.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 110.897 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -73.16 -39.65 65.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 72.510000000000005 110.889 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -122.42 28.47 7.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.473 . . . . 74.530000000000001 110.927 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.675 ' CB ' HD13 ' A' ' 367' ' ' LEU . . . -87.29 128.96 35.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 70.319999999999993 111.105 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.1 p -58.48 173.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 64.129999999999995 110.828 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -60.59 -54.57 43.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 72.299999999999997 110.847 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.14 -33.86 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.209999999999994 110.842 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.514 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 24.5 tp60 -55.28 -41.15 71.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 72.25 110.919 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.502 ' HA ' HD11 ' A' ' 367' ' ' LEU . . . -58.55 -38.23 77.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 54.240000000000002 111.131 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.12 79.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.102 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.6 -50.12 81.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.409999999999997 111.093 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.99 97.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 52.25 111.121 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.501 HD12 HG11 ' A' ' 362' ' ' VAL . 0.7 OUTLIER -57.48 -36.5 71.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 74.040000000000006 110.863 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -74.86 -34.45 62.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.938 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.51 18.09 10.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.530000000000001 110.97 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 386' ' ' VAL . . . -68.03 -53.81 23.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 75.239999999999995 111.114 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 132.05 -144.75 16.53 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.8 -0.714 . . . . 61.509999999999998 112.56 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -93.08 12.54 23.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.340000000000003 110.889 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 98.7 m -162.44 96.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.186 -0.461 . . . . 62.43 111.148 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 382' ' ' ALA . 14.9 m -77.56 112.31 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 111.096 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 36.1 p -107.32 104.66 14.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 55.240000000000002 111.076 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.739 HG21 HD12 ' A' ' 359' ' ' ILE . 3.9 mp -112.56 133.25 58.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 111.135 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.649 HD12 ' OG ' ' A' ' 361' ' ' SER . 26.0 mt -89.06 118.41 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.25 111.092 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 357' ' ' ASP . . . -116.18 129.82 56.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 44.009999999999998 111.064 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -124.67 143.26 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -54.19 111.28 0.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.918 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -149.98 69.1 9.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.882 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 -31.04 20.73 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.253 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -75.94 -36.04 59.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 61.240000000000002 110.86 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -68.14 -47.95 66.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 54.140000000000001 110.879 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -69.45 -31.35 69.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 75.239999999999995 110.91 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 12.7 t -53.92 -24.85 17.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 61.039999999999999 110.895 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 7.8 ptt85 -59.49 -33.43 71.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 72.239999999999995 110.929 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -75.39 -47.89 25.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 75.530000000000001 110.826 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.98 105.15 16.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.858 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.113 179.903 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 14.9 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.923 0.392 . . . . 72.530000000000001 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 1.3 mp -138.76 146.48 41.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 51.520000000000003 110.948 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -117.19 -35.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.745 -0.741 . . . . 53.149999999999999 112.432 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -51.99 156.19 1.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.303 . . . . 71.230000000000004 110.86 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -157.52 101.98 1.87 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.916 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -174.47 150.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 60.340000000000003 110.858 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 24.4 mm 66.05 131.94 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.635 0.731 . . . . 74.430000000000007 111.157 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.61 78.39 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 72.420000000000002 112.372 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -140.08 72.59 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.446 . . . . 52.100000000000001 110.918 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.54 159.39 85.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.632 0.729 . . . . 74.010000000000005 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 156.68 62.65 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.642 2.228 . . . . 75.019999999999996 112.414 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 33.4 ttt85 -149.41 117.23 6.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.942 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -91.64 127.81 37.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 71.140000000000001 110.881 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 387' ' ' THR . 25.0 mm -107.6 130.19 60.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.103 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.8 p -98.2 120.89 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 44.240000000000002 111.113 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 386' ' ' VAL . 3.4 mp -137.98 153.19 26.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.144 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 386' ' ' VAL . 9.2 t60 -67.49 172.97 4.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 63.439999999999998 110.841 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.66 136.56 10.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 71.099999999999994 110.825 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -147.05 92.46 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 74.239999999999995 112.497 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 33.0 t -95.0 -32.23 13.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.027 0.441 . . . . 74.129999999999995 110.852 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.1 27.03 6.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.096 -0.502 . . . . 70.019999999999996 111.129 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -73.68 72.76 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.741 -0.742 . . . . 65.430000000000007 112.443 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.48 -4.81 50.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.893 0.377 . . . . 64.239999999999995 110.965 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.41 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . -46.93 -46.54 19.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.420000000000002 112.486 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.635 ' CD2' ' HB2' ' A' ' 347' ' ' ALA . 28.3 p90 -99.21 155.2 17.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 110.87 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -115.07 147.46 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 110.867 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.64 HD11 HG12 ' A' ' 336' ' ' ILE . 15.8 tt -125.17 138.58 53.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 72.340000000000003 111.133 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.67 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -127.84 155.99 39.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.099999999999994 111.143 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -160.06 -165.03 16.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.737 . . . . 70.230000000000004 112.454 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -131.74 -140.0 4.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 41.310000000000002 112.499 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -99.99 145.54 27.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.836 0.35 . . . . 71.409999999999997 110.904 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 50.93 33.04 8.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.111 -0.495 . . . . 54.549999999999997 110.899 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 53.31 52.66 39.32 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.741 -0.743 . . . . 62.039999999999999 112.462 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.43 -29.95 69.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 71.030000000000001 110.873 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 173.82 99.92 0.13 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.040000000000006 112.496 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.64 HG12 HD11 ' A' ' 327' ' ' ILE . 0.5 OUTLIER -96.25 124.77 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.381 . . . . 73.129999999999995 111.11 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -138.27 168.82 18.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 72.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 359' ' ' ILE . 4.5 mp -72.43 146.02 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 61.420000000000002 111.137 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.56 -45.91 4.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 72.420000000000002 110.807 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.51 167.31 23.64 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.272 0.558 . . . . 73.439999999999998 110.906 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.41 HD12 ' HA2' ' A' ' 324' ' ' GLY . 67.2 mt -105.42 150.88 24.87 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.466 3.303 . . . . 73.420000000000002 110.924 169.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.89 143.31 39.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.441 . . . . 72.120000000000005 111.122 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 99.0 -21.85 43.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.453 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -82.78 179.35 53.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.74 -0.743 . . . . 52.0 112.428 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -33.36 16.72 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.71 2.274 . . . . 75.5 112.359 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.635 ' HB2' ' CD2' ' A' ' 325' ' ' PHE . . . -55.16 -51.7 65.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.094 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.17 -34.92 68.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 64.310000000000002 110.863 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.35 -53.14 60.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 71.310000000000002 110.946 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 53.2 p -57.5 -41.27 80.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 73.340000000000003 110.797 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 79.69 31.92 38.9 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 70.329999999999998 112.508 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.477 ' HG2' HD11 ' A' ' 314' ' ' ILE . 11.4 tp10 -128.73 -53.05 1.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.973 0.416 . . . . 74.5 110.934 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.19 114.86 7.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.073 -0.512 . . . . 71.340000000000003 110.969 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -148.86 174.28 12.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 74.120000000000005 110.846 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -58.7 123.83 17.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.867 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.92 -29.46 9.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.747 -0.74 . . . . 41.200000000000003 112.549 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.528 ' HB3' HD13 ' A' ' 338' ' ' ILE . 11.4 t70 -67.87 148.96 50.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 54.109999999999999 110.833 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -111.18 145.48 38.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 63.450000000000003 110.898 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 338' ' ' ILE . 46.6 mm -98.91 126.39 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 65.310000000000002 111.152 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.928 HD12 HG21 ' A' ' 389' ' ' ILE . 77.4 mt -90.81 -55.37 3.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 64.329999999999998 110.951 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 88.3 p -144.07 161.69 38.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 73.140000000000001 110.852 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 367' ' ' LEU . 3.6 p -138.13 111.81 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 70.400000000000006 111.182 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 54.84 31.24 15.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.010000000000005 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.38 -67.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.798 -0.715 . . . . 32.329999999999998 112.535 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 378' ' ' ALA . 3.4 m -51.51 125.38 5.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.777 0.322 . . . . 64.420000000000002 111.148 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.83 121.43 27.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 64.019999999999996 110.809 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 362' ' ' VAL . 5.6 mp -96.24 33.8 1.7 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 71.319999999999993 110.966 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -71.66 -35.2 70.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 72.510000000000005 110.828 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -126.32 28.18 6.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.939 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -92.88 131.29 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.103 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 22.9 t -58.79 177.18 0.16 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 64.129999999999995 110.852 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -62.81 -54.44 38.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.479 . . . . 72.299999999999997 110.834 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.12 -34.64 68.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 110.914 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -55.19 -40.05 70.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 72.25 110.919 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.35 89.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 54.240000000000002 111.118 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.465 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -64.22 -34.14 77.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 111.092 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 47.6 mt -58.68 -51.56 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 53.409999999999997 111.074 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.38 -40.05 93.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 52.25 111.115 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 362' ' ' VAL . 33.8 mt -57.3 -36.85 71.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 74.040000000000006 110.956 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.63 -35.6 62.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -93.95 18.33 10.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.932 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -57.27 -58.93 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.239999999999995 110.993 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.36 -135.29 8.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.785 -0.722 . . . . 61.509999999999998 112.486 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -107.26 26.7 9.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.354 . . . . 74.340000000000003 110.859 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.99 118.42 1.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 62.43 111.21 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 317' ' ' HIS . 3.2 p -104.35 111.22 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 71.420000000000002 111.16 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 314' ' ' ILE . 91.7 m -125.88 102.89 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 55.240000000000002 111.165 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.447 HG22 ' HB ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -113.03 138.48 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.234 -0.439 . . . . 72.430000000000007 111.118 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.928 HG21 HD12 ' A' ' 360' ' ' LEU . 73.1 mt -83.21 134.17 27.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 74.25 111.145 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -114.78 129.89 56.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 44.009999999999998 111.15 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -142.13 120.87 12.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 75.0 110.895 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -53.03 112.92 0.94 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.921 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -150.02 67.34 8.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.554 0.692 . . . . 75.019999999999996 110.825 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.9 -30.27 21.9 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.297 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.39 -36.84 83.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 61.240000000000002 110.928 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -76.89 -47.69 20.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 54.140000000000001 110.894 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -64.49 -31.66 72.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.882 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 3.3 t -54.35 -25.41 24.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.798 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -60.51 -32.52 71.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 72.239999999999995 110.896 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 328' ' ' ILE . 50.9 m-85 -76.05 -47.88 22.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.844 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -87.05 105.04 16.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.340000000000003 110.888 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.158 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 2.7 t80 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.79 0.329 . . . . 72.530000000000001 110.863 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.96 79.36 1.26 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.181 -0.463 . . . . 51.520000000000003 110.937 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -112.65 131.85 10.37 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 53.149999999999999 112.462 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -112.06 -71.34 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.84 0.352 . . . . 71.230000000000004 110.948 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -107.96 63.63 0.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 110.891 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.21 171.18 16.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 60.340000000000003 110.871 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 3.5 pt -152.37 67.37 6.8 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.636 0.732 . . . . 74.430000000000007 111.099 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -171.5 0.48 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.6 2.2 . . . . 72.420000000000002 112.385 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -103.15 174.14 6.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.271 -0.422 . . . . 52.100000000000001 110.915 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -63.44 120.03 58.68 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.582 0.706 . . . . 74.010000000000005 110.946 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.26 69.11 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.681 2.254 . . . . 75.019999999999996 112.275 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 138.88 20.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.912 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.626 ' HB3' HG22 ' A' ' 387' ' ' THR . 18.7 mtt180 -93.34 142.55 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 71.140000000000001 110.877 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 51.0 mm -103.78 118.33 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 111.143 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.0 p -91.91 117.8 35.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 44.240000000000002 111.158 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . . . . . . . . . 9.0 pt -138.38 160.3 31.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 73.450000000000003 111.141 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -66.65 172.05 4.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 63.439999999999998 110.885 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -49.37 119.73 3.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 71.099999999999994 110.913 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -135.26 47.76 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.5 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 37.0 t -51.8 -39.46 58.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.956 0.408 . . . . 74.129999999999995 110.86 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.5 m -101.97 26.98 6.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 70.019999999999996 111.171 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -50.98 103.86 0.11 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.788 -0.72 . . . . 65.430000000000007 112.457 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.22 -29.62 15.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 64.239999999999995 110.95 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.97 -49.61 35.36 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 75.420000000000002 112.516 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -99.04 166.11 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.389 . . . . 75.109999999999999 110.821 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -148.33 155.34 41.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.125 -0.488 . . . . 72.140000000000001 110.841 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 22.5 pt -113.99 139.17 41.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 111.14 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 4.1 tt -119.51 145.48 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 111.129 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.7 -177.48 42.09 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.758 -0.734 . . . . 70.230000000000004 112.5 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -125.97 -139.06 5.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 41.310000000000002 112.468 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -99.92 150.07 22.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.825 0.345 . . . . 71.409999999999997 110.941 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 53.81 28.03 7.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.129 -0.487 . . . . 54.549999999999997 110.836 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.22 48.59 46.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.764 -0.732 . . . . 62.039999999999999 112.466 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -61.79 -29.88 70.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.843 0.354 . . . . 71.030000000000001 110.893 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 174.58 106.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 74.040000000000006 112.474 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.99 134.6 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 73.129999999999995 111.164 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -137.7 167.91 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 72.430000000000007 110.933 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.75 HD12 ' CB ' ' A' ' 357' ' ' ASP . 85.5 mt -82.03 142.16 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.145 -0.479 . . . . 61.420000000000002 111.087 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 47.2 t -134.86 35.53 3.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.839 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.529 ' H ' HG22 ' A' ' 338' ' ' ILE . 0.3 OUTLIER -67.82 135.28 52.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.316 0.579 . . . . 73.439999999999998 110.911 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 16.7 mt -90.71 132.19 35.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 124.445 3.293 . . . . 73.420000000000002 110.917 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -77.26 153.5 33.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 84.75 13.74 71.83 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.768 -0.73 . . . . 73.319999999999993 112.473 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -106.36 170.16 16.21 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.812 -0.709 . . . . 52.0 112.522 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -31.44 20.61 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.697 2.265 . . . . 75.5 112.31 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.908 ' HB1' HD12 ' A' ' 353' ' ' LEU . . . -61.96 -52.06 65.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.102 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.05 76.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.897 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 15.9 mt -56.12 -35.61 67.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 71.310000000000002 110.899 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.62 -35.62 22.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 73.340000000000003 110.88 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 72.99 55.15 6.53 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 70.329999999999998 112.472 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.47 -38.84 1.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.5 110.906 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.908 HD12 ' HB1' ' A' ' 347' ' ' ALA . 42.7 mt -69.79 125.22 26.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.913 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 13.7 mtt-85 -130.68 137.31 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.927 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.05 134.95 38.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 71.430000000000007 110.838 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 110.89 -28.97 9.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.788 -0.72 . . . . 41.200000000000003 112.515 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.75 ' CB ' HD12 ' A' ' 338' ' ' ILE . 89.2 m-20 -54.11 149.16 9.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.764 0.316 . . . . 54.109999999999999 110.862 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -113.58 145.65 40.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 110.941 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.563 HD11 HG12 ' A' ' 338' ' ' ILE . 47.6 mm -99.32 112.28 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 65.310000000000002 111.114 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.78 -36.46 12.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.934 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 1.2 m -159.28 159.31 33.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.18 -0.463 . . . . 73.140000000000001 110.766 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.758 HG21 HD12 ' A' ' 379' ' ' LEU . 3.9 p -138.56 115.14 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 70.400000000000006 111.181 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.5 m120 50.8 32.42 7.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.501 . . . . 75.010000000000005 110.896 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.59 -70.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.695 -0.764 . . . . 32.329999999999998 112.466 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 HG13 ' A' ' 362' ' ' VAL . 2.9 m -49.58 122.33 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.1 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -78.0 134.97 37.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 64.019999999999996 110.878 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.589 HD13 HG12 ' A' ' 362' ' ' VAL . 6.5 mp -113.17 34.04 4.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 71.319999999999993 110.922 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 60.7 mtm-85 -70.39 -35.02 73.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 72.510000000000005 110.931 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -125.21 28.32 6.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.129 -0.487 . . . . 74.530000000000001 110.89 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.534 ' HB1' ' HG3' ' A' ' 374' ' ' GLN . . . -94.13 129.34 40.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 70.319999999999993 111.149 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.3 t -59.69 177.04 0.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.834 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -63.14 -54.21 41.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 72.299999999999997 110.899 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.62 -33.63 66.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.832 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.534 ' HG3' ' HB1' ' A' ' 370' ' ' ALA . 28.9 tp60 -55.62 -43.03 75.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 72.25 110.879 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.12 74.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.108 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.56 -32.75 73.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 111.104 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 48.8 mt -58.45 -51.69 68.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.288 -0.414 . . . . 53.409999999999997 111.076 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.34 -41.0 73.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 52.25 111.138 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.758 HD12 HG21 ' A' ' 362' ' ' VAL . 1.5 tp -57.61 -36.99 72.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 74.040000000000006 110.897 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 24.2 ttpp -58.29 -35.65 72.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.899 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -102.54 18.21 21.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 71.530000000000001 110.813 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -54.4 -35.45 62.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 75.239999999999995 111.149 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 112.77 -134.87 12.25 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 61.509999999999998 112.482 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -113.2 27.45 9.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 74.340000000000003 110.947 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.34 128.89 4.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.169 -0.469 . . . . 62.43 111.123 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.07 110.99 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 111.182 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.626 HG22 ' HB3' ' A' ' 313' ' ' ARG . 0.4 OUTLIER -126.21 103.16 7.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 55.240000000000002 111.094 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.562 HG22 ' HB ' ' A' ' 362' ' ' VAL . 8.1 pt -118.94 141.47 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.161 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 13.2 mt -84.61 132.35 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.25 111.07 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -115.56 136.32 53.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 44.009999999999998 111.09 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -137.79 137.05 37.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.439 . . . . 75.0 110.974 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -53.54 111.98 0.82 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 64.439999999999998 110.875 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 21.7 mmmt -150.06 65.43 7.42 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.57 0.7 . . . . 75.019999999999996 110.908 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 -37.95 8.49 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.361 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.72 -48.04 67.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 61.240000000000002 110.924 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -61.5 -47.4 85.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.483 . . . . 54.140000000000001 110.93 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -69.93 -31.27 68.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 1.1 t -54.29 -25.21 22.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.138 -0.483 . . . . 61.039999999999999 110.82 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -59.56 -32.62 70.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 72.239999999999995 110.909 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -74.95 -47.8 27.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 75.530000000000001 110.836 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -86.78 105.22 16.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.909 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 111.029 179.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.878 0.371 . . . . 72.530000000000001 110.86 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 10.5 mt -137.65 166.15 24.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 51.520000000000003 110.884 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -173.77 -176.54 42.3 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 53.149999999999999 112.548 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.59 -175.37 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 71.230000000000004 110.844 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -140.38 66.31 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 110.91 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -119.95 -49.99 2.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 60.340000000000003 110.901 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 308' ' ' PRO . 48.6 mm -51.62 133.1 36.0 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.645 0.736 . . . . 74.430000000000007 111.129 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 307' ' ' ILE . 53.5 Cg_endo -69.73 -42.23 3.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.724 2.283 . . . . 72.420000000000002 112.358 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -80.55 86.68 5.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 52.100000000000001 110.826 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -51.36 143.9 17.47 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.611 0.72 . . . . 74.010000000000005 110.89 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 158.6 56.48 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.629 2.219 . . . . 75.019999999999996 112.42 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.41 137.78 19.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.431 . . . . 71.5 110.87 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -83.95 141.44 31.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 71.140000000000001 110.946 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 316' ' ' ILE . 10.4 tt -105.08 137.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 111.095 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 315' ' ' VAL . 4.4 p -97.8 117.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 44.240000000000002 111.157 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.677 HD11 HG23 ' A' ' 314' ' ' ILE . 2.0 mp -132.61 158.05 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 73.450000000000003 111.126 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.421 ' N ' HG22 ' A' ' 316' ' ' ILE . 1.8 t-80 -67.1 173.28 3.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.903 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -46.46 136.07 7.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.099999999999994 110.781 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -122.61 122.57 5.08 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.738 . . . . 74.239999999999995 112.491 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 13.2 p -95.01 -40.02 9.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.99 0.424 . . . . 74.129999999999995 110.875 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.8 p -131.98 3.17 4.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 70.019999999999996 111.132 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 50.05 31.88 18.98 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.76 -0.733 . . . . 65.430000000000007 112.471 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.45 HD21 HD13 ' A' ' 342' ' ' LEU . 9.6 tt -55.82 -30.53 61.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 64.239999999999995 110.92 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -49.52 -30.31 12.73 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 75.420000000000002 112.491 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -136.83 169.22 18.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.914 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -113.88 164.32 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.858 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.05 136.95 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 72.340000000000003 111.154 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.686 HG21 ' CE1' ' A' ' 397' ' ' TYR . 18.6 tt -130.97 149.67 33.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 73.099999999999994 111.075 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -158.46 -171.02 23.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.687 -0.768 . . . . 70.230000000000004 112.485 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.14 -134.96 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 41.310000000000002 112.506 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.85 144.55 28.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 71.409999999999997 110.872 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 51.23 30.58 5.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 54.549999999999997 110.895 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 55.8 44.53 86.99 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.694 -0.765 . . . . 62.039999999999999 112.52 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -55.9 -30.0 60.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 71.030000000000001 110.886 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . 0.427 ' C ' HD12 ' A' ' 336' ' ' ILE . . . 170.97 120.47 0.54 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 74.040000000000006 112.516 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.427 HD12 ' C ' ' A' ' 335' ' ' GLY . 1.8 mp -113.99 128.19 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.362 . . . . 73.129999999999995 111.107 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.513 ' O ' HG22 ' A' ' 328' ' ' ILE . 4.9 m-85 -137.81 155.95 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.892 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.78 HD12 ' HB2' ' A' ' 357' ' ' ASP . 58.1 mt -58.61 141.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 61.420000000000002 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 2.2 t -104.9 -65.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.478 . . . . 72.420000000000002 110.848 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -152.73 162.82 40.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.32 0.581 . . . . 73.439999999999998 110.909 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.45 HD13 HD21 ' A' ' 323' ' ' LEU . 13.0 mt -106.12 128.34 53.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 124.319 3.236 . . . . 73.420000000000002 110.917 169.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -63.44 142.86 58.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.109 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 95.45 -22.39 39.14 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 73.319999999999993 112.441 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -65.63 165.55 36.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.751 . . . . 52.0 112.484 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -46.24 1.29 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.648 2.232 . . . . 75.5 112.395 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -64.22 -35.3 80.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 111.116 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.48 -36.41 73.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 64.310000000000002 110.797 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 38.5 mt -56.51 -42.56 78.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 71.310000000000002 110.906 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 1.2 t -57.32 -44.75 84.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 110.881 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 74.93 41.53 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.701 -0.762 . . . . 70.329999999999998 112.492 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.455 ' HB3' HD12 ' A' ' 314' ' ' ILE . 0.5 OUTLIER -116.93 -53.41 2.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 74.5 110.879 -179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 338' ' ' ILE . 64.3 mt -70.75 126.69 30.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 71.340000000000003 110.924 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.6 mtt85 -148.85 164.28 34.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.906 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.19 138.74 25.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 71.430000000000007 110.841 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 102.46 -28.98 13.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 41.200000000000003 112.486 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.78 ' HB2' HD12 ' A' ' 338' ' ' ILE . 3.6 m-20 -64.39 148.92 49.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 54.109999999999999 110.785 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -106.19 143.67 33.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 63.450000000000003 110.892 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.92 HD12 HG21 ' A' ' 388' ' ' ILE . 31.7 mm -99.6 111.93 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 65.310000000000002 111.109 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.721 HD13 HG22 ' A' ' 389' ' ' ILE . 5.6 mp -91.82 -48.61 6.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.975 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.14 160.76 40.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.857 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.478 ' O ' HG13 ' A' ' 362' ' ' VAL . 3.7 p -138.55 109.04 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 70.400000000000006 111.151 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 51.84 30.81 7.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 75.010000000000005 110.935 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 119.18 -75.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.744 -0.741 . . . . 32.329999999999998 112.487 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.519 HG21 ' HB1' ' A' ' 378' ' ' ALA . 31.4 m -49.49 133.24 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.871 0.367 . . . . 64.420000000000002 111.133 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -81.89 143.18 31.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 64.019999999999996 110.896 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.584 HD12 HG21 ' A' ' 359' ' ' ILE . 80.1 mt -116.33 30.59 7.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 71.319999999999993 110.879 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -72.36 -48.9 38.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 110.849 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -113.54 27.79 9.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 74.530000000000001 110.945 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.72 35.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 70.319999999999993 111.096 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.0 p -57.33 172.78 0.29 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 110.853 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -59.21 -54.45 46.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 72.299999999999997 110.848 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -71.8 -33.56 68.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.86 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -55.35 -42.42 73.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 72.25 110.882 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.57 85.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.121 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -62.71 -33.29 74.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.142 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 50.8 mt -58.34 -52.11 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 53.409999999999997 111.178 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 365' ' ' VAL . . . -65.49 -35.47 80.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 52.25 111.166 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 379' ' ' LEU . 8.3 tp -63.49 -37.56 87.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.836 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -74.73 -37.37 62.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 110.857 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -93.92 18.55 10.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 71.530000000000001 110.893 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -51.0 -59.14 4.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 75.239999999999995 111.094 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 131.84 -135.29 8.1 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.767 -0.73 . . . . 61.509999999999998 112.46 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -97.75 -6.73 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.925 0.393 . . . . 74.340000000000003 110.883 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 7.2 m -141.81 138.41 32.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.183 -0.462 . . . . 62.43 111.115 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.509 ' O ' HD12 ' A' ' 316' ' ' ILE . 48.3 t -113.72 111.68 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 111.17 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.9 m -125.86 103.95 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 55.240000000000002 111.163 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.92 HG21 HD12 ' A' ' 359' ' ' ILE . 15.6 mt -116.31 141.7 32.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.430000000000007 111.072 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.721 HG22 HD13 ' A' ' 360' ' ' LEU . 12.8 mt -82.66 129.88 36.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 74.25 111.104 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.404 ' HB2' ' CD2' ' A' ' 353' ' ' LEU . . . -116.26 131.37 56.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 44.009999999999998 111.089 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -136.56 133.23 36.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -53.46 111.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.969 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -150.01 67.34 8.4 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 75.019999999999996 110.912 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 -38.17 7.96 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.638 2.226 . . . . 73.530000000000001 112.357 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.65 -41.15 79.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 61.240000000000002 110.959 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -61.96 -47.57 84.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 54.140000000000001 110.879 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.686 ' CE1' HG21 ' A' ' 328' ' ' ILE . 8.6 t80 -74.13 -32.27 63.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 75.239999999999995 110.892 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 28.0 t -54.51 -27.11 35.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 61.039999999999999 110.87 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -60.94 -32.6 72.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.077 -0.51 . . . . 72.239999999999995 110.863 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -71.46 -46.91 58.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 75.530000000000001 110.855 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -86.38 105.67 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.96 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.047 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.887 0.375 . . . . 72.530000000000001 110.878 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 3.0 tt -138.28 114.65 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 51.520000000000003 110.818 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.04 179.36 47.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 53.149999999999999 112.465 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -85.3 172.17 11.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.735 0.302 . . . . 71.230000000000004 110.899 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -153.02 -179.54 7.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 110.925 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -68.74 -34.3 75.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 60.340000000000003 110.908 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 25.9 mt 65.07 67.86 0.77 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 74.430000000000007 111.09 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 119.03 6.04 Favored 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.723 2.282 . . . . 72.420000000000002 112.359 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -111.27 69.19 0.68 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.163 -0.471 . . . . 52.100000000000001 110.818 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -51.15 160.92 0.79 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.618 0.723 . . . . 74.010000000000005 110.839 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 121.18 7.87 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.618 2.212 . . . . 75.019999999999996 112.288 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.59 167.14 23.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.5 110.877 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 387' ' ' THR . 5.2 mtt180 -117.36 141.94 47.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 71.140000000000001 110.84 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.91 118.17 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 111.145 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.8 118.89 34.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 44.240000000000002 111.125 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.9 pt -136.64 160.58 37.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 73.450000000000003 111.11 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -66.4 172.58 3.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 63.439999999999998 110.819 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 40.9 ttm-85 -46.5 122.68 4.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.171 -0.468 . . . . 71.099999999999994 110.92 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -92.76 55.09 2.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.757 -0.735 . . . . 74.239999999999995 112.538 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 77.4 p -90.43 11.13 22.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 74.129999999999995 110.86 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.3 m -117.32 27.05 9.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 70.019999999999996 111.146 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 103.97 144.11 13.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.718 . . . . 65.430000000000007 112.515 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.627 ' CD1' HD13 ' A' ' 379' ' ' LEU . 6.5 mt -71.0 -39.96 72.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 64.239999999999995 110.951 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 82.15 25.78 50.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 75.420000000000002 112.495 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.508 ' HD2' ' HB2' ' A' ' 347' ' ' ALA . 31.0 p90 -167.51 168.71 12.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.88 0.371 . . . . 75.109999999999999 110.902 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -119.87 136.7 54.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 72.140000000000001 110.881 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.578 HD11 HG12 ' A' ' 336' ' ' ILE . 18.3 tt -116.15 144.76 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 72.340000000000003 111.219 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.696 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.7 pp -126.73 152.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 111.129 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.75 -158.85 9.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.799 -0.715 . . . . 70.230000000000004 112.476 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -139.09 -140.04 3.9 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.739 -0.744 . . . . 41.310000000000002 112.517 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -99.88 146.23 26.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.783 0.325 . . . . 71.409999999999997 110.94 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 50.46 31.3 5.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 54.549999999999997 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 54.96 45.38 81.24 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.68 -0.772 . . . . 62.039999999999999 112.487 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -62.75 -30.11 71.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.876 0.369 . . . . 71.030000000000001 110.863 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 178.33 105.91 0.2 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.705 -0.76 . . . . 74.040000000000006 112.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.578 HG12 HD11 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -106.3 125.29 62.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 111.114 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . 0.417 ' HB2' HD11 ' A' ' 328' ' ' ILE . 27.0 m-85 -138.78 169.06 18.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.430000000000007 110.889 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.489 HD11 HD11 ' A' ' 359' ' ' ILE . 39.9 mm -74.73 147.88 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 61.420000000000002 111.13 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.24 -54.63 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.821 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -161.91 167.39 24.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.26 0.552 . . . . 73.439999999999998 110.897 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 22.0 mt -95.54 138.78 32.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 124.386 3.266 . . . . 73.420000000000002 110.955 169.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.94 155.35 32.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 111.107 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 80.02 14.14 81.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 73.319999999999993 112.51 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -123.41 179.96 15.97 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.693 -0.765 . . . . 52.0 112.44 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 -33.84 16.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.703 2.269 . . . . 75.5 112.357 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -54.33 -51.32 65.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.209999999999994 111.069 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -70.59 -36.29 73.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.828 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.15 -54.09 50.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.922 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.04 -34.77 72.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 65.49 43.7 94.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 70.329999999999998 112.516 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -128.14 -53.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 74.5 110.838 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.426 HD23 ' HB2' ' A' ' 390' ' ' ALA . 18.6 mt -74.47 118.08 17.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.87 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.19 169.91 16.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.49 . . . . 74.120000000000005 110.879 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.76 139.27 39.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 71.430000000000007 110.93 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 99.08 -28.98 12.76 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.789 -0.72 . . . . 41.200000000000003 112.468 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -63.83 148.92 48.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.724 0.297 . . . . 54.109999999999999 110.874 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -113.91 139.92 48.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 63.450000000000003 110.929 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 327' ' ' ILE . 27.8 mt -99.79 117.52 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.164 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 58.1 mt -92.18 -35.56 13.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.907 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . 0.652 ' OG ' HD12 ' A' ' 389' ' ' ILE . 0.0 OUTLIER -154.47 158.23 39.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.808 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.733 HG13 ' CG1' ' A' ' 388' ' ' ILE . 1.6 t -138.24 108.77 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 70.400000000000006 111.151 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 5.3 t30 50.95 34.02 9.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 75.010000000000005 110.931 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 115.48 -71.84 0.25 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.734 -0.746 . . . . 32.329999999999998 112.455 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 5.6 m -49.79 126.74 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 64.420000000000002 111.173 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -76.21 143.48 41.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 64.019999999999996 110.887 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.994 HD13 ' HB3' ' A' ' 370' ' ' ALA . 0.8 OUTLIER -114.18 25.5 11.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.898 -179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -73.13 -35.64 66.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.510000000000005 110.86 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -125.57 28.6 6.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 110.809 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . 0.994 ' HB3' HD13 ' A' ' 367' ' ' LEU . . . -91.58 127.84 37.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 70.319999999999993 111.135 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.0 t -65.08 177.24 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 64.129999999999995 110.872 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.27 -54.55 44.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 110.877 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.15 -34.79 71.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -55.49 -42.37 74.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 72.25 110.849 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -58.18 -42.79 86.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.240000000000002 111.073 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.65 ' HA ' HD12 ' A' ' 379' ' ' LEU . . . -60.36 -34.37 73.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 111.122 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.62 -42.12 84.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.409999999999997 111.207 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.21 74.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 52.25 111.123 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.65 HD12 ' HA ' ' A' ' 376' ' ' ALA . 71.2 mt -57.3 -44.77 84.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 74.040000000000006 110.899 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -67.79 -35.36 78.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 110.924 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.67 18.3 11.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 71.530000000000001 110.87 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -55.22 -59.06 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 111.107 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 122.05 -135.39 10.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.721 -0.752 . . . . 61.509999999999998 112.444 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -108.16 21.33 17.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 74.340000000000003 110.931 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 20.5 m -161.53 126.61 3.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 62.43 111.127 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' A' ' 316' ' ' ILE . 96.8 t -102.77 111.62 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.125 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 313' ' ' ARG . 16.6 m -121.33 103.95 9.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.240000000000002 111.101 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.733 ' CG1' HG13 ' A' ' 362' ' ' VAL . 15.7 mt -119.27 137.0 54.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.25 -0.432 . . . . 72.430000000000007 111.109 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.652 HD12 ' OG ' ' A' ' 361' ' ' SER . 96.6 mt -88.51 121.62 38.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 74.25 111.136 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.426 ' HB2' HD23 ' A' ' 353' ' ' LEU . . . -115.6 129.95 56.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 44.009999999999998 111.086 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -140.4 141.23 35.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.0 110.953 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -53.48 111.99 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 64.439999999999998 110.937 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -149.99 66.36 7.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.535 0.683 . . . . 75.019999999999996 110.933 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -32.83 18.09 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.738 2.292 . . . . 73.530000000000001 112.343 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -70.25 -44.01 69.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 61.240000000000002 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -61.78 -45.06 95.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 54.140000000000001 110.917 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -75.11 -31.67 61.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 110.969 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.9 t -54.18 -25.49 22.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.101 -0.5 . . . . 61.039999999999999 110.834 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -60.23 -32.55 71.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.851 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . 0.432 ' CD2' HD13 ' A' ' 328' ' ' ILE . 14.6 m-85 -73.63 -47.84 37.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 75.530000000000001 110.887 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -86.63 105.49 16.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.884 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.340000000000003 111.065 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.879 0.371 . . . . 72.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 153.51 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 51.520000000000003 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -52.76 128.51 36.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.826 -0.702 . . . . 53.149999999999999 112.534 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -138.97 -177.89 5.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 71.230000000000004 110.902 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -108.12 -178.14 3.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 74.140000000000001 110.895 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.75 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 60.340000000000003 110.853 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . . . . . . . . . 8.9 pt -153.34 73.57 6.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 74.430000000000007 111.079 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 156.61 62.92 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.761 2.307 . . . . 72.420000000000002 112.388 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -126.2 106.89 9.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 52.100000000000001 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -85.7 160.17 53.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.654 0.74 . . . . 74.010000000000005 110.882 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 131.95 22.34 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.724 2.283 . . . . 75.019999999999996 112.256 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.43 167.08 28.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 71.5 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -107.26 141.95 37.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.876 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 390' ' ' ALA . 5.4 mp -105.06 118.63 52.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 73.329999999999998 111.152 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 315' ' ' VAL . 5.9 p -94.06 120.54 43.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 44.240000000000002 111.147 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.597 HD11 ' HB ' ' A' ' 386' ' ' VAL . 9.5 pt -138.11 160.2 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 73.450000000000003 111.144 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.63 172.72 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 63.439999999999998 110.883 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -47.78 119.81 3.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 71.099999999999994 110.855 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.6 48.88 3.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.751 . . . . 74.239999999999995 112.481 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 41.2 t -94.93 10.98 33.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.384 . . . . 74.129999999999995 110.808 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.8 m -115.35 26.97 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.019999999999996 111.149 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 105.74 107.18 3.19 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.664 -0.779 . . . . 65.430000000000007 112.451 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.58 HD12 ' O ' ' A' ' 325' ' ' PHE . 0.0 OUTLIER -50.78 -48.23 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 64.239999999999995 110.902 -179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . 72.77 36.32 58.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.792 -0.718 . . . . 75.420000000000002 112.464 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.58 ' O ' HD12 ' A' ' 323' ' ' LEU . 12.6 p90 -166.88 169.67 12.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.891 0.377 . . . . 75.109999999999999 110.831 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -130.41 161.11 32.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 110.916 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . 0.81 HG12 HD11 ' A' ' 336' ' ' ILE . 4.2 tt -134.3 131.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.340000000000003 111.135 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 20.6 tt -121.31 137.84 53.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 73.099999999999994 111.114 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . 0.645 ' HA3' HD12 ' A' ' 336' ' ' ILE . . . -147.39 -168.95 14.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.776 -0.726 . . . . 70.230000000000004 112.457 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.45 -139.64 4.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.75 . . . . 41.310000000000002 112.482 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -97.14 150.45 20.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.919 0.39 . . . . 71.409999999999997 110.84 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 41.08 38.31 0.69 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 54.549999999999997 110.824 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 50.3 51.08 32.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.732 -0.747 . . . . 62.039999999999999 112.483 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -66.29 -23.98 66.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.842 0.353 . . . . 71.030000000000001 110.855 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 168.19 93.14 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.758 -0.734 . . . . 74.040000000000006 112.485 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.81 HD11 HG12 ' A' ' 327' ' ' ILE . 0.9 OUTLIER -96.36 124.89 49.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.347 . . . . 73.129999999999995 111.159 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -138.05 167.87 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 72.430000000000007 110.875 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.825 HD12 ' HB2' ' A' ' 357' ' ' ASP . 46.0 mt -70.74 147.94 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 61.420000000000002 111.106 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 1.9 t -100.1 -75.12 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 110.804 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -150.5 166.73 29.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.296 0.57 . . . . 73.439999999999998 110.892 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 24.5 mt -108.24 129.41 55.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 124.377 3.262 . . . . 73.420000000000002 110.93 169.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -51.89 149.0 5.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 72.120000000000005 111.102 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 78.09 14.3 82.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 73.319999999999993 112.447 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -109.86 167.0 12.61 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 52.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -32.75 17.77 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.694 2.263 . . . . 75.5 112.311 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -56.05 -50.95 69.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.209999999999994 111.136 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -66.22 -46.22 77.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 64.310000000000002 110.847 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.88 -45.26 82.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 71.310000000000002 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 2.5 t -61.09 -36.34 79.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 110.897 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 70.77 33.31 66.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 70.329999999999998 112.509 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.64 -42.98 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.907 0.384 . . . . 74.5 110.847 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.696 HD21 HD11 ' A' ' 388' ' ' ILE . 15.5 mt -97.16 114.64 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.914 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -148.08 173.68 12.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.120000000000005 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.44 139.29 49.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.959 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 104.17 -29.26 12.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.74 . . . . 41.200000000000003 112.433 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.825 ' HB2' HD12 ' A' ' 338' ' ' ILE . 13.1 m-20 -64.13 148.65 49.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 54.109999999999999 110.855 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.71 126.05 54.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 63.450000000000003 110.908 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.641 HG22 HD12 ' A' ' 367' ' ' LEU . 31.6 mm -86.1 125.99 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 65.310000000000002 111.145 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.757 HD13 ' CG2' ' A' ' 389' ' ' ILE . 5.3 mp -103.44 -34.96 8.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 110.919 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.94 156.72 36.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 73.140000000000001 110.823 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.637 ' CG1' HD11 ' A' ' 367' ' ' LEU . 4.7 m -135.74 126.71 43.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.136 -0.484 . . . . 70.400000000000006 111.106 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 43.84 35.81 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 75.010000000000005 110.904 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 108.48 -73.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.74 -0.743 . . . . 32.329999999999998 112.456 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.14 129.5 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 64.420000000000002 111.149 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -83.41 140.95 32.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.871 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 359' ' ' ILE . 11.5 mt -104.66 36.19 2.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 71.319999999999993 110.847 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -69.62 -37.01 76.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.228 -0.442 . . . . 72.510000000000005 110.878 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -129.65 27.64 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.530000000000001 110.841 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -95.23 128.76 42.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 70.319999999999993 111.119 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 23.1 t -60.3 177.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 64.129999999999995 110.898 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 21.6 t-160 -60.03 -54.48 45.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 72.299999999999997 110.863 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -67.0 -32.47 73.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 74.209999999999994 110.864 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -55.06 -44.3 74.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.895 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.72 -36.68 74.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 54.240000000000002 111.1 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -66.57 -32.9 74.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.09 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 49.0 mt -58.22 -42.08 82.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 53.409999999999997 111.173 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.49 72.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 52.25 111.068 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 38.2 mt -58.42 -45.04 89.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.919 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -58.38 -35.69 72.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 72.120000000000005 110.922 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -99.11 18.05 18.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.829 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -53.24 -58.84 5.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 75.239999999999995 111.096 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 115.48 -135.05 11.93 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.729 -0.748 . . . . 61.509999999999998 112.463 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -107.82 24.34 13.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.911 0.386 . . . . 74.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 13.0 m -161.71 125.08 3.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.153 -0.476 . . . . 62.43 111.116 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 316' ' ' ILE . 21.2 t -101.85 112.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.278 -0.419 . . . . 71.420000000000002 111.115 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 2.0 m -121.87 104.36 9.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 55.240000000000002 111.11 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.696 HD11 HD21 ' A' ' 353' ' ' LEU . 0.2 OUTLIER -132.69 143.27 40.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 111.152 179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.757 ' CG2' HD13 ' A' ' 360' ' ' LEU . 12.5 mt -81.56 119.06 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.129 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.477 ' HB1' ' OD2' ' A' ' 357' ' ' ASP . . . -115.23 137.31 52.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 44.009999999999998 111.139 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -150.27 133.51 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.0 110.909 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -53.75 112.55 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 64.439999999999998 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 27.7 tptt -150.03 68.14 8.69 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.607 0.717 . . . . 75.019999999999996 110.866 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -31.31 20.77 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 73.530000000000001 112.308 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -65.45 -48.18 73.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.888 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.08 -47.49 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 54.140000000000001 110.849 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -65.48 -32.07 73.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 110.936 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 6.4 t -54.7 -25.34 26.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 61.039999999999999 110.839 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.0 ptt85 -60.05 -32.61 71.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.877 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -73.45 -47.81 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 75.530000000000001 110.87 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -86.57 105.43 16.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.917 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 20.4 p90 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.856 0.36 . . . . 72.530000000000001 110.94 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.67 -74.43 0.52 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 51.520000000000003 110.937 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -176.35 -176.72 44.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 53.149999999999999 112.501 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -126.17 -174.7 3.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 71.230000000000004 110.883 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . 0.602 ' HB3' HG22 ' A' ' 307' ' ' ILE . 4.4 tp10 -165.77 166.84 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -51.86 -35.22 44.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.135 -0.484 . . . . 60.340000000000003 110.921 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 305' ' ' GLU . 2.8 tp -51.4 131.49 34.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.606 0.717 . . . . 74.430000000000007 111.154 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.85 -39.67 6.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.666 2.244 . . . . 72.420000000000002 112.326 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -92.12 44.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 52.100000000000001 110.887 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.42 153.69 13.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.64 0.733 . . . . 74.010000000000005 110.894 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . 0.419 ' HB3' HD12 ' A' ' 360' ' ' LEU . 53.4 Cg_endo -69.84 127.26 14.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.676 2.25 . . . . 75.019999999999996 112.26 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.73 144.32 43.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 71.5 110.925 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . 0.658 ' HA ' HD13 ' A' ' 389' ' ' ILE . 0.1 OUTLIER -76.27 141.52 41.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 71.140000000000001 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.725 HD13 ' HB3' ' A' ' 352' ' ' GLU . 38.9 mt -116.81 134.61 59.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 111.166 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.4 p -79.36 118.86 27.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 44.240000000000002 111.156 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.726 HD13 ' O ' ' A' ' 315' ' ' VAL . 12.4 mm -130.54 158.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 111.068 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . 0.413 ' N ' HG22 ' A' ' 316' ' ' ILE . 17.1 m-70 -66.86 173.15 3.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 63.439999999999998 110.868 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -44.74 122.85 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 71.099999999999994 110.915 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.42 -28.2 19.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.742 -0.742 . . . . 74.239999999999995 112.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 2.8 t -52.2 -35.59 49.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.388 . . . . 74.129999999999995 110.866 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 1.1 m -103.13 26.97 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 70.019999999999996 111.131 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -93.62 32.54 5.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.509 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.87 -26.6 59.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.812 0.339 . . . . 64.239999999999995 110.886 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . . . . . . . . . . . -48.84 -40.68 26.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.787 -0.721 . . . . 75.420000000000002 112.453 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.419 ' CE1' HD21 ' A' ' 379' ' ' LEU . 28.1 p90 -98.97 158.81 15.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.338 . . . . 75.109999999999999 110.934 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -119.55 166.74 12.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.3 144.01 37.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 111.148 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . . . . . . . . . 17.3 tt -131.36 138.73 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.099999999999994 111.085 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -150.28 -176.94 23.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.729 -0.748 . . . . 70.230000000000004 112.521 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -115.13 -139.83 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.728 -0.748 . . . . 41.310000000000002 112.535 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.89 144.9 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.778 0.323 . . . . 71.409999999999997 110.888 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 51.31 30.35 5.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.188 -0.46 . . . . 54.549999999999997 110.87 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 58.13 49.89 71.3 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.681 -0.771 . . . . 62.039999999999999 112.518 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -63.75 -30.03 71.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.897 0.379 . . . . 71.030000000000001 110.881 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 170.91 104.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.809 -0.71 . . . . 74.040000000000006 112.516 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.401 ' O ' HG23 ' A' ' 336' ' ' ILE . 0.5 OUTLIER -101.59 128.02 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 111.153 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -136.49 167.43 21.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.92 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 359' ' ' ILE . 37.3 mm -63.23 140.6 19.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.116 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -61.83 1.32 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.869 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -161.81 167.66 24.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.235 0.541 . . . . 73.439999999999998 110.914 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . . . . . . . . . 96.4 mt -108.58 156.27 19.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 124.401 3.273 . . . . 73.420000000000002 110.888 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -70.69 140.04 51.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 72.120000000000005 111.12 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 91.0 -19.82 43.63 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.764 -0.731 . . . . 73.319999999999993 112.498 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -70.3 172.03 42.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.777 -0.725 . . . . 52.0 112.492 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . 0.417 ' HA ' HD21 ' A' ' 349' ' ' LEU . 53.6 Cg_endo -69.8 -30.75 21.59 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.695 2.264 . . . . 75.5 112.309 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -70.06 -36.01 74.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 111.064 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -54.44 35.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.310000000000002 110.912 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 350' ' ' SER . 3.6 pp -62.05 -35.4 78.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 71.310000000000002 110.909 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . 0.588 ' N ' HD12 ' A' ' 349' ' ' LEU . 57.4 m -61.25 -36.0 78.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.340000000000003 110.859 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 59.19 37.02 91.18 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 70.329999999999998 112.507 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.725 ' HB3' HD13 ' A' ' 314' ' ' ILE . 17.9 mm-40 -128.56 -53.61 1.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 74.5 110.916 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.47 125.22 28.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 71.340000000000003 110.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -148.42 163.53 36.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 74.120000000000005 110.937 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.84 135.21 30.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 71.430000000000007 110.923 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 103.44 -29.09 13.01 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 41.200000000000003 112.427 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 139.23 58.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.737 0.303 . . . . 54.109999999999999 110.856 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -104.6 143.67 32.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.478 . . . . 63.450000000000003 110.912 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . 0.995 HD11 HD11 ' A' ' 338' ' ' ILE . 38.2 mm -99.01 126.33 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 65.310000000000002 111.07 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 311' ' ' PRO . 14.1 mt -98.77 -43.11 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 64.329999999999998 110.98 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 2.3 m -161.4 160.78 29.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 110.901 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 388' ' ' ILE . 17.8 m -138.14 125.65 28.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 70.400000000000006 111.061 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.611 ' HB3' HG13 ' A' ' 386' ' ' VAL . 5.0 p-10 43.54 34.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.463 . . . . 75.010000000000005 110.919 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 109.99 -71.43 0.21 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.727 -0.749 . . . . 32.329999999999998 112.454 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.43 HG23 HG23 ' A' ' 362' ' ' VAL . 6.7 m -48.31 125.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.86 0.362 . . . . 64.420000000000002 111.103 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -83.92 131.84 34.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 64.019999999999996 110.81 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.51 HD12 HG21 ' A' ' 359' ' ' ILE . 41.4 mt -103.17 30.38 4.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.901 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -72.36 -34.1 67.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 72.510000000000005 110.888 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -120.28 28.23 8.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.878 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -93.57 128.42 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 111.113 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.8 p -58.53 175.14 0.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 110.839 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -62.19 -54.46 40.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 72.299999999999997 110.846 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -71.58 -33.74 69.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.823 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -55.08 -43.57 74.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 72.25 110.912 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -58.87 -35.54 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 54.240000000000002 111.072 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.15 76.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 111.092 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 40.9 mt -58.59 -46.72 89.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 53.409999999999997 111.09 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.66 72.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 52.25 111.115 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.419 HD21 ' CE1' ' A' ' 325' ' ' PHE . 1.3 tp -62.19 -39.14 91.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 74.040000000000006 110.906 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -68.87 -35.1 76.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 72.120000000000005 110.921 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -100.78 19.01 17.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 71.530000000000001 110.916 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . 0.706 ' HB1' HG21 ' A' ' 386' ' ' VAL . . . -50.12 -59.29 4.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.137 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 128.27 -135.36 8.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 61.509999999999998 112.421 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.18 -26.14 14.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.818 0.342 . . . . 74.340000000000003 110.881 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.83 114.98 2.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 62.43 111.152 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . 0.706 HG21 ' HB1' ' A' ' 382' ' ' ALA . 30.5 t -119.17 126.9 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 71.420000000000002 111.149 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.82 114.31 21.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 55.240000000000002 111.138 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.692 ' CG2' HD12 ' A' ' 359' ' ' ILE . 6.8 mt -102.89 133.69 45.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 72.430000000000007 111.148 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' A' ' 313' ' ' ARG . 48.7 mm -86.2 126.2 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 74.25 111.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.5 ' HB3' HD11 ' A' ' 314' ' ' ILE . . . -116.14 129.77 56.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 44.009999999999998 111.086 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -136.73 141.18 43.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 75.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -66.69 111.29 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.234 -0.439 . . . . 64.439999999999998 110.944 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -149.92 66.56 8.11 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.524 0.678 . . . . 75.019999999999996 110.936 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -31.65 19.97 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.394 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -66.98 -35.29 79.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 61.240000000000002 110.9 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -75.4 -48.06 24.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 54.140000000000001 110.878 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -68.64 -30.06 68.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.239999999999995 110.908 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 5.3 t -53.12 -26.07 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 61.039999999999999 110.856 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -64.19 -34.65 78.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 72.239999999999995 110.855 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -71.17 -38.24 72.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 110.845 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -87.58 104.63 16.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.886 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.340000000000003 111.118 179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.932 0.396 . . . . 72.530000000000001 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.39 64.48 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 51.520000000000003 110.904 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLY . . . . . . . . . . . . . . . -94.53 99.23 2.42 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 53.149999999999999 112.476 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -141.53 141.98 33.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.791 0.329 . . . . 71.230000000000004 111.003 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.84 116.57 7.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.829 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 307' ' ' ILE . 0.1 OUTLIER -120.91 -74.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.124 -0.489 . . . . 60.340000000000003 110.927 179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 306' ' ' ASP . 1.1 tt 35.28 79.67 0.29 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.576 0.703 . . . . 74.430000000000007 111.137 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 161.75 44.7 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 72.420000000000002 112.385 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -117.8 45.54 1.93 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 52.100000000000001 110.897 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.45 160.5 82.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.624 0.725 . . . . 74.010000000000005 110.936 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 158.61 56.39 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.696 2.264 . . . . 75.019999999999996 112.37 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -147.82 129.7 15.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 71.5 110.831 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -98.65 136.67 38.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 71.140000000000001 110.805 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 388' ' ' ILE . 10.5 tp -112.41 134.14 55.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 73.329999999999998 111.102 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.639 ' O ' HD13 ' A' ' 316' ' ' ILE . 5.2 p -106.01 119.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.240000000000002 111.149 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ILE . . . . . 0.639 HD13 ' O ' ' A' ' 315' ' ' VAL . 24.3 mm -135.55 150.93 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 111.105 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -67.5 173.21 4.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 63.439999999999998 110.895 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -46.22 119.81 2.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 110.891 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -136.98 34.53 2.19 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.76 . . . . 74.239999999999995 112.483 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . . . . . . . . . 4.5 t -58.86 -35.14 72.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.971 0.415 . . . . 74.129999999999995 110.891 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 38.0 p -102.19 27.07 6.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 70.019999999999996 111.166 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -174.48 105.37 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.815 -0.707 . . . . 65.430000000000007 112.581 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 379' ' ' LEU . 11.0 mp -93.02 -46.84 7.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.909 0.385 . . . . 64.239999999999995 110.895 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 342' ' ' LEU . . . 76.82 27.24 61.01 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.744 -0.741 . . . . 75.420000000000002 112.457 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' PHE . . . . . 0.486 ' CE1' HD23 ' A' ' 323' ' ' LEU . 5.8 p90 -167.39 169.27 12.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.897 0.379 . . . . 75.109999999999999 110.922 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -123.32 138.41 54.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.889 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.07 131.4 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 72.340000000000003 111.116 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ILE . . . . . 0.57 ' O ' HD12 ' A' ' 328' ' ' ILE . 2.8 pp -125.5 144.93 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.112 -0.495 . . . . 73.099999999999994 111.095 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -169.86 -153.1 8.35 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 70.230000000000004 112.521 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -134.52 -139.99 4.19 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.743 -0.742 . . . . 41.310000000000002 112.467 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -100.03 152.43 20.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 71.409999999999997 110.917 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 55.25 31.55 16.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 54.549999999999997 110.908 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' GLY . . . . . . . . . . . . . . . 51.21 44.24 51.62 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.776 -0.726 . . . . 62.039999999999999 112.475 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -55.6 -25.41 38.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 71.030000000000001 110.868 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLY . . . . . . . . . . . . . . . 162.76 86.68 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.686 -0.769 . . . . 74.040000000000006 112.462 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 336' ' ' ILE . 1.4 tt -91.85 124.48 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 73.129999999999995 111.154 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -137.31 168.41 19.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.87 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 357' ' ' ASP . 5.2 mp -73.7 135.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.125 -0.488 . . . . 61.420000000000002 111.161 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.16 -37.01 8.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.420000000000002 110.86 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -162.11 167.47 24.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.302 0.573 . . . . 73.439999999999998 110.934 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' AZH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.547 HD12 ' HA2' ' A' ' 324' ' ' GLY . 46.2 mt -108.31 142.93 37.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 124.476 3.307 . . . . 73.420000000000002 110.932 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -76.72 139.13 40.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.120000000000005 111.083 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.36 85.4 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 73.319999999999993 112.532 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLY . . . . . . . . . . . . . . . -101.56 -173.73 28.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.792 -0.718 . . . . 52.0 112.466 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -34.2 14.82 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.639 2.226 . . . . 75.5 112.364 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 325' ' ' PHE . . . -69.04 -50.95 44.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.209999999999994 111.11 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.54 -44.63 86.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.817 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 21.0 mt -58.87 -49.05 79.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 71.310000000000002 110.931 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' SER . . . . . . . . . . . . . 66.5 p -57.67 -36.11 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 73.340000000000003 110.872 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 71.0 36.33 64.56 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.677 -0.773 . . . . 70.329999999999998 112.463 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -128.57 -52.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.953 0.406 . . . . 74.5 110.943 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 388' ' ' ILE . 21.1 mt -75.26 115.07 14.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 71.340000000000003 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 17.6 ttp85 -148.82 174.18 12.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 110.875 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -53.06 134.23 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.47 9.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.779 -0.724 . . . . 41.200000000000003 112.478 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ASP . . . . . 0.586 ' HB2' HD13 ' A' ' 338' ' ' ILE . 69.3 m-20 -63.75 149.07 47.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 54.109999999999999 110.901 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -116.12 142.43 46.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 63.450000000000003 110.857 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 36.2 mm -91.67 126.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.310000000000002 111.183 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 15.6 mt -113.35 -42.0 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 64.329999999999998 110.901 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' SER . . . . . . . . . . . . . 8.0 t -154.48 160.38 41.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.918 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.672 HG22 HG22 ' A' ' 388' ' ' ILE . 4.2 t -138.36 108.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 70.400000000000006 111.151 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 14.5 t30 57.03 31.87 20.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 110.926 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' GLY . . . . . . . . . . . . . . . 114.72 -67.82 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.779 -0.724 . . . . 32.329999999999998 112.495 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 3.5 m -51.83 123.08 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 111.134 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -81.26 125.81 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 64.019999999999996 110.938 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.633 HD22 ' CG2' ' A' ' 362' ' ' VAL . 7.4 mp -101.62 29.71 4.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.913 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.51 -34.12 77.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.855 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.47 28.58 7.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.85 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ALA . . . . . . . . . . . . . . . -91.45 130.17 37.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 111.085 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.99 177.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.851 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 16.1 t-160 -60.02 -55.34 35.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 110.888 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -73.42 -35.68 65.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.455 . . . . 74.209999999999994 110.886 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -55.02 -33.96 63.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.25 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ALA . . . . . . . . . . . . . . . -62.53 -48.78 78.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 54.240000000000002 111.081 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.8 68.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.13 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' ILE . . . . . . . . . . . . . 1.2 mp -70.81 -38.19 71.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 53.409999999999997 111.119 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.459 ' CB ' HD11 ' A' ' 367' ' ' LEU . . . -64.35 -49.24 72.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 52.25 111.097 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . 0.603 HD21 HD21 ' A' ' 323' ' ' LEU . 1.2 pp -69.13 -32.31 71.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.474 . . . . 74.040000000000006 110.907 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 31.1 mtmt -66.52 -36.01 81.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.895 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -95.35 18.37 12.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.877 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ALA . . . . . . . . . . . . . . . -65.81 -56.19 13.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 75.239999999999995 111.05 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 133.2 -141.1 12.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 61.509999999999998 112.472 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -95.69 26.14 4.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.881 0.372 . . . . 74.340000000000003 110.953 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.3 m -162.89 109.15 1.18 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 62.43 111.152 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' VAL . . . . . . . . . . . . . 57.3 t -97.67 111.56 27.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.327 -0.397 . . . . 71.420000000000002 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 314' ' ' ILE . 98.7 m -121.24 103.12 8.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 55.240000000000002 111.147 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.73 ' O ' HG22 ' A' ' 314' ' ' ILE . 18.9 pt -108.34 140.91 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 72.430000000000007 111.076 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.02 122.61 43.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.141 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.473 ' HB1' ' CG ' ' A' ' 357' ' ' ASP . . . -115.67 129.78 56.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 44.009999999999998 111.139 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -129.0 133.87 47.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 75.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.31 110.13 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 64.439999999999998 110.902 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 7.3 tptm -150.07 65.31 7.35 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.581 0.705 . . . . 75.019999999999996 110.948 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -32.8 17.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 73.530000000000001 112.371 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.75 -37.09 85.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 61.240000000000002 110.873 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -76.56 -47.84 21.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 54.140000000000001 110.955 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -65.97 -32.37 73.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.927 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' SER . . . . . . . . . . . . . 11.8 t -55.37 -25.26 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 61.039999999999999 110.915 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -60.04 -33.52 72.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 110.863 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' PHE . . . . . 0.505 ' CG ' HD13 ' A' ' 328' ' ' ILE . 21.8 m-85 -80.44 -48.22 13.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.873 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.67 104.19 16.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.857 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 74.340000000000003 111.083 179.965 . . . . . . . . 0 0 . 1 stop_ save_